


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:51:37Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12404895" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12404895</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>ijmm</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Med</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Med</journal-id><journal-id journal-id-type="pmc-domain-id">1936</journal-id><journal-id journal-id-type="pmc-domain">ijmm</journal-id><journal-id journal-id-type="publisher-id">IJMM</journal-id><journal-title-group><journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group><issn pub-type="ppub">1107-3756</issn><issn pub-type="epub">1791-244X</issn><publisher><publisher-name>Spandidos Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12404895</article-id><article-id pub-id-type="pmcid-ver">PMC12404895.1</article-id><article-id pub-id-type="pmcaid">12404895</article-id><article-id pub-id-type="pmcaiid">12404895</article-id><article-id pub-id-type="pmid">40849807</article-id><article-id pub-id-type="doi">10.3892/ijmm.2025.5613</article-id><article-id pub-id-type="publisher-id">ijmm-56-05-05613</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Copper homeostasis and cuproptosis in Alzheimer's disease (Review)</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Cong</surname><given-names initials="C">Chao</given-names></name><xref rid="af1-ijmm-56-05-05613" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cong</surname><given-names initials="H">He</given-names></name><xref rid="af2-ijmm-56-05-05613" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yao</surname><given-names initials="Y">Yuan</given-names></name><xref rid="af1-ijmm-56-05-05613" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bai</surname><given-names initials="Y">Yuquan</given-names></name><xref rid="af1-ijmm-56-05-05613" ref-type="aff">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Xu</surname><given-names initials="L">Lianwei</given-names></name><xref rid="af1-ijmm-56-05-05613" ref-type="aff">1</xref><xref rid="c1-ijmm-56-05-05613" ref-type="corresp"/></contrib></contrib-group><aff id="af1-ijmm-56-05-05613">
<label>1</label>Department of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, P.R. China;</aff><aff id="af2-ijmm-56-05-05613">
<label>2</label>Department of General Traditional Chinese Medicine, Nanshan Hospital, First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Shenzhen, Guangdong 518052, P.R. China</aff><author-notes><corresp id="c1-ijmm-56-05-05613">Correspondence to: Professor Lianwei Xu, Department of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 725 Wanping South Road, Xuhui, Shanghai 200032, P.R. China, E-mail: <email>doctorsherryxlw@163.com</email></corresp></author-notes><pub-date pub-type="collection"><month>11</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>21</day><month>8</month><year>2025</year></pub-date><volume>56</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">495445</issue-id><elocation-id>172</elocation-id><history><date date-type="received"><day>08</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>25</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>21</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright: &#169; 2025 Cong et al.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="ijmm-56-05-05613.pdf"/><abstract><p>Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by neuroinflammation, synaptic dysfunction and neuronal loss. Research has revealed a connection between copper metabolism and the pathophysiology of AD, particularly through a newly identified form of copper-dependent cell death referred to as cuproptosis. Cuproptosis is driven by the aggregation of lipoylated proteins and proteotoxic stress caused by excessive copper accumulation, leading to cellular demise, which is a key event in AD. While studies on copper levels in the brain in AD remain inconclusive, there is mounting evidence suggesting that an imbalance in copper homeostasis, particularly elevated labile copper levels, contributes to oxidative damage and neurodegeneration in patients with AD. The present review examines the role of cuproptosis in AD and discusses how targeting this pathway may provide novel therapeutic opportunities. By investigating the underlying mechanisms and potential clinical implications, the present review highlights that regulation of cuproptosis provides a promising approach for modulating disease progression and developing personalized treatment strategies for AD.</p></abstract><kwd-group><title>Key words</title><kwd>cuproptosis</kwd><kwd>Alzheimer's disease</kwd><kwd>neuroinflammation</kwd></kwd-group><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>82305290</award-id></award-group><funding-statement>The present study received funding from the National Natural Science Foundation of China (grant no. 82305290).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><label>1.</label><title>Introduction</title><p>Copper is a redox-active transition metal and is essential for brain function, serving as a cofactor in critical enzymatic systems, including the cytochrome <italic toggle="yes">c</italic> oxidase (CCO; Complex IV) system for mitochondrial oxidative phosphorylation (OXPHOS) and the copper/zinc superoxide dismutase 1 (Cu/Zn-SOD1) system for antioxidant defense (<xref rid="b1-ijmm-56-05-05613" ref-type="bibr">1</xref>,<xref rid="b2-ijmm-56-05-05613" ref-type="bibr">2</xref>). The distribution of copper in the brain, particularly in glutamatergic synapses and locus coeruleus neurons, is tightly regulated by copper transporter 1 (CTR1)-mediated uptake, ATP7A/B-dependent trafficking and metallothionein buffering systems (<xref rid="b3-ijmm-56-05-05613" ref-type="bibr">3</xref>). Copper also serves regulatory roles in synaptic plasticity, including in N-methyl-D-aspartate receptor (NMDA-R) endocytosis and aminomethylphosphonic acid receptor trafficking, and modulates &gt;30 central nervous system (CNS) enzymes essential for neuropeptide maturation (<xref rid="b4-ijmm-56-05-05613" ref-type="bibr">4</xref>,<xref rid="b5-ijmm-56-05-05613" ref-type="bibr">5</xref>).</p><p>The disruption of copper homeostasis has increasingly been implicated in the pathogenesis of Alzheimer's disease (AD), a neurodegenerative disorder characterized by amyloid-&#946; (A&#946;) plaques, neurofibrillary tangles (NFTs) of hyperphosphorylated tau and neuronal loss (<xref rid="b6-ijmm-56-05-05613" ref-type="bibr">6</xref>,<xref rid="b7-ijmm-56-05-05613" ref-type="bibr">7</xref>). Pathological copper accumulation exerts dual toxicity: i) Catalytic generation of reactive oxygen species (ROS) via Fenton-like reactions; and ii) structural disruption of A&#946; peptides, thereby promoting oligomerization and plaque formation (<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>). In patients with AD, elevated labile copper levels in cerebrospinal fluid (CSF) and cortical regions, particularly within A&#946; plaques, exacerbate mitochondrial dysfunction by inhibiting Complex IV and depleting glutathione (GSH), creating a vicious cycle of oxidative damage (<xref rid="b9-ijmm-56-05-05613" ref-type="bibr">9</xref>).</p><p>Studies have identified cuproptosis, a copper-specific cell death pathway distinct from apoptosis and ferroptosis, as a key mechanism in AD-related neurodegeneration (<xref rid="b6-ijmm-56-05-05613" ref-type="bibr">6</xref>,<xref rid="b10-ijmm-56-05-05613" ref-type="bibr">10</xref>). Cuproptosis involves copper-induced oligomerization of lipoylated mitochondrial enzymes, particularly those in the tricarboxylic acid (TCA) cycle, resulting in proteotoxic stress and disruption of iron-sulfur (Fe-S) cluster biosynthesis (<xref rid="b11-ijmm-56-05-05613" ref-type="bibr">11</xref>). This process not only impairs cellular energy metabolism but also exacerbates oxidative stress, further contributing to neuronal death (<xref rid="b12-ijmm-56-05-05613" ref-type="bibr">12</xref>,<xref rid="b13-ijmm-56-05-05613" ref-type="bibr">13</xref>). In addition, synaptic copper dysregulation impairs hippocampal function via multiple pathways, including competitive inhibition of NMDA-R at glutamatergic synapses, suppression of the cAMP response element-binding protein (CREB) pathway via PP1/PP2A phosphatase activation, and impaired activity-dependent brain-derived neurotrophic factor (BDNF) secretion, which is vital for synaptic plasticity and memory formation (<xref rid="b14-ijmm-56-05-05613" ref-type="bibr">14</xref>).</p><p>Therapeutic strategies targeting copper homeostasis are currently under investigation, with promising approaches including selective copper chelators [such as blood-brain barrier (BBB)-permeable clioquinol (CQ) analogs], zinc-induced metallothionein expression for competitive ion displacement and antioxidant interventions to enhance Cu/Zn-SOD activity (<xref rid="b15-ijmm-56-05-05613" ref-type="bibr">15</xref>). Preclinical studies have highlighted the importance of temporal specificity in therapeutic interventions (<xref rid="b16-ijmm-56-05-05613" ref-type="bibr">16</xref>-<xref rid="b18-ijmm-56-05-05613" ref-type="bibr">18</xref>). Aggressive copper chelation may be beneficial in advanced AD to lower toxic copper pools, while pro-homeostatic approaches (such as copper chaperones) can be more effective during prodromal stages to restore the physiological copper balance (<xref rid="b16-ijmm-56-05-05613" ref-type="bibr">16</xref>). However, the U-shaped relationship between copper levels and cognitive decline highlights the need for careful biomarker-guided personalized therapies to avoid the risks of copper deficiency, which can also impair brain function (<xref rid="b9-ijmm-56-05-05613" ref-type="bibr">9</xref>).</p><p>The present review investigates the dual roles of copper in AD, integrating the emerging concept of cuproptosis with classical A&#946;/tau hypotheses, and critically evaluates copper-targeted therapeutic strategies. By synthesizing recent advances in the field, the present review aims to propose a precision medicine framework that addresses the multifactorial pathology of AD and suggests potential therapeutic strategies.</p></sec><sec sec-type="other"><label>2.</label><title>Fundamentals of copper metabolism</title><sec><title>Copper homeostasis</title><p>Copper homeostasis is a tightly regulated process, which is essential for maintaining physiological functions such as mitochondrial respiration, antioxidant defense and neurotransmitter synthesis, while avoiding redox toxicity (<xref rid="b19-ijmm-56-05-05613" ref-type="bibr">19</xref>). This balance is achieved through the coordinated actions of copper transporters, metalloreductases, cytosolic chaperones and organelle-specific trafficking proteins (<xref rid="b20-ijmm-56-05-05613" ref-type="bibr">20</xref>). Collectively, these components ensure appropriate cellular copper uptake, distribution, utilization, storage and excretion (<xref rid="f1-ijmm-56-05-05613" ref-type="fig">Fig. 1</xref>). In neurons, disruptions in systemic copper transport, such as altered CTR1 expression, ceruloplasmin (CP) dysfunction or hepatic clearance defects, can impair copper delivery and increase the risk of oxidative stress (<xref rid="b21-ijmm-56-05-05613" ref-type="bibr">21</xref>-<xref rid="b23-ijmm-56-05-05613" ref-type="bibr">23</xref>).</p></sec><sec><title>Copper absorption and transport</title><p>Dietary copper is primarily obtained from foods such as meat, offal, nuts and cereals (<xref rid="f1-ijmm-56-05-05613" ref-type="fig">Fig. 1</xref>) (<xref rid="b24-ijmm-56-05-05613" ref-type="bibr">24</xref>,<xref rid="b25-ijmm-56-05-05613" ref-type="bibr">25</xref>). Copper absorption primarily occurs in the duodenum, where dietary Cu<sup>2+</sup> is reduced to Cu<sup>+</sup> by metalloreductases such as six-transmembrane epithelial antigen of the prostate 4 and duodenal cytochrome B (<xref rid="b26-ijmm-56-05-05613" ref-type="bibr">26</xref>,<xref rid="b27-ijmm-56-05-05613" ref-type="bibr">27</xref>). The reduced form is then imported into enterocytes via the high-affinity copper transporter CTR1 (<xref rid="f1-ijmm-56-05-05613" ref-type="fig">Fig. 1</xref>). In enterocytes, copper can either be transiently sequestered by metallothioneins or exported into the portal circulation via ATP7A (<xref rid="b28-ijmm-56-05-05613" ref-type="bibr">28</xref>,<xref rid="b29-ijmm-56-05-05613" ref-type="bibr">29</xref>). In the circulation, copper binds to human serum albumin and transcuprein and is delivered to the liver, where it is incorporated into metallothionein (MT) or excreted via ATP7B-mediated biliary pathways to maintain the systemic copper balance (<xref rid="b30-ijmm-56-05-05613" ref-type="bibr">30</xref>-<xref rid="b32-ijmm-56-05-05613" ref-type="bibr">32</xref>) (<xref rid="f1-ijmm-56-05-05613" ref-type="fig">Fig. 1</xref>).</p></sec><sec><title>Copper storage and pools</title><p>Upon delivery to the liver, circulating copper is taken up by hepatocytes via CTR1 (<xref rid="f1-ijmm-56-05-05613" ref-type="fig">Fig. 1</xref>) (<xref rid="b33-ijmm-56-05-05613" ref-type="bibr">33</xref>). Intracellular copper is distributed into two major pools: A stationary enzymatic pool tightly bound to copper-dependent enzymes such as cyclooxygenase (COX) and SOD1 (<xref rid="b34-ijmm-56-05-05613" ref-type="bibr">34</xref>-<xref rid="b36-ijmm-56-05-05613" ref-type="bibr">36</xref>), and a labile exchangeable pool associated with copper chaperones, including copper chaperone for superoxide dismutase (CCS), COX17 and antioxidant-1 (ATOX1). The enzymatic pool maintains essential bioenergetic and antioxidant functions, while the labile pool regulates dynamic cellular signaling and trafficking (<xref rid="f1-ijmm-56-05-05613" ref-type="fig">Fig. 1</xref>) (<xref rid="b37-ijmm-56-05-05613" ref-type="bibr">37</xref>).</p><p>Copper chaperones direct intracellular copper to specific organelles. For instance, ATOX1 delivers copper to ATP7A and ATP7B in the trans-Golgi network for enzyme metalation (<xref rid="b38-ijmm-56-05-05613" ref-type="bibr">38</xref>,<xref rid="b39-ijmm-56-05-05613" ref-type="bibr">39</xref>). In addition, ATOX1 functions as a copper-sensitive transcription factor through interactions with Sp1 and metal regulatory transcription factor 1, thereby affecting genes involved in the oxidative stress response and neuronal plasticity (<xref rid="b40-ijmm-56-05-05613" ref-type="bibr">40</xref>,<xref rid="b41-ijmm-56-05-05613" ref-type="bibr">41</xref>). COX17 mediates mitochondrial copper delivery, which is critical for CCO assembly and electron transport chain (ETC) integrity (<xref rid="b42-ijmm-56-05-05613" ref-type="bibr">42</xref>,<xref rid="b43-ijmm-56-05-05613" ref-type="bibr">43</xref>). CCS transfers copper to SOD1, which is essential for superoxide detoxification (<xref rid="b44-ijmm-56-05-05613" ref-type="bibr">44</xref>).</p><p>To prevent redox toxicity, excess cytosolic copper is sequestered by MT and GSH (<xref rid="f1-ijmm-56-05-05613" ref-type="fig">Fig. 1</xref>) (<xref rid="b44-ijmm-56-05-05613" ref-type="bibr">44</xref>). The thioredoxin system further contributes to cellular redox buffering, particularly in neurons where copper dysregulation can induce oxidative injury (<xref rid="b45-ijmm-56-05-05613" ref-type="bibr">45</xref>).</p></sec><sec><title>Copper excretion</title><p>Copper is mainly excreted through bile, a process facilitated by ATP7B, which accounts for ~95% of total copper excretion, with a minor fraction expelled via urine (<xref rid="f1-ijmm-56-05-05613" ref-type="fig">Fig. 1</xref>) (<xref rid="b46-ijmm-56-05-05613" ref-type="bibr">46</xref>,<xref rid="b47-ijmm-56-05-05613" ref-type="bibr">47</xref>). This efficient ATP7B-mediated biliary excretion system ensures controlled copper levels and can minimize toxicity. The ability of the liver to regulate copper excretion through ATP7B is crucial for maintaining the systemic copper balance and preventing toxic accumulation (<xref rid="b47-ijmm-56-05-05613" ref-type="bibr">47</xref>,<xref rid="b48-ijmm-56-05-05613" ref-type="bibr">48</xref>).</p></sec><sec><title>Regulation of copper homeostasis</title><p>The liver exerts a central effect on maintaining the systemic copper balance by regulating intestinal absorption, hepatic storage and biliary excretion (<xref rid="b49-ijmm-56-05-05613" ref-type="bibr">49</xref>,<xref rid="b50-ijmm-56-05-05613" ref-type="bibr">50</xref>). Under conditions of hepatic copper excess, the high-affinity transporter CTR1 undergoes endocytosis and degradation to reduce further uptake, while ATP7B expression is upregulated to promote copper excretion via bile (<xref rid="b29-ijmm-56-05-05613" ref-type="bibr">29</xref>,<xref rid="b51-ijmm-56-05-05613" ref-type="bibr">51</xref>). By contrast, during copper deficiency, intestinal copper uptake is enhanced via increased CTR1 activity (<xref rid="b52-ijmm-56-05-05613" ref-type="bibr">52</xref>). The gut-liver axis further modulates copper homeostasis. Intestinal peptides such as hepcidin, although classically involved in iron metabolism, have been implicated in copper regulation under overload conditions (<xref rid="b53-ijmm-56-05-05613" ref-type="bibr">53</xref>). Furthermore, the gut microbiota influences copper bioavailability by altering intestinal absorption and producing copper-binding metabolites that impact host copper metabolism (<xref rid="b54-ijmm-56-05-05613" ref-type="bibr">54</xref>).</p><p>Copper levels are monitored and adjusted via transcriptional and post-translational feedback mechanisms. Changes in intracellular copper concentrations can affect the localization and stability of copper transporters (such as CTR1 and ATP7A/B) and the expression of regulatory genes (<xref rid="b47-ijmm-56-05-05613" ref-type="bibr">47</xref>,<xref rid="b55-ijmm-56-05-05613" ref-type="bibr">55</xref>,<xref rid="b56-ijmm-56-05-05613" ref-type="bibr">56</xref>). Furthermore, copper-inducible kinases, such as unc-51 like autophagy activating kinase 1, serve a role in copper-dependent autophagy, eventually promoting the degradation of copper-enriched organelles and maintaining the intracellular copper equilibrium (<xref rid="b57-ijmm-56-05-05613" ref-type="bibr">57</xref>,<xref rid="b58-ijmm-56-05-05613" ref-type="bibr">58</xref>).</p><p>In the CNS, ATP7A facilitates copper transport across the BBB and into synaptic vesicles, while ATP7B contributes to copper efflux into the CSF, thus maintaining the neural copper balance and protecting against redox-induced damage (<xref rid="b59-ijmm-56-05-05613" ref-type="bibr">59</xref>,<xref rid="b60-ijmm-56-05-05613" ref-type="bibr">60</xref>). Disruptions in these transport pathways have been associated with neurodegenerative diseases, including AD and Wilson's disease (<xref rid="b61-ijmm-56-05-05613" ref-type="bibr">61</xref>).</p></sec><sec><title>Biological roles of copper in the CNS</title><p>Copper is an essential trace element and serves critical physiological roles in the CNS. Considering the high oxidative metabolism and limited regenerative capacity of the CNS, it is particularly sensitive to disturbances in copper homeostasis (<xref rid="b62-ijmm-56-05-05613" ref-type="bibr">62</xref>,<xref rid="b63-ijmm-56-05-05613" ref-type="bibr">63</xref>). Copper is primarily transported into neurons via CTR1, a high-affinity copper transporter, and functions as a cofactor for several crucial enzymes, including COX, SOD1, dopamine &#946;-hydroxylase (DBH) and peptidylglycine &#945;-amidating monooxygenase (<xref rid="b64-ijmm-56-05-05613" ref-type="bibr">64</xref>). It is extensively involved in physiological processes, including synaptic function, energy metabolism, antioxidant defense and neurodevelopment (<xref rid="b65-ijmm-56-05-05613" ref-type="bibr">65</xref>,<xref rid="b66-ijmm-56-05-05613" ref-type="bibr">66</xref>). This intricate involvement underscores the necessity of precise copper regulation to maintain CNS function and prevent neurodegenerative disorders.</p><p>Copper serves a vital role in neurotransmitter synthesis and synaptic signal transmission at the neurochemical level (<xref rid="b62-ijmm-56-05-05613" ref-type="bibr">62</xref>). DBH, a copper-dependent enzyme, catalyzes the conversion of dopamine (DA) to norepinephrine (NE) within synaptic vesicles, a key reaction in emotional regulation and stress responses (<xref rid="b9-ijmm-56-05-05613" ref-type="bibr">9</xref>). Additionally, peptidylglycine &#945;-amidating monooxygenase, another copper-dependent enzyme, modifies various neuropeptides, such as oxytocin and Substance P (<xref rid="b67-ijmm-56-05-05613" ref-type="bibr">67</xref>,<xref rid="b68-ijmm-56-05-05613" ref-type="bibr">68</xref>).</p><p>Copper is vital for cellular energy metabolism, particularly in the mitochondrial ETC (<xref rid="b69-ijmm-56-05-05613" ref-type="bibr">69</xref>). CCO (Complex IV), a copper-dependent enzyme, catalyzes the reduction of oxygen in a process that couples electron transfer to ATP synthesis, which is essential for maintaining neuronal energy supply (<xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>). A deficiency in copper can diminish the activity of Complex IV, leading to reduced ATP synthesis. This reduction can precipitate an energy crisis in neurons, exacerbating neurodegenerative changes (<xref rid="b69-ijmm-56-05-05613" ref-type="bibr">69</xref>).</p><p>Due to their high metabolic rate, neurons are particularly susceptible to damage from ROS, and copper serves a crucial role in antioxidant defense (<xref rid="b71-ijmm-56-05-05613" ref-type="bibr">71</xref>). Cu/Zn-SOD1, which utilizes copper as a catalytic center, effectively eliminates superoxide radicals, thus preventing oxidative damage to neurons (<xref rid="b72-ijmm-56-05-05613" ref-type="bibr">72</xref>). Dysfunctional SOD1 has been linked to neurodegenerative diseases such as amyotrophic lateral sclerosis (<xref rid="b73-ijmm-56-05-05613" ref-type="bibr">73</xref>). Additionally, CP, a copper-dependent ferroxidase, catalyzes the oxidation of Fe<sup>2+</sup> to Fe<sup>3+</sup>, facilitating transmembrane iron transport and maintaining iron homeostasis (<xref rid="b74-ijmm-56-05-05613" ref-type="bibr">74</xref>). Copper deficiency can lead to abnormal intracellular iron accumulation, exacerbating oxidative stress and neuronal damage in the CNS, which may contribute to the development of neurodegenerative diseases (<xref rid="b75-ijmm-56-05-05613" ref-type="bibr">75</xref>-<xref rid="b77-ijmm-56-05-05613" ref-type="bibr">77</xref>).</p><p>During neurodevelopment, copper serves a critical role in myelination. Copper supports the normal function of oligodendrocytes, the cells responsible for myelin production, thereby ensuring efficient neural signal transmission (<xref rid="b78-ijmm-56-05-05613" ref-type="bibr">78</xref>,<xref rid="b79-ijmm-56-05-05613" ref-type="bibr">79</xref>). Copper deficiency, such as that observed in Menkes disease, can lead to hypomyelination, causing motor disorders and cognitive deficits due to impaired neural system functionality (<xref rid="b80-ijmm-56-05-05613" ref-type="bibr">80</xref>,<xref rid="b81-ijmm-56-05-05613" ref-type="bibr">81</xref>). Furthermore, copper serves a pivotal role in neurogenesis and synaptic formation. Copper deficiency during pregnancy can result in abnormal neuronal differentiation and reduced synaptic plasticity, severely impacting normal CNS development (<xref rid="b82-ijmm-56-05-05613" ref-type="bibr">82</xref>,<xref rid="b83-ijmm-56-05-05613" ref-type="bibr">83</xref>). From an epigenetic perspective, copper can also regulate gene expression through histone demethylases such as lysine demethylase 5B, affecting cell differentiation, neural network remodeling and stress responses (<xref rid="b84-ijmm-56-05-05613" ref-type="bibr">84</xref>).</p></sec></sec><sec sec-type="other"><label>3.</label><title>Copper dysregulation and cuproptosis</title><sec><title>Copper dysregulation</title><p>Dysregulation of copper metabolism serves a critical role in cellular dysfunction in neurological diseases (<xref rid="b85-ijmm-56-05-05613" ref-type="bibr">85</xref>). Therefore, investigating the underlying mechanisms of this dysregulation is necessary to understand disease pathogenesis and develop potential therapeutic strategies.</p></sec><sec><title>Copper deficiency</title><p>Copper deficiency contributes to a spectrum of neurological impairments through multiple interconnected mechanisms, including disrupted mitochondrial energy metabolism, impaired neurotransmitter synthesis, dysregulated iron homeostasis and heightened oxidative stress (<xref rid="b86-ijmm-56-05-05613" ref-type="bibr">86</xref>). Both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> studies have consistently demonstrated that inadequate copper availability compromises key neuronal processes involved in maintaining the redox balance and bioenergetic function (<xref rid="tI-ijmm-56-05-05613" ref-type="table">Table I</xref>) (<xref rid="b87-ijmm-56-05-05613" ref-type="bibr">87</xref>-<xref rid="b95-ijmm-56-05-05613" ref-type="bibr">95</xref>).</p><sec><label>i)</label><title>Disrupted energy metabolism</title><p>Copper is an essential cofactor for CCO, a critical component of the mitochondrial ETC. Deficiency in copper impairs CCO activity, leading to reduced mitochondrial respiration and ATP production, thereby disrupting cellular energy metabolism. The function of oligodendrocytes, which are highly dependent on ATP, may be compromised, leading to hypomyelination and subsequent neurological deficits (<xref rid="b96-ijmm-56-05-05613" ref-type="bibr">96</xref>,<xref rid="b97-ijmm-56-05-05613" ref-type="bibr">97</xref>). In the spinal cord, copper deficiency can cause degeneration of the dorsal columns, which manifests as sensory ataxia and gait instability (<xref rid="b98-ijmm-56-05-05613" ref-type="bibr">98</xref>). Peripheral neuropathy may present with limb numbness and paresthesia, while optic neuropathy can result in visual impairment (<xref rid="b99-ijmm-56-05-05613" ref-type="bibr">99</xref>,<xref rid="b100-ijmm-56-05-05613" ref-type="bibr">100</xref>). While these manifestations are most apparent in acquired copper deficiency syndromes, they highlight the critical role of copper in maintaining both central and peripheral nervous system integrity, disruption of which may contribute to the complex neurodegenerative features observed in AD.</p><p><italic toggle="yes">In vitro</italic> studies using SH-SY5Y neuroblastoma cells have demonstrated that copper deficiency can impair mitochondrial function, leading to increased oxidative stress and reduced ATP production (<xref rid="b101-ijmm-56-05-05613" ref-type="bibr">101</xref>,<xref rid="b102-ijmm-56-05-05613" ref-type="bibr">102</xref>). These cellular changes may mimic the metabolic dysfunction observed in AD models, suggesting a mechanistic link between disrupted copper homeostasis and neurodegeneration.</p></sec><sec><label>ii)</label><title>Impaired neurotransmitter synthesis</title><p>Copper deficiency can reduce the activity of DBH, hindering NE synthesis and affecting sympathetic nervous function (<xref rid="b103-ijmm-56-05-05613" ref-type="bibr">103</xref>,<xref rid="b104-ijmm-56-05-05613" ref-type="bibr">104</xref>). This may induce hypotension, orthostatic hypotension, arrhythmias and impaired thermoregulation (<xref rid="b95-ijmm-56-05-05613" ref-type="bibr">95</xref>). Monoamine oxidase (MAO), another copper-dependent enzyme, is involved in the metabolism of serotonin and DA. Reduced MAO activity may contribute to mood disorders and cognitive dysfunction, and can exacerbate neurological damage (<xref rid="b105-ijmm-56-05-05613" ref-type="bibr">105</xref>,<xref rid="b106-ijmm-56-05-05613" ref-type="bibr">106</xref>). Experimental evidence from cell culture studies also indicates that copper deficiency decreases DBH activity, thereby reducing NE levels and disrupting catecholamine metabolism, which may explain the autonomic dysfunction observed in neurological conditions (<xref rid="b95-ijmm-56-05-05613" ref-type="bibr">95</xref>,<xref rid="b103-ijmm-56-05-05613" ref-type="bibr">103</xref>,<xref rid="b107-ijmm-56-05-05613" ref-type="bibr">107</xref>-<xref rid="b109-ijmm-56-05-05613" ref-type="bibr">109</xref>).</p></sec><sec><label>iii)</label><title>Altered iron homeostasis</title><p>CP, a copper-dependent ferroxidase, serves a pivotal role in iron metabolism. Copper deficiency can impair CP synthesis, which leads to inadequate oxidation of Fe<sup>2+</sup> to Fe<sup>3+</sup>, disrupts iron mobilization and transport, and results in functional iron deficiency and anemia (<xref rid="b53-ijmm-56-05-05613" ref-type="bibr">53</xref>,<xref rid="b110-ijmm-56-05-05613" ref-type="bibr">110</xref>). Abnormal iron metabolism may cause iron accumulation in various tissues, including the brain, liver and pancreas, potentially inducing neurodegenerative changes such as neuronal loss, gliosis and mitochondrial dysfunction, which may clinically manifest as ataxia, dystonia and dementia (<xref rid="b23-ijmm-56-05-05613" ref-type="bibr">23</xref>). As reported in animal studies, reduced copper availability decreases CP activity, promoting iron accumulation in brain tissues. This disruption has been shown to be associated with increased neuroinflammatory markers and A&#946; deposition in transgenic AD mouse models, suggesting that iron dysregulation driven by copper deficiency may exacerbate AD pathology (<xref rid="b76-ijmm-56-05-05613" ref-type="bibr">76</xref>,<xref rid="b111-ijmm-56-05-05613" ref-type="bibr">111</xref>).</p></sec><sec><label>iv)</label><title>Increased oxidative stress</title><p>Cu/Zn-SOD1 is a copper-dependent antioxidant enzyme, and is crucial for scavenging free radicals and mitigating oxidative stress (<xref rid="b112-ijmm-56-05-05613" ref-type="bibr">112</xref>). Copper deficiency can decrease Cu/Zn-SOD1 activity, thus diminishing the free radical-scavenging capacity, exacerbating oxidative damage and further impairing neuronal function (<xref rid="tII-ijmm-56-05-05613" ref-type="table">Table II</xref>) (<xref rid="b113-ijmm-56-05-05613" ref-type="bibr">113</xref>-<xref rid="b115-ijmm-56-05-05613" ref-type="bibr">115</xref>). However, whether the protein levels of Cu/Zn-SOD1 concurrently decline remains a subject of debate (<xref rid="b116-ijmm-56-05-05613" ref-type="bibr">116</xref>). <italic toggle="yes">In vivo</italic> studies using copper-deficient animal models have indicated a reduction in Cu/Zn-SOD1 activity, compared with that in copper-sufficient controls, leading to elevated oxidative marker levels and neuronal damage (<xref rid="b117-ijmm-56-05-05613" ref-type="bibr">117</xref>-<xref rid="b119-ijmm-56-05-05613" ref-type="bibr">119</xref>). These findings highlight that copper deficiency not only impacts enzyme function but may also increase vulnerability to oxidative stress in AD.</p></sec></sec><sec><title>Copper overload</title><p>Excessive copper accumulation can cause damage to the nervous system. In copper metabolic disorders, such as Wilson's disease, copper accumulates excessively in neural tissues, particularly in the basal ganglia and other critical brain regions, leading to neurological dysfunction (<xref rid="b120-ijmm-56-05-05613" ref-type="bibr">120</xref>-<xref rid="b122-ijmm-56-05-05613" ref-type="bibr">122</xref>). These observations indicate that copper overload may serve a crucial role in neurodegenerative diseases.</p><sec><label>i)</label><title>Increased oxidative stress</title><p>Copper is a redox-active transition metal, and its excessive accumulation can markedly enhance the generation of ROS. Through Fenton-like reactions, copper facilitates the decomposition of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), producing highly reactive hydroxyl radicals (OH&#183;), thus inducing cellular oxidative damage. Simultaneously, copper overload can impair the cellular antioxidant defense system, exacerbating oxidative injury (<xref rid="b123-ijmm-56-05-05613" ref-type="bibr">123</xref>-<xref rid="b125-ijmm-56-05-05613" ref-type="bibr">125</xref>). Under normal conditions, antioxidant enzymes such as SOD, GSH peroxidase and catalase eliminate excessive ROS, maintaining the cellular redox balance. However, copper overload can inhibit the activity of these enzymes and deplete GSH, a key non-enzymatic antioxidant, leading to decreased GSH levels and reduced antioxidant enzyme activity (<xref rid="b126-ijmm-56-05-05613" ref-type="bibr">126</xref>,<xref rid="b127-ijmm-56-05-05613" ref-type="bibr">127</xref>). This imbalance results in ROS accumulation, further aggravating oxidative damage (<xref rid="b128-ijmm-56-05-05613" ref-type="bibr">128</xref>,<xref rid="b129-ijmm-56-05-05613" ref-type="bibr">129</xref>).</p></sec><sec><label>ii)</label><title>Disrupted energy metabolism</title><p>Copper can directly or indirectly damage mitochondrial DNA (mtDNA), especially the D-loop region, which is critical for mtDNA replication and transcription (<xref rid="b130-ijmm-56-05-05613" ref-type="bibr">130</xref>). Copper overload can catalyze redox cycling, promoting ROS generation, such as that of OH&#183;. These ROS can induce mtDNA oxidative damage, influencing mitochondrial gene expression and functional stability (<xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>). Additionally, copper overload can inhibit the activities of mitochondrial respiratory chain complexes (Complexes I-IV), leading to reduced ATP production and compromised neuronal energy supply (<xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>). The oxidative environment further disrupts mitochondrial membrane integrity, impairs ETC function and inhibits ATP synthesis, causing neuronal metabolic disorders and functional impairment (<xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>). Additionally, copper overload can promote lipid peroxidation and increase malondialdehyde (MDA) production. As a marker of membrane oxidative damage, MDA can further destabilize mitochondrial membranes, finally accelerating mitochondrial functional failure (<xref rid="b131-ijmm-56-05-05613" ref-type="bibr">131</xref>).</p></sec><sec><label>iii)</label><title>Activation of the inflammatory response</title><p>Copper can exacerbate inflammatory responses through various mechanisms. Copper overload can lead to excessive ROS accumulation, enhance myeloperoxidase activity and activate the NF-&#954;B signaling pathway, promoting the release of pro-inflammatory cytokines (such as IL-1&#945; and TNF-&#946;) while inhibiting anti-inflammatory cytokines, resulting in a chronic inflammatory state (<xref rid="b132-ijmm-56-05-05613" ref-type="bibr">132</xref>,<xref rid="b133-ijmm-56-05-05613" ref-type="bibr">133</xref>). Additionally, copper can activate the innate immune system via the &#945; kinase 1-dependent pathway, further amplifying inflammatory signals (<xref rid="b132-ijmm-56-05-05613" ref-type="bibr">132</xref>). Copper can also activate the NLR family pyrin domain containing 3 (NLRP3) inflammasome, promoting IL-1&#946; production and exacerbating inflammatory damage (<xref rid="b132-ijmm-56-05-05613" ref-type="bibr">132</xref>,<xref rid="b134-ijmm-56-05-05613" ref-type="bibr">134</xref>).</p></sec><sec><label>iv)</label><title>Activation of other forms of programmed cell death</title><p>Copper overload can induce other forms of programmed cell death, notably ferroptosis and apoptosis, through distinct molecular mechanisms. Classical ferroptosis is an iron-dependent process characterized primarily by lipid peroxidation and subsequent cell membrane damage, and is predominantly mediated by iron-catalyzed Fenton reactions (<xref rid="b135-ijmm-56-05-05613" ref-type="bibr">135</xref>). In this classical pathway, depletion of intracellular GSH and subsequent inactivation of GSH peroxidase 4 (GPX4) lead to the accumulation of lipid hydroperoxides, resulting in extensive membrane disruption and cell death (<xref rid="b136-ijmm-56-05-05613" ref-type="bibr">136</xref>). By contrast, copper-induced ferroptosis follows a unique pathway distinct from the classical iron-dependent mechanism. Specifically, copper directly interacts with GPX4 to facilitate its aggregation and subsequent autophagic degradation (<xref rid="b137-ijmm-56-05-05613" ref-type="bibr">137</xref>). This copper-mediated GPX4 degradation disrupts cellular antioxidant defenses, indirectly amplifying lipid peroxidation and promoting ferroptosis. Additionally, copper ions themselves catalyze Fenton-like reactions to generate ROS, exacerbating oxidative stress either independently or synergistically with iron (<xref rid="b138-ijmm-56-05-05613" ref-type="bibr">138</xref>).</p><p>Copper can displace zinc ions at p53 binding sites, causing p53 protein misfolding and weakening its DNA-binding ability, thereby disrupting the p53-mediated DNA damage response and cell cycle regulation (<xref rid="b139-ijmm-56-05-05613" ref-type="bibr">139</xref>). This mechanism may reduce the capacity of cells to repair DNA damage, increasing genomic instability and promoting apoptosis. Simultaneously, copper overload can lead to loss of mitochondrial membrane potential (&#916;&#936;m), which triggers cytochrome <italic toggle="yes">c</italic> release, further activates the intrinsic apoptosis pathway, accelerates cell death and causes tissue damage (<xref rid="b140-ijmm-56-05-05613" ref-type="bibr">140</xref>,<xref rid="b141-ijmm-56-05-05613" ref-type="bibr">141</xref>).</p></sec></sec><sec><title>Cuproptosis</title><p>Research has indicated that copper overload can trigger cuproptosis, a unique form of cell death induced by excessive accumulation of copper within mitochondria (<xref rid="b142-ijmm-56-05-05613" ref-type="bibr">142</xref>) (<xref rid="f2-ijmm-56-05-05613" ref-type="fig">Fig. 2</xref>). This mechanism offers a novel pathological perspective on the role of copper in neurodegenerative disorders.</p><p>Cuproptosis is a copper-dependent form of programmed cell death first described by Tsvetkov <italic toggle="yes">et al</italic> (<xref rid="b12-ijmm-56-05-05613" ref-type="bibr">12</xref>) in 2022, who identified a distinct mechanism by which copper induces cell death through mitochondrial metabolic disruption. Unlike classical forms of cell death such as apoptosis, ferroptosis and necroptosis, cuproptosis does not involve traditional cell death markers. Subsequent research has demonstrated that interventions aiming at inhibiting apoptosis, necroptosis, pyroptosis and ferroptosis do not prevent copper-induced cell death, confirming that cuproptosis represents a unique and independent cell death pathway (<xref rid="b12-ijmm-56-05-05613" ref-type="bibr">12</xref>,<xref rid="b143-ijmm-56-05-05613" ref-type="bibr">143</xref>).</p></sec><sec><title>Mitochondrial dependence</title><p>Cuproptosis, a form of mitochondrial-dependent programmed cell death, is contingent upon mitochondrial copper overload. This cell death pathway is particularly toxic to cells that rely on OXPHOS for energy metabolism, such as neurons, whereas cells primarily dependent on glycolysis exhibit greater tolerance (<xref rid="b140-ijmm-56-05-05613" ref-type="bibr">140</xref>,<xref rid="b144-ijmm-56-05-05613" ref-type="bibr">144</xref>). Under physiological conditions, mitochondria not only serve as the central site for cellular respiration and ATP production but also serve a critical role in the regulation of copper metabolism (<xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>,<xref rid="b145-ijmm-56-05-05613" ref-type="bibr">145</xref>).</p><p>Excessive copper can enter neurons in the form of either Cu<sup>2+</sup> or Cu<sup>+</sup> (<xref rid="b60-ijmm-56-05-05613" ref-type="bibr">60</xref>). Cu<sup>2+</sup> may enter cells through specialized copper-ionophore complexes such as elesclomol, or alternatively, it can be reduced extracellularly to Cu<sup>+</sup> by metalloreductases (<xref rid="b146-ijmm-56-05-05613" ref-type="bibr">146</xref>,<xref rid="b147-ijmm-56-05-05613" ref-type="bibr">147</xref>). Following this reduction, Cu<sup>+</sup> is primarily transported into the cytoplasm via the high-affinity copper transporter CTR1 (<xref rid="b148-ijmm-56-05-05613" ref-type="bibr">148</xref>) (<xref rid="f2-ijmm-56-05-05613" ref-type="fig">Fig. 2</xref>). The mechanisms of copper entry into mitochondria remain only partially understood. It has been proposed that copper may enter as anionic copper ligands (CuL) or complexed with GSH (<xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>), possibly passing through the outer mitochondrial membrane into the intermembrane space (IMS). In the IMS, copper is delivered to the active sites Cu_A and Cu_B of CCO by copper chaperones COX17, synthesis of cytochrome <italic toggle="yes">c</italic> oxidase (SCO)1 and SCO2, ensuring catalytic function (<xref rid="b69-ijmm-56-05-05613" ref-type="bibr">69</xref>,<xref rid="b149-ijmm-56-05-05613" ref-type="bibr">149</xref>). CCO, as the Complex IV of the ETC, transfers electrons from cytochrome <italic toggle="yes">c</italic> to oxygen, facilitating ATP synthesis (<xref rid="b69-ijmm-56-05-05613" ref-type="bibr">69</xref>). Transport across the inner mitochondrial membrane likely involves transporters such as solute carrier family 25 member 3 and mitoferrin-1, where copper is stored in a CuL-bound form to support copper-dependent enzymes (<xref rid="b150-ijmm-56-05-05613" ref-type="bibr">150</xref>).</p><p>Proper assembly of CCO requires SCO1 and SCO2, which help maintain copper homeostasis and enzymatic function (<xref rid="b151-ijmm-56-05-05613" ref-type="bibr">151</xref>). Additionally, copper-binding proteins COX23 and COX19 also participate in the assembly of CCO, where COX19 may influence copper transport to COX11 by regulating the redox status, although the specific role of COX23 in copper transport remains unclear (<xref rid="b152-ijmm-56-05-05613" ref-type="bibr">152</xref>). The correct assembly and function of CCO serve a crucial role in ensuring proper copper distribution and maintaining the normal function of copper-dependent enzymes in mitochondria (<xref rid="b152-ijmm-56-05-05613" ref-type="bibr">152</xref>,<xref rid="b153-ijmm-56-05-05613" ref-type="bibr">153</xref>).</p><p>Mitochondria contain Cu/Zn-SOD1, the copper metalation of which is mediated by the copper chaperone CCS (<xref rid="b154-ijmm-56-05-05613" ref-type="bibr">154</xref>). Apo-SOD1 is first imported into the IMS, where it binds to CCS for metalation, ultimately forming mature SOD1 that performs antioxidative functions by scavenging superoxide radicals (<xref rid="b155-ijmm-56-05-05613" ref-type="bibr">155</xref>,<xref rid="b156-ijmm-56-05-05613" ref-type="bibr">156</xref>). As a result, the precise regulation and supply of copper are vital for the normal functions of CCO and SOD1, thus ensuring efficient oxidative phosphorylation and robust antioxidant protection.</p></sec><sec><title>Mechanistic process</title><p>Cuproptosis is characterized by three core processes: Copper ion delivery and acylation modification, abnormal aggregation of acylated proteins, and proteotoxic stress leading to mitochondrial dysfunction (<xref rid="b122-ijmm-56-05-05613" ref-type="bibr">122</xref>,<xref rid="b157-ijmm-56-05-05613" ref-type="bibr">157</xref>) (<xref rid="f2-ijmm-56-05-05613" ref-type="fig">Fig. 2</xref>).</p><p>The process is initiated by ferredoxin 1 (FDX1), which mediates the reduction of Cu<sup>2+</sup> to Cu<sup>+</sup>, allowing copper to bind to lipoylated sites on mitochondrial enzymes (<xref rid="b158-ijmm-56-05-05613" ref-type="bibr">158</xref>). Lipoylation, a critical post-translational modification for TCA cycle enzymes, including pyruvate dehydrogenase, &#945;-ketoglutarate dehydrogenase, branched-chain &#945;-ketoacid dehydrogenase and the glycine decarboxylase complex, enhances their catalytic activity under normal conditions (<xref rid="b159-ijmm-56-05-05613" ref-type="bibr">159</xref>).</p><p>However, when copper binds to these lipoylated proteins, it triggers their aggregation, particularly affecting critical TCA cycle enzymes such as dihydrolipoamide S-acetyltransferase (DLAT) and dihydrolipoamide branched-chain transacylase E2 (DBT) (<xref rid="f2-ijmm-56-05-05613" ref-type="fig">Fig. 2</xref>) (<xref rid="b158-ijmm-56-05-05613" ref-type="bibr">158</xref>). This aggregation inhibits the TCA cycle and OXPHOS, reducing the production of acetyl-CoA and reduced form of NADH, disrupting the ETC, and leading to metabolic dysregulation (<xref rid="b12-ijmm-56-05-05613" ref-type="bibr">12</xref>). Whole-genome CRISPR screening has further validated that lipoylation modifications are central to copper-induced cell death (cuproptosis), with DLAT aggregation serving as a crucial molecular hallmark (<xref rid="b159-ijmm-56-05-05613" ref-type="bibr">159</xref>,<xref rid="b160-ijmm-56-05-05613" ref-type="bibr">160</xref>).</p><p>The aggregation of copper-bound mitochondrial proteins triggers proteotoxic stress, leading to the destabilization and breakdown of Fe-S clusters. These Fe-S clusters are essential cofactors for several critical enzymes involved in the TCA cycle and ETC complexes I-III (<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>). The loss or disruption of Fe-S clusters subsequently impairs ETC function, resulting in a decreased &#916;&#936;m and augmented oxidative stress.</p><p>The protein aggregation and subsequent Fe-S cluster disruption induced by copper overload activate cellular protein quality control pathways, including the increased expression of molecular chaperones such as heat shock protein 70 (HSP70), which attempts to mitigate the proteotoxic burden (<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>,<xref rid="b160-ijmm-56-05-05613" ref-type="bibr">160</xref>). Nevertheless, when the proteotoxic and oxidative stresses exceed the cellular regulatory and compensatory capacities, the resulting protein homeostasis imbalance further deteriorates mitochondrial function (<xref rid="b161-ijmm-56-05-05613" ref-type="bibr">161</xref>). This dysfunction can trigger the intrinsic apoptotic pathway, marked by mitochondrial outer membrane permeabilization and subsequent caspase activation (<xref rid="b162-ijmm-56-05-05613" ref-type="bibr">162</xref>). Mitochondrial dysfunction serves as a pivotal convergence point connecting cuproptosis and ferroptosis (<xref rid="b163-ijmm-56-05-05613" ref-type="bibr">163</xref>). Specifically, copper-induced destabilization of mitochondrial Fe-S clusters may exacerbate the release or redistribution of labile iron, thereby potentiating the iron-dependent lipid peroxidation characteristic of ferroptosis (<xref rid="b164-ijmm-56-05-05613" ref-type="bibr">164</xref>).</p></sec></sec><sec sec-type="other"><label>4.</label><title>Copper dysregulation in AD</title><p>Copper serves a dual role in AD pathology. As an essential trace element, it supports mitochondrial respiration, antioxidant defense and neurotransmitter synthesis (<xref rid="tII-ijmm-56-05-05613" ref-type="table">Table II</xref>) (<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>,<xref rid="b50-ijmm-56-05-05613" ref-type="bibr">50</xref>, <xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>,<xref rid="b108-ijmm-56-05-05613" ref-type="bibr">108</xref>,<xref rid="b109-ijmm-56-05-05613" ref-type="bibr">109</xref>,<xref rid="b113-ijmm-56-05-05613" ref-type="bibr">113</xref>-<xref rid="b115-ijmm-56-05-05613" ref-type="bibr">115</xref>,<xref rid="b153-ijmm-56-05-05613" ref-type="bibr">153</xref>,<xref rid="b165-ijmm-56-05-05613" ref-type="bibr">165</xref>-<xref rid="b170-ijmm-56-05-05613" ref-type="bibr">170</xref>). However, dysregulation of copper homeostasis, either deficiency or overload, can exacerbate neurodegeneration (<xref rid="b171-ijmm-56-05-05613" ref-type="bibr">171</xref>). Copper deficiency impairs CCO activity and antioxidant capacity, while copper overload promotes A&#946; aggregation, tau phosphorylation, oxidative stress and mitochondrial dysfunction (<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>,<xref rid="b50-ijmm-56-05-05613" ref-type="bibr">50</xref>,<xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>,<xref rid="b167-ijmm-56-05-05613" ref-type="bibr">167</xref>). Experimental studies have suggested that low-to-moderate copper exposure enhances amyloidogenic processing, whereas excessive copper induces cytotoxicity (<xref rid="b87-ijmm-56-05-05613" ref-type="bibr">87</xref>,<xref rid="b88-ijmm-56-05-05613" ref-type="bibr">88</xref>). In transgenic AD mouse models, dietary copper supplementation increased A&#946; deposition, &#946;-secretase [&#946;-site APP cleaving enzyme 1 (BACE1)] expression, neuroinflammation and cognitive deficits. Conversely, controlled copper delivery via copper complexes alleviated AD-related pathological parameters, including reductions in A&#946; accumulation, decreased tau phosphorylation, attenuation of oxidative stress and neuroinflammation, and improvement in cognitive performance (<xref rid="b87-ijmm-56-05-05613" ref-type="bibr">87</xref>-<xref rid="b94-ijmm-56-05-05613" ref-type="bibr">94</xref>). These findings highlight the importance of maintaining copper balance, as both excess and deficiency can independently drive AD progression.</p><sec><title>Copper overload and cuproptosis in AD</title><p>Some studies have demonstrated that brain tissue copper concentrations in patients with AD can reach levels as high as 400 <italic toggle="yes">&#956;</italic>M, compared with ~70 <italic toggle="yes">&#956;</italic>M in age-matched healthy individuals (<xref rid="b172-ijmm-56-05-05613" ref-type="bibr">172</xref>-<xref rid="b174-ijmm-56-05-05613" ref-type="bibr">174</xref>). Excessive copper accumulation in the brain is increasingly being recognized as a critical pathogenic factor driving the progression of AD (<xref rid="b175-ijmm-56-05-05613" ref-type="bibr">175</xref>,<xref rid="b176-ijmm-56-05-05613" ref-type="bibr">176</xref>). Elevated copper levels detected in the serum and CSF have been closely associated with accelerated neurodegeneration and atrophy in specific brain regions, including the entorhinal cortex and hippocampal CA1 area (<xref rid="b177-ijmm-56-05-05613" ref-type="bibr">177</xref>,<xref rid="b178-ijmm-56-05-05613" ref-type="bibr">178</xref>). Furthermore, copper overload promotes A&#946; aggregation, tau phosphorylation, oxidative stress and neuroinflammation (<xref rid="b88-ijmm-56-05-05613" ref-type="bibr">88</xref>,<xref rid="b179-ijmm-56-05-05613" ref-type="bibr">179</xref>) (<xref rid="f3-ijmm-56-05-05613" ref-type="fig">Fig. 3</xref>).</p></sec><sec><title>A&#946; plaques</title><p>A&#946; is a 39- to 42-amino acid polypeptide derived from the amyloid precursor protein (APP) through proteolytic processing involving BACE1 and the &#947;-secretase complex (<xref rid="b180-ijmm-56-05-05613" ref-type="bibr">180</xref>,<xref rid="b181-ijmm-56-05-05613" ref-type="bibr">181</xref>). In aqueous environments, A&#946; exhibits a hydrophilic N-terminus and a hydrophobic C-terminus, with both termini being unstructured (<xref rid="b182-ijmm-56-05-05613" ref-type="bibr">182</xref>). Residues His13 to Asp23 form an &#945;-helix, a structure that predisposes A&#946; to aggregate into &#946;-sheet-rich assemblies, leading to the deposition of senile plaques, a hallmark of AD (<xref rid="b183-ijmm-56-05-05613" ref-type="bibr">183</xref>,<xref rid="b184-ijmm-56-05-05613" ref-type="bibr">184</xref>).</p><p>At the molecular level, copper directly interacts with A&#946; and tau proteins, facilitating their abnormal aggregation, enhancing neurotoxicity, and promoting both A&#946; deposition and tau hyperphosphorylation, ultimately leading to neuronal dysfunction and injury (<xref rid="b185-ijmm-56-05-05613" ref-type="bibr">185</xref>). Copper ions [Cu<sup>2+</sup>/Cu<sup>+</sup>] serve a role in A&#946; aggregation and neurotoxicity (<xref rid="b186-ijmm-56-05-05613" ref-type="bibr">186</xref>,<xref rid="b187-ijmm-56-05-05613" ref-type="bibr">187</xref>). Cu<sup>2+</sup> binds to histidine residues at the N-terminus of A&#946; (His6, His13 and His14), promoting the formation of &#946;-sheet-rich oligomers that are resistant to proteolytic degradation, thereby accelerating A&#946; deposition (<xref rid="b188-ijmm-56-05-05613" ref-type="bibr">188</xref>). Under physiological pH conditions, two primary coordination modes exist for Cu<sup>2+</sup> binding to A&#946; monomers: Mode I involves the NH<sub>2</sub> group, one oxygen atom and two histidine residues (His6 and either His13 or His14); mode II involves the substitution of one histidine by a deprotonated amide (<xref rid="b189-ijmm-56-05-05613" ref-type="bibr">189</xref>). A&#946; exhibits a higher affinity for Cu<sup>+</sup> than for Cu<sup>2+</sup>, suggesting that Cu<sup>+</sup> may be the more biologically relevant oxidation state; however, the specific role of Cu<sup>+</sup> in A&#946; aggregation remains controversial. Some studies suggest that Cu<sup>+</sup> may stabilize A&#946; monomers and inhibit aggregation by occupying critical histidine residues, thereby reducing fibrillization (<xref rid="b190-ijmm-56-05-05613" ref-type="bibr">190</xref>,<xref rid="b191-ijmm-56-05-05613" ref-type="bibr">191</xref>). By contrast, other evidence indicates that Cu<sup>+</sup> may promote the formation of soluble toxic oligomers or redox cycling with Cu<sup>2+</sup>, contributing to oxidative stress and aggregation (<xref rid="b192-ijmm-56-05-05613" ref-type="bibr">192</xref>,<xref rid="b193-ijmm-56-05-05613" ref-type="bibr">193</xref>). The inconsistency likely arises from differences in experimental conditions, such as pH, Cu<sup>+</sup>/Cu<sup>2+</sup> ratio, A&#946; isoform, and the presence of reducing agents or cofactors (<xref rid="b190-ijmm-56-05-05613" ref-type="bibr">190</xref>). Additional cellular studies using mouse hippocampal HT-22 cells exposed to A&#946;1-42 oligomers have demonstrated that copper overload can promote A&#946;-induced neuronal damage via the NLRP3/caspase-1/Gasdermin D pathway (<xref rid="b179-ijmm-56-05-05613" ref-type="bibr">179</xref>,<xref rid="b194-ijmm-56-05-05613" ref-type="bibr">194</xref>). In addition, these experiments revealed that copper chloride treatment exacerbated the toxic effects of A&#946;, suggesting a synergistic relationship between copper accumulation and AD pathology (<xref rid="b179-ijmm-56-05-05613" ref-type="bibr">179</xref>). Research on aging mice has demonstrated that copper accumulation in brain capillaries is associated with reduced low-density lipoprotein receptor-related protein 1 (LRP1) expression and higher brain A&#946; levels (<xref rid="b195-ijmm-56-05-05613" ref-type="bibr">195</xref>).</p><p>A&#946; can bind Cu<sup>2+</sup>/Cu<sup>+</sup> to facilitate aggregation. Additionally, A&#946; may reduce Cu<sup>2+</sup> to Cu<sup>+</sup>, which can subsequently participate in Fenton-like reactions with H<sub>2</sub>O<sub>2</sub> to produce OH&#183;, thereby inducing oxidative stress (<xref rid="b196-ijmm-56-05-05613" ref-type="bibr">196</xref>). Oxidation of the Met35 residue in A&#946; to methionine sulfoxide increases A&#946; hydrophobicity, promoting cross-&#946; stacking and further accelerating A&#946; deposition (<xref rid="b197-ijmm-56-05-05613" ref-type="bibr">197</xref>). Studies have indicated that Cu<sup>2+</sup> can influence A&#946; metabolism and tau phosphorylation (<xref rid="b198-ijmm-56-05-05613" ref-type="bibr">198</xref>,<xref rid="b199-ijmm-56-05-05613" ref-type="bibr">199</xref>). In SH-SY5Y neuroblastoma cells, treatment with CuCl<sub>2</sub> for 48 h increased A&#946; oligomerization, and upregulated APP translation and protein expression (<xref rid="b198-ijmm-56-05-05613" ref-type="bibr">198</xref>). Notably, the use of the cell-permeable copper complex Copper<sup>2+</sup>-glyox albis(N4-methylthiosemicarbazonato) [Cu<sup>2+</sup>(gtsm)] mitigated AD-like changes by promoting GSK3&#946; inhibition, reducing tau phosphorylation and decreasing A&#946; oligomers, highlighting its potential as a therapeutic strategy for safe and bioavailable copper supplementation (<xref rid="b89-ijmm-56-05-05613" ref-type="bibr">89</xref>). Furthermore, copper redistribution induced by A&#946;1-42 fibrils shifts Cu<sup>2+</sup> to Cu<sup>+</sup> in mitochondria and lysosomes, triggering ROS accumulation, mitochondrial dysfunction and autophagy, which are the key features of AD neurodegeneration (<xref rid="b90-ijmm-56-05-05613" ref-type="bibr">90</xref>).</p><p>Copper influences AD pathology through its interaction with key proteins involved in disease progression (<xref rid="tII-ijmm-56-05-05613" ref-type="table">Table II</xref>). Cu<sup>2+</sup> binding to APP has been shown to promote A&#946; oligomerization and plaque formation, thereby exacerbating neurotoxicity. Additionally, the interaction of copper with BACE1 via Cu<sup>+</sup> binding can alter APP processing, linking copper dysregulation to increased A&#946; production (<xref rid="b24-ijmm-56-05-05613" ref-type="bibr">24</xref>). Copper also impacts antioxidant defenses by modulating SOD1 activity, where reduced copper availability decreases the free radical-scavenging capacity of SOD1, leading to oxidative stress. Furthermore, copper can modulate tau pathology by inhibiting GSK3&#946; via Akt signaling, reducing tau phosphorylation and potentially mitigating NFT formation. Animal studies have indicated that cholesterol intake combined with copper exposure may synergistically promote AD-related pathological changes (<xref rid="b93-ijmm-56-05-05613" ref-type="bibr">93</xref>,<xref rid="b200-ijmm-56-05-05613" ref-type="bibr">200</xref>). In rabbits fed a cholesterol-rich diet, supplementation with trace amounts of copper (0.12 ppm) in drinking water markedly increased A&#946; deposition, leading to the formation of senile plaque-like structures in the hippocampus and temporal lobe. This combination also markedly impaired the ability of rabbits to perform complex learning tasks, suggesting that elevated copper levels may interact with altered lipid metabolism to exacerbate AD pathology (<xref rid="b93-ijmm-56-05-05613" ref-type="bibr">93</xref>).</p><p>Copper modulates LRP1-mediated A&#946; clearance across the BBB. In healthy individuals, this mechanism maintains A&#946; homeostasis; however, in aging patients or patients with AD, elevated vascular copper levels may impair LRP1-mediated A&#946; clearance, leading to A&#946; accumulation in the brain and exacerbating AD pathology (<xref rid="b195-ijmm-56-05-05613" ref-type="bibr">195</xref>).</p></sec><sec><title>Tau tangles</title><p>Tau is a microtubule-associated protein that, under normal physiological conditions, stabilizes microtubules to maintain neuronal structural integrity and facilitate axonal transport (<xref rid="b201-ijmm-56-05-05613" ref-type="bibr">201</xref>). In AD, tau undergoes hyperphosphorylation, leading to the loss of its microtubule-stabilizing function. This dysfunction impairs axonal transport and synaptic activity (<xref rid="b201-ijmm-56-05-05613" ref-type="bibr">201</xref>). Hyperphosphorylated tau aggregates into paired helical filaments, which further assemble into NFTs (<xref rid="b202-ijmm-56-05-05613" ref-type="bibr">202</xref>,<xref rid="b203-ijmm-56-05-05613" ref-type="bibr">203</xref>). The accumulation of NFTs disrupts neuronal function and is associated with cognitive decline in patients with AD (<xref rid="b204-ijmm-56-05-05613" ref-type="bibr">204</xref>).</p><p>Cu<sup>2+</sup> can directly bind to tau, influencing its conformation and promoting aggregation. Each tau monomer can bind to one Cu<sup>2+</sup> ion, with a dissociation constant in the micromolar range (<xref rid="b205-ijmm-56-05-05613" ref-type="bibr">205</xref>). This interaction may facilitate the formation of &#946;-sheet-rich tau fibrils, contributing to synaptic failure, neuronal death and cognitive decline observed in patients with AD (<xref rid="b199-ijmm-56-05-05613" ref-type="bibr">199</xref>). In addition, copper-induced oxidative stress can activate kinases responsible for tau phosphorylation, thereby enhancing the propensity of tau to form toxic aggregates. This process is driven by GSK-3&#946; activation and PP2A inhibition (<xref rid="b206-ijmm-56-05-05613" ref-type="bibr">206</xref>). When Cu<sup>2+</sup> binds to A&#946;, it also produces ROS, which leads to neuronal damage (<xref rid="b207-ijmm-56-05-05613" ref-type="bibr">207</xref>). Oligomers isolated from postmortem brains of patients with AD have been found to potently induce AD-type tau phosphorylation (<xref rid="b208-ijmm-56-05-05613" ref-type="bibr">208</xref>,<xref rid="b209-ijmm-56-05-05613" ref-type="bibr">209</xref>).</p></sec><sec><title>Cuproptosis</title><p>In addition to the classical pathological hallmarks of AD, including extracellular A&#946; plaque deposition and phosphorylated tau, studies have suggested that cuproptosis may also contribute to AD pathogenesis (<xref rid="b10-ijmm-56-05-05613" ref-type="bibr">10</xref>,<xref rid="b210-ijmm-56-05-05613" ref-type="bibr">210</xref>) (<xref rid="f3-ijmm-56-05-05613" ref-type="fig">Fig. 3</xref>). This pathway is defined by the aggregation of lipoylated mitochondrial proteins and destabilization of Fe-S clusters, ultimately leading to proteotoxic stress and mitochondrial dysfunction. Postmortem analyses of patients with AD have revealed the abnormal accumulation of DLAT within hippocampal neurons, where it colocalizes with phosphorylated tau (<xref rid="b10-ijmm-56-05-05613" ref-type="bibr">10</xref>,<xref rid="b211-ijmm-56-05-05613" ref-type="bibr">211</xref>).</p><p>Transcriptomic and proteomic analyses in AD-like models further demonstrate the dysregulation of core cuproptosis-related enzymes. Specifically, dihydrolipoamide dehydrogenase, FDX1, glutaminase and pyruvate dehydrogenase E1 subunit &#946; are markedly downregulated, while DBT is markedly upregulated under AD-mimicking conditions (<xref rid="b212-ijmm-56-05-05613" ref-type="bibr">212</xref>). Complementary bioinformatics analyses of clinical datasets have revealed upregulation of multiple cuproptosis-associated genes in patients with AD, including MAP2K1 and solute carrier family 31 member 1, the latter of which encodes CTR1 (<xref rid="b213-ijmm-56-05-05613" ref-type="bibr">213</xref>,<xref rid="b214-ijmm-56-05-05613" ref-type="bibr">214</xref>). Predictive models based on these gene signatures exhibit moderate diagnostic performance in distinguishing patients with AD from healthy controls (<xref rid="b215-ijmm-56-05-05613" ref-type="bibr">215</xref>). <italic toggle="yes">In vitro</italic> experiments using SH-SY5Y neuronal cells treated with A&#946;(<xref rid="b25-ijmm-56-05-05613" ref-type="bibr">25</xref>-<xref rid="b35-ijmm-56-05-05613" ref-type="bibr">35</xref>) oligomers have demonstrated the robust upregulation of FDX1 compared with untreated controls, further supporting the activation of cuproptosis pathways in AD-like conditions (<xref rid="b213-ijmm-56-05-05613" ref-type="bibr">213</xref>). In one study, C57BL/6 mice exposed to polystyrene nanoplastics (an environmental vector for copper) exhibited increased cerebral copper accumulation, DLAT lipid acylation and dysregulation of cuproptosis regulators [such as FDX1, lipoic acid synthase (LIAS) and HSP70]. These molecular disturbances were accompanied by mitochondrial damage, synaptic dysfunction and behavioral impairments, including memory deficits (<xref rid="b216-ijmm-56-05-05613" ref-type="bibr">216</xref>). Furthermore, FDX1, a central mediator of copper reduction and lipoylated protein regulation, has been found to be markedly upregulated in both AD animal models and human subjects, particularly in individuals carrying the apolipoprotein E &#949;4/&#949;4 genotype (<xref rid="b213-ijmm-56-05-05613" ref-type="bibr">213</xref>).</p></sec><sec><title>Neuroinflammation and neuronal loss</title><p>Copper ion overload can directly cause neuronal damage or death, accelerating the pathological process of AD (<xref rid="b9-ijmm-56-05-05613" ref-type="bibr">9</xref>). In AD mouse models, low-dose copper exposure exacerbates neuroinflammation, further impairing neuronal function (<xref rid="b195-ijmm-56-05-05613" ref-type="bibr">195</xref>). In the brains of patients with AD, microglia enhance intracellular copper accumulation by upregulating the copper transporter CTR1, triggering microglial cuproptosis. Dying microglia release pro-inflammatory factors (such as IL-1&#946; and TNF-&#945;) and mtDNA, further activating the NLRP3 inflammasome in astrocytes and promoting chronic neuroinflammation (<xref rid="b9-ijmm-56-05-05613" ref-type="bibr">9</xref>,<xref rid="b217-ijmm-56-05-05613" ref-type="bibr">217</xref>). Additionally, prolonged high copper exposure can lead to astrocyte dysfunction and apoptosis, further exacerbating neuronal damage. Astrocytes surrounding A&#946; plaques exhibit mitochondrial copper overload and DLAT protein accumulation, both of which are closely associated with local synaptic loss (<xref rid="b10-ijmm-56-05-05613" ref-type="bibr">10</xref>,<xref rid="b211-ijmm-56-05-05613" ref-type="bibr">211</xref>). Copper overload can also cause synaptic injury, disrupting synaptic plasticity. This is manifested by the downregulation of synaptophysin, affecting synaptic vesicle cycling; the loss of postsynaptic density protein 95, disrupting NMDA-R clustering; and the inhibited phosphorylation of CREB, leading to reduced secretion of BDNF and inhibition of the tropomyosin receptor kinase B receptor signaling pathway, ultimately impairing synaptic plasticity and accelerating the progression of AD (<xref rid="b218-ijmm-56-05-05613" ref-type="bibr">218</xref>,<xref rid="b219-ijmm-56-05-05613" ref-type="bibr">219</xref>).</p></sec><sec><title>Copper deficiency in AD</title><p>Despite seeming contradictory, the 'copper deficiency vs. overload' scenarios are two sides of the same coin; both imply a breakdown of normal copper homeostasis. Both conditions can lead to pathogenic outcomes; in particular, neuronal copper deficiency may impair essential cuproenzymes and antioxidant defenses (<xref rid="b220-ijmm-56-05-05613" ref-type="bibr">220</xref>). Multiple post-mortem studies have demonstrated that brain copper levels are markedly reduced in AD (<xref rid="b221-ijmm-56-05-05613" ref-type="bibr">221</xref>-<xref rid="b223-ijmm-56-05-05613" ref-type="bibr">223</xref>). For example, a 2017 metallomic analysis of human brain tissues reveled that copper concentrations in AD were only 53-70% of those in age-matched controls across all examined regions, suggesting a widespread 'pan-cerebral' copper deficiency (<xref rid="b221-ijmm-56-05-05613" ref-type="bibr">221</xref>). The magnitude of this drop is notable; brain copper levels in AD are lowered to levels approaching those observed in Menkes disease, a genetic disorder of severe copper deficiency. These findings are consistent with earlier observations such as those by Deibel <italic toggle="yes">et al</italic> (<xref rid="b224-ijmm-56-05-05613" ref-type="bibr">224</xref>) and were confirmed by a meta-analysis (<xref rid="b225-ijmm-56-05-05613" ref-type="bibr">225</xref>). A quantitative meta-analysis compiling data from prior studies concluded that copper was significantly depleted in the AD neocortex (P=0.0003), although some other metals (such as iron) exhibited no uniform increase (<xref rid="b222-ijmm-56-05-05613" ref-type="bibr">222</xref>). Previous reviews have reinforced that most studies since 2015 have reported reduced brain copper levels in patients with AD (<xref rid="b226-ijmm-56-05-05613" ref-type="bibr">226</xref>,<xref rid="b227-ijmm-56-05-05613" ref-type="bibr">227</xref>). For example, a 2021 review noted that AD brains tended to exhibit decreased copper levels, with only a few contradictory reports of normal or elevated copper levels (<xref rid="b223-ijmm-56-05-05613" ref-type="bibr">223</xref>).</p><p>While copper overload has been traditionally emphasized in AD pathology, it is equally important to recognize that copper deficiency may also contribute to disease progression. Copper is a cofactor for enzymes such as CCO (Complex IV of mitochondria), Cu/Zn-SOD1, SOD3 and CP, which protect against oxidative damage and support energy metabolism. According to previous studies, decreased brain copper levels can impair antioxidant defenses and increase susceptibility to oxidative stress, suggesting that both excess and deficiency warrant careful consideration when evaluating the role of copper in AD (<xref rid="b9-ijmm-56-05-05613" ref-type="bibr">9</xref>,<xref rid="b228-ijmm-56-05-05613" ref-type="bibr">228</xref>,<xref rid="b229-ijmm-56-05-05613" ref-type="bibr">229</xref>). Copper deficiency impairs the activity of copper-dependent enzymes such as CCO and SOD1, resulting in mitochondrial dysfunction and compromised antioxidant defense (<xref rid="b118-ijmm-56-05-05613" ref-type="bibr">118</xref>,<xref rid="b170-ijmm-56-05-05613" ref-type="bibr">170</xref>). This leads to increased oxidative stress, impaired nitric oxide (NO) clearance and accumulation of peroxynitrite, further damaging neuronal structures. Both extremes disrupt NO signaling, leading to synaptic dysfunction and neuroinflammation (<xref rid="b230-ijmm-56-05-05613" ref-type="bibr">230</xref>). These findings underscore the bidirectional impact of copper imbalance on AD and support a therapeutic strategy aiming at restoring copper homeostasis (<xref rid="f3-ijmm-56-05-05613" ref-type="fig">Fig. 3</xref>). Research has indicated that copper deficiency may serve a paradoxical role in the pathogenesis of AD, affecting A&#946; metabolism, iron homeostasis and neuronal energy metabolism (<xref rid="b195-ijmm-56-05-05613" ref-type="bibr">195</xref>). A meta-analysis and subsequent studies have demonstrated a decrease in total brain copper levels in patients with AD (<xref rid="b222-ijmm-56-05-05613" ref-type="bibr">222</xref>,<xref rid="b231-ijmm-56-05-05613" ref-type="bibr">231</xref>,<xref rid="b232-ijmm-56-05-05613" ref-type="bibr">232</xref>). Copper deficiency is associated with increased activity of BACE1, and excessive activation of BACE1 enhances the amyloidogenic pathway, leading to increased production of A&#946; (<xref rid="b233-ijmm-56-05-05613" ref-type="bibr">233</xref>). Additionally, copper serves a critical role in the transcription and processing of APP (<xref rid="b234-ijmm-56-05-05613" ref-type="bibr">234</xref>). Physiological levels of copper activate the Sp1 transcription factor, which binds to the APP promoter, maintaining basal APP expression essential for synaptic plasticity (<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>,<xref rid="b234-ijmm-56-05-05613" ref-type="bibr">234</xref>). Dietary treatment of APP23 transgenic mice with Cu sulfate for a 3-month interval extended the lifetime of the mice considerably and restored SOD1 activity back to normal levels (<xref rid="b235-ijmm-56-05-05613" ref-type="bibr">235</xref>). In agreement with the benefit of Cu treatment, Cu supplementation may prevent the premature death observed in APP transgenic mice treated with CQ (<xref rid="b236-ijmm-56-05-05613" ref-type="bibr">236</xref>). However, copper deficiency can downregulate APP expression and, by reducing competition for non-amyloidogenic processing, shift APP processing toward the amyloidogenic pathway (<xref rid="b237-ijmm-56-05-05613" ref-type="bibr">237</xref>). Additionally, disturbances in iron homeostasis are a notable link between copper deficiency and AD pathology. In a state of copper deficiency, CP loses its ferroxidase activity, impairing the oxidation of Fe<sup>2+</sup> to Fe<sup>3+</sup>, which leads to iron deposition in the basal ganglia and cortical areas of patients with AD, enhances ferroptosis and oxidative stress through the Fenton reaction, and further exacerbates A&#946;-mediated neurotoxicity (<xref rid="b238-ijmm-56-05-05613" ref-type="bibr">238</xref>,<xref rid="b239-ijmm-56-05-05613" ref-type="bibr">239</xref>).</p></sec></sec><sec sec-type="other"><label>5.</label><title>Therapeutic advances, limitations and future directions</title><sec><title>Advances</title><p>Copper chelation has emerged as a potential therapeutic strategy for AD, aiming to reduce copper-mediated oxidative stress and protein toxicity while preserving essential physiological copper-dependent enzyme activity (<xref rid="b22-ijmm-56-05-05613" ref-type="bibr">22</xref>). First-generation copper chelators, including the 8-hydroxyquinoline derivative CQ, have shown efficacy in preclinical models by redistributing metal ions within A&#946; plaques, reducing A&#946;-induced neurotoxicity and improving cognitive performance in transgenic mouse models of AD (<xref rid="b240-ijmm-56-05-05613" ref-type="bibr">240</xref>). However, the limited BBB permeability and potential off-target effects associated with CQ restrict its further clinical application, prompting the development of second-generation chelators (<xref rid="b241-ijmm-56-05-05613" ref-type="bibr">241</xref>). Among these second-generation chelators, PBT2, a hydroxylquinoline-derived compound designed to modulate metal-protein interactions, exhibits superior BBB permeability, optimized pharmacokinetic properties and improved specificity (<xref rid="b242-ijmm-56-05-05613" ref-type="bibr">242</xref>). Preclinical studies have indicated that PBT2 can effectively restore neuronal copper homeostasis and decreased A&#946; oligomer formation (<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>,<xref rid="b243-ijmm-56-05-05613" ref-type="bibr">243</xref>,<xref rid="b244-ijmm-56-05-05613" ref-type="bibr">244</xref>). In a phase II clinical trial, treatment with PBT2 resulted in a 25% improvement in cognitive scores relative to placebo controls and restored copper availability to critical copper-dependent enzymes such as SOD1 and CCO, thereby potentially reducing oxidative stress and mitochondrial dysfunction (<xref rid="b245-ijmm-56-05-05613" ref-type="bibr">245</xref>). However, in a subsequent phase II trial (IMAGINE), PBT2 failed to demonstrate significant improvements in cognitive function or reductions in A&#946; burden compared with placebo after 12 months of treatment. Despite promising early results, the trial did not meet its primary endpoints, raising questions regarding the long-term efficacy and clinical applicability of PBT2 in AD management (<xref rid="b246-ijmm-56-05-05613" ref-type="bibr">246</xref>,<xref rid="b247-ijmm-56-05-05613" ref-type="bibr">247</xref>). Another study indicated that treatment with the copper complex Cu<sup>2+</sup>(gtsm) for 24 h enhanced inhibition of GSK-3&#946;, lowering tau hyperphosphorylation and decreasing A&#946; oligomer formation. These findings suggested that modulating copper homeostasis may simultaneously influence multiple pathological pathways implicated in AD, including A&#946; aggregation, tau pathology and oxidative stress. Treatment with the antioxidant N-acetylcysteine alleviated these adverse effects by reducing oxidative stress and restoring cuproptosis-related oxidative mechanisms, providing therapeutic validation of the cuproptosis pathway (<xref rid="b216-ijmm-56-05-05613" ref-type="bibr">216</xref>).</p><p>However, it is important to critically assess the therapeutic window of copper chelation, as both insufficient and excessive copper levels can adversely affect neuronal health. Some studies have reported that brain copper levels may actually decrease in AD, raising concerns that over-chelation may potentially impair essential copper-dependent functions (<xref rid="b14-ijmm-56-05-05613" ref-type="bibr">14</xref>,<xref rid="b248-ijmm-56-05-05613" ref-type="bibr">248</xref>). This underscores the need for a more nuanced therapeutic approach, balancing the reduction of copper toxicity with the preservation of physiological functions, and highlights the importance of reliable biomarkers to monitor copper levels during treatment.</p></sec><sec><title>Limitations</title><p>Copper chelation strategies have exhibited potential in the treatment of AD. However, balancing the reduction of copper toxicity with the maintenance of physiological copper functions remains a critical challenge in optimizing therapeutic approaches (<xref rid="b122-ijmm-56-05-05613" ref-type="bibr">122</xref>,<xref rid="b245-ijmm-56-05-05613" ref-type="bibr">245</xref>,<xref rid="b249-ijmm-56-05-05613" ref-type="bibr">249</xref>).</p><p>First-generation copper chelators, such as CQ, have exhibited limited efficacy in clinical trials, primarily due to their low BBB permeability (&lt;5% penetration into brain tissue), thereby restricting their ability to modulate neuronal copper homeostasis effectively (<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>,<xref rid="b9-ijmm-56-05-05613" ref-type="bibr">9</xref>,<xref rid="b250-ijmm-56-05-05613" ref-type="bibr">250</xref>). Additionally, their non-selective metal-binding properties can disrupt iron and zinc homeostasis, potentially exacerbating conditions such as anemia, underscoring the need for precise copper regulation (<xref rid="b251-ijmm-56-05-05613" ref-type="bibr">251</xref>,<xref rid="b252-ijmm-56-05-05613" ref-type="bibr">252</xref>).</p><p>Second-generation chelators, such as PBT2, have exhibited dose-dependent effects in clinical studies. While a low dose (30 mg/day) improves synaptic function, a higher dose (250 mg/day) induces copper-deficiency encephalopathy, increasing the risks associated with excessive chelation (<xref rid="b9-ijmm-56-05-05613" ref-type="bibr">9</xref>,<xref rid="b242-ijmm-56-05-05613" ref-type="bibr">242</xref>). Prolonged copper deprivation may lead to depletion of intracellular copper reserves, impair NMDA-R trafficking, disrupt mitochondrial retrograde signaling and ultimately exacerbate neuronal energy metabolism disorders (<xref rid="b253-ijmm-56-05-05613" ref-type="bibr">253</xref>,<xref rid="b254-ijmm-56-05-05613" ref-type="bibr">254</xref>). Furthermore, clinical trials of PBT2 have raised concerns regarding its clinical efficacy, as some studies report no significant differences in cognitive outcomes compared with placebo (<xref rid="b241-ijmm-56-05-05613" ref-type="bibr">241</xref>,<xref rid="b247-ijmm-56-05-05613" ref-type="bibr">247</xref>). These findings suggest that while PBT2 shows potential in preclinical settings, it remains challenging to translate these benefits into clinical improvements, emphasizing the need for more comprehensive and targeted clinical trials.</p><p>Genetic factors add complexity to copper-targeted interventions: Polymorphisms in the ATP7B gene may impair hepatic copper excretion, leading to systemic copper overload, and mutations in APP can alter the copper-binding affinity of A&#946;, thus influencing plaque formation and its neurotoxicity (<xref rid="b255-ijmm-56-05-05613" ref-type="bibr">255</xref>).</p><p>The U-shaped dose-response curve refers to the phenomenon where both copper deficiency and copper excess result in neurotoxicity, while only a narrow intermediate range supports neuronal health (<xref rid="b256-ijmm-56-05-05613" ref-type="bibr">256</xref>-<xref rid="b259-ijmm-56-05-05613" ref-type="bibr">259</xref>). At low concentrations, insufficient copper impairs the activity of critical cuproenzymes such as CCO and SOD1, leading to mitochondrial dysfunction and oxidative stress. Conversely, excessive copper promotes A&#946; aggregation, tau hyperphosphorylation and ROS generation, thereby accelerating neurodegenerative processes (<xref rid="b256-ijmm-56-05-05613" ref-type="bibr">256</xref>,<xref rid="b257-ijmm-56-05-05613" ref-type="bibr">257</xref>,<xref rid="b260-ijmm-56-05-05613" ref-type="bibr">260</xref>). This biphasic response has been observed in both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> studies, highlighting the therapeutic challenge of achieving optimal copper levels without tipping the balance toward deficiency or overload (<xref rid="b140-ijmm-56-05-05613" ref-type="bibr">140</xref>,<xref rid="b261-ijmm-56-05-05613" ref-type="bibr">261</xref>).</p></sec><sec><title>Future directions</title><sec><title>Selective inhibition of cuproptosis</title><p>Selective inhibition of cuproptosis is a pivotal research focus, aiming to mitigate copper-induced cytotoxicity while preserving the physiological functions of essential cuproenzymes. One promising strategy involves targeting FDX1, a critical regulator in the cuproptosis pathway (<xref rid="b262-ijmm-56-05-05613" ref-type="bibr">262</xref>). Previous studies have identified disulfiram, traditionally used for alcohol aversion therapy, as an agent that downregulates FDX1 expression (<xref rid="b263-ijmm-56-05-05613" ref-type="bibr">263</xref>,<xref rid="b264-ijmm-56-05-05613" ref-type="bibr">264</xref>). This modulation of copper levels has been shown to lower the infarct volume in experimental cerebral ischemia models, suggesting that FDX1 may serve as an effective target for selectively inhibiting cuproptosis (<xref rid="b263-ijmm-56-05-05613" ref-type="bibr">263</xref>). Another avenue of research focuses on dietary modulation of &#945;-lipoic acid, the synthesis of which depends on LIAS and requires FDX1 as a cofactor (<xref rid="b150-ijmm-56-05-05613" ref-type="bibr">150</xref>,<xref rid="b265-ijmm-56-05-05613" ref-type="bibr">265</xref>). Studies have demonstrated that lipoic acid can improve mitochondrial respiratory function in Atp7a<sup>&#8722;/&#8722;</sup> cells, thereby alleviating key pathological processes associated with cuproptosis (<xref rid="b266-ijmm-56-05-05613" ref-type="bibr">266</xref>,<xref rid="b267-ijmm-56-05-05613" ref-type="bibr">267</xref>). Collectively, these findings highlight the potential of precisely modulating molecular pathways to selectively inhibit cuproptosis, offering novel therapeutic insights for diseases associated with copper dyshomeostasis. The differential expression patterns observed in human datasets refer to alterations in the expression of key cuproptosis-related genes, such as FDX1, LIAS, DLAT, pyruvate dehydrogenase E1 subunit &#945;1 and ATP7B, in the brains of patients with AD compared with age-matched healthy controls (<xref rid="b213-ijmm-56-05-05613" ref-type="bibr">213</xref>,<xref rid="b268-ijmm-56-05-05613" ref-type="bibr">268</xref>,<xref rid="b269-ijmm-56-05-05613" ref-type="bibr">269</xref>). These expression changes are predominantly detected in regions vulnerable to neurodegeneration (such as the hippocampus and temporal cortex), and in some cases associated with disease severity (<xref rid="b213-ijmm-56-05-05613" ref-type="bibr">213</xref>,<xref rid="b268-ijmm-56-05-05613" ref-type="bibr">268</xref>,<xref rid="b269-ijmm-56-05-05613" ref-type="bibr">269</xref>). These human findings mirror alterations observed in AD mouse models subjected to copper overload or deficiency, supporting the translational relevance of cuproptosis as a contributing mechanism in copper-related neurodegeneration (<xref rid="b245-ijmm-56-05-05613" ref-type="bibr">245</xref>,<xref rid="b214-ijmm-56-05-05613" ref-type="bibr">214</xref>).</p></sec><sec><title>Targeted interventions</title><p>Traditional copper chelators often lack specificity, potentially disrupting essential copper-dependent enzymatic functions and exacerbating systemic deficiencies (<xref rid="b270-ijmm-56-05-05613" ref-type="bibr">270</xref>). To address the existing issues, innovative strategies are under investigation. Copper bis-choline complexes are engineered to facilitate CP-independent copper transport, aiming to deliver copper directly to neuronal tissues (<xref rid="b220-ijmm-56-05-05613" ref-type="bibr">220</xref>,<xref rid="b271-ijmm-56-05-05613" ref-type="bibr">271</xref>). Through bypassing traditional copper-binding proteins, they may restore copper homeostasis within the CNS without affecting systemic copper levels. This targeted approach seeks to mitigate neuronal deficits associated with copper imbalance while minimizing peripheral side effects (<xref rid="b272-ijmm-56-05-05613" ref-type="bibr">272</xref>). For instance, bis-choline tetrathiomolybdate has exhibited efficacy in reducing systemic free copper levels by forming stable tripartite complexes with copper and albumin, although its specific effects in AD remain under investigation (<ext-link ext-link-type="pmc:clinical-trial" xlink:href="NCT04573309">NCT04573309</ext-link>).</p><p>Advancements in nanotechnology have led to the development of nanoparticles designed to interact specifically with A&#946; plaques (<xref rid="b273-ijmm-56-05-05613" ref-type="bibr">273</xref>). These nanoparticles can bind to A&#946; aggregates, potentially altering their conformation and reducing their neurotoxicity. By sequestering excess copper ions within the brain, they may prevent copper-induced oxidative stress and subsequent neuronal damage (<xref rid="b274-ijmm-56-05-05613" ref-type="bibr">274</xref>). This method offers a dual therapeutic effect, namely, modulating A&#946; plaque toxicity and correcting local copper dyshomeostasis (<xref rid="b275-ijmm-56-05-05613" ref-type="bibr">275</xref>). For example, gold nanocages functionalized with phenylboronic acid have been utilized to encapsulate CQ, a metal chelator. Upon exposure to the elevated H<sub>2</sub>O<sub>2</sub> levels associated with A&#946; aggregation, these nanocages release CQ, which chelates Cu<sup>2+</sup> ions and inhibits further amyloid fibrillation and oxidative stress (<xref rid="b276-ijmm-56-05-05613" ref-type="bibr">276</xref>). It is essential to develop reliable biomarkers for labile copper levels. Techniques such as positron emission tomography imaging with copper-specific radiotracers and CSF labile copper assays are promising approaches (<xref rid="b277-ijmm-56-05-05613" ref-type="bibr">277</xref>-<xref rid="b279-ijmm-56-05-05613" ref-type="bibr">279</xref>). These methods can provide real-time monitoring of copper dynamics in the brain, guiding targeted interventions and helping to personalize copper-targeted therapies (<xref rid="b280-ijmm-56-05-05613" ref-type="bibr">280</xref>). Implementing biomarkers such as serum or CSF levels of copper-binding proteins (such as ceruloplasmin, ATP7B and SOD1) and expression profiles of cuproptosis-related genes (such as FDX1, DLAT and LIAS) will enable clinicians to assess the efficacy of copper modulation strategies and optimize treatment protocols for individual patients (<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>,<xref rid="b279-ijmm-56-05-05613" ref-type="bibr">279</xref>,<xref rid="b281-ijmm-56-05-05613" ref-type="bibr">281</xref>). These innovative approaches aim to enhance the specificity and efficacy of copper-targeted therapies in neurodegenerative diseases such as AD, potentially overcoming the limitations associated with traditional chelation strategies. These innovative approaches aim to enhance the specificity and efficacy of copper-targeted therapies in neurodegenerative diseases such as AD, potentially overcoming the limitations associated with traditional chelation strategies.</p></sec></sec></sec><sec sec-type="conclusions"><label>6.</label><title>Conclusions</title><p>Copper dyshomeostasis serves a multifaceted role in the pathogenesis of AD, contributing to amyloid-&#946; aggregation, tau hyperphosphorylation, oxidative stress and neuroinflammation. Both copper deficiency and overload are detrimental, emphasizing the need for finely tuned copper regulation. The emerging concept of cuproptosis, a copper-dependent form of cell death, provides novel mechanistic insights into copper-related neurotoxicity. Preclinical studies suggest that targeted modulation of copper levels via chelators, copper-delivery compounds or antioxidants may attenuate AD pathology (<xref rid="b282-ijmm-56-05-05613" ref-type="bibr">282</xref>-<xref rid="b284-ijmm-56-05-05613" ref-type="bibr">284</xref>). However, clinical translation remains limited. Future efforts should focus on identifying reliable biomarkers of copper status and cuproptosis activity to enable personalized, copper-based therapeutic strategies for AD and related neurodegenerative diseases.</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><sec sec-type="data-availability"><title>Availability of data and materials</title><p>Not applicable.</p></sec><sec sec-type="other"><title>Authors' contributions</title><p>CC, HC and LX contributed to writing and editing of the review. YY and YB revised the review. Data authentication is not applicable. All authors have read and approved the final version of the manuscript.</p></sec><sec sec-type="other"><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec sec-type="other"><title>Patient consent for publication</title><p>Not applicable.</p></sec><sec sec-type="COI-statement"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><ref-list><title>References</title><ref id="b1-ijmm-56-05-05613"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>N&#253;vltov&#225;</surname><given-names>E</given-names></name><name name-style="western"><surname>Dietz</surname><given-names>JV</given-names></name><name name-style="western"><surname>Seravalli</surname><given-names>J</given-names></name><name name-style="western"><surname>Khalimonchuk</surname><given-names>O</given-names></name><name name-style="western"><surname>Barrientos</surname><given-names>A</given-names></name></person-group><article-title>Coordination of metal center biogenesis in human cytochrome c oxidase</article-title><source>Nat Commun</source><volume>13</volume><fpage>3615</fpage><year>2022</year><pub-id pub-id-type="doi">10.1038/s41467-022-31413-1</pub-id><pub-id pub-id-type="pmid">35750769</pub-id><pub-id pub-id-type="pmcid">PMC9232578</pub-id></element-citation></ref><ref id="b2-ijmm-56-05-05613"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Yue</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Copper modulates mitochondrial oxidative phosphorylation to enhance dermal papilla cells proliferation in rex rabbits</article-title><source>Int J Mol Sci</source><volume>23</volume><fpage>6209</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/ijms23116209</pub-id><pub-id pub-id-type="pmid">35682888</pub-id><pub-id pub-id-type="pmcid">PMC9181294</pub-id></element-citation></ref><ref id="b3-ijmm-56-05-05613"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dodani</surname><given-names>SC</given-names></name><name name-style="western"><surname>Domaille</surname><given-names>DW</given-names></name><name name-style="western"><surname>Nam</surname><given-names>CI</given-names></name><name name-style="western"><surname>Miller</surname><given-names>EW</given-names></name><name name-style="western"><surname>Finney</surname><given-names>LA</given-names></name><name name-style="western"><surname>Vogt</surname><given-names>S</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CJ</given-names></name></person-group><article-title>Calcium-dependent copper redistributions in neuronal cells revealed by a fluorescent copper sensor and X-ray fluorescence microscopy</article-title><source>Proc Natl Acad Sci USA</source><volume>108</volume><fpage>5980</fpage><lpage>5985</lpage><year>2011</year><pub-id pub-id-type="doi">10.1073/pnas.1009932108</pub-id><pub-id pub-id-type="pmid">21444780</pub-id><pub-id pub-id-type="pmcid">PMC3076884</pub-id></element-citation></ref><ref id="b4-ijmm-56-05-05613"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhattacharyya</surname><given-names>S</given-names></name><name name-style="western"><surname>Biou</surname><given-names>V</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Schl&#252;ter</surname><given-names>O</given-names></name><name name-style="western"><surname>Malenka</surname><given-names>RC</given-names></name></person-group><article-title>A critical role for PSD-95/AKAP interactions in endocytosis of synaptic AMPA receptors</article-title><source>Nat Neurosci</source><volume>12</volume><fpage>172</fpage><lpage>181</lpage><year>2009</year><pub-id pub-id-type="doi">10.1038/nn.2249</pub-id><pub-id pub-id-type="pmid">19169250</pub-id><pub-id pub-id-type="pmcid">PMC2694745</pub-id></element-citation></ref><ref id="b5-ijmm-56-05-05613"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Bladen</surname><given-names>C</given-names></name><name name-style="western"><surname>Stys</surname><given-names>PK</given-names></name><name name-style="western"><surname>Zamponi</surname><given-names>GW</given-names></name></person-group><article-title>Differential modulation of NMDA and AMPA receptors by cellular prion protein and copper ions</article-title><source>Mol Brain</source><volume>11</volume><fpage>62</fpage><year>2018</year><pub-id pub-id-type="doi">10.1186/s13041-018-0406-3</pub-id><pub-id pub-id-type="pmid">30359282</pub-id><pub-id pub-id-type="pmcid">PMC6202830</pub-id></element-citation></ref><ref id="b6-ijmm-56-05-05613"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitazawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>HW</given-names></name><name name-style="western"><surname>Medeiros</surname><given-names>R</given-names></name></person-group><article-title>Copper exposure perturbs brain inflammatory responses and impairs clearance of amyloid-beta</article-title><source>Toxicol Sci</source><volume>152</volume><fpage>194</fpage><lpage>204</lpage><year>2016</year><pub-id pub-id-type="doi">10.1093/toxsci/kfw081</pub-id><pub-id pub-id-type="pmid">27122238</pub-id><pub-id pub-id-type="pmcid">PMC4922545</pub-id></element-citation></ref><ref id="b7-ijmm-56-05-05613"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheltens</surname><given-names>P</given-names></name><name name-style="western"><surname>De Strooper</surname><given-names>B</given-names></name><name name-style="western"><surname>Kivipelto</surname><given-names>M</given-names></name><name name-style="western"><surname>Holstege</surname><given-names>H</given-names></name><name name-style="western"><surname>Ch&#233;telat</surname><given-names>G</given-names></name><name name-style="western"><surname>Teunissen</surname><given-names>CE</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>J</given-names></name><name name-style="western"><surname>van der Flier</surname><given-names>WM</given-names></name></person-group><article-title>Alzheimer's disease</article-title><source>Lancet</source><volume>397</volume><fpage>1577</fpage><lpage>1590</lpage><year>2021</year><pub-id pub-id-type="doi">10.1016/S0140-6736(20)32205-4</pub-id><pub-id pub-id-type="pmid">33667416</pub-id><pub-id pub-id-type="pmcid">PMC8354300</pub-id></element-citation></ref><ref id="b8-ijmm-56-05-05613"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Song</surname><given-names>M</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J</given-names></name><name name-style="western"><surname>Liang</surname><given-names>L</given-names></name><name name-style="western"><surname>Mao</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name></person-group><article-title>Copper homeostasis and cuproptosis in central nervous system diseases</article-title><source>Cell Death Dis</source><volume>15</volume><fpage>850</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41419-024-07206-3</pub-id><pub-id pub-id-type="pmid">39567497</pub-id><pub-id pub-id-type="pmcid">PMC11579297</pub-id></element-citation></ref><ref id="b9-ijmm-56-05-05613"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ejaz</surname><given-names>HW</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Lang</surname><given-names>M</given-names></name></person-group><article-title>Copper toxicity links to pathogenesis of Alzheimer's disease and therapeutics approaches</article-title><source>Int J Mol Sci</source><volume>21</volume><fpage>7660</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/ijms21207660</pub-id><pub-id pub-id-type="pmid">33081348</pub-id><pub-id pub-id-type="pmcid">PMC7589751</pub-id></element-citation></ref><ref id="b10-ijmm-56-05-05613"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Kan</surname><given-names>YK</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title>Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer's disease</article-title><source>Biomed Pharmacother</source><volume>183</volume><fpage>117814</fpage><year>2025</year><pub-id pub-id-type="doi">10.1016/j.biopha.2025.117814</pub-id><pub-id pub-id-type="pmid">39809124</pub-id></element-citation></ref><ref id="b11-ijmm-56-05-05613"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schlief</surname><given-names>ML</given-names></name><name name-style="western"><surname>West</surname><given-names>T</given-names></name><name name-style="western"><surname>Craig</surname><given-names>AM</given-names></name><name name-style="western"><surname>Holtzman</surname><given-names>DM</given-names></name><name name-style="western"><surname>Gitlin</surname><given-names>JD</given-names></name></person-group><article-title>Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity</article-title><source>Proc Natl Acad Sci USA</source><volume>103</volume><fpage>14919</fpage><lpage>14924</lpage><year>2006</year><pub-id pub-id-type="doi">10.1073/pnas.0605390103</pub-id><pub-id pub-id-type="pmid">17003121</pub-id><pub-id pub-id-type="pmcid">PMC1578502</pub-id></element-citation></ref><ref id="b12-ijmm-56-05-05613"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsvetkov</surname><given-names>P</given-names></name><name name-style="western"><surname>Coy</surname><given-names>S</given-names></name><name name-style="western"><surname>Petrova</surname><given-names>B</given-names></name><name name-style="western"><surname>Dreishpoon</surname><given-names>M</given-names></name><name name-style="western"><surname>Verma</surname><given-names>A</given-names></name><name name-style="western"><surname>Abdusamad</surname><given-names>M</given-names></name><name name-style="western"><surname>Rossen</surname><given-names>J</given-names></name><name name-style="western"><surname>Joesch-Cohen</surname><given-names>L</given-names></name><name name-style="western"><surname>Humeidi</surname><given-names>R</given-names></name><name name-style="western"><surname>Spangler</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Copper induces cell death by targeting lipoylated TCA cycle proteins</article-title><source>Science</source><volume>375</volume><fpage>1254</fpage><lpage>1261</lpage><year>2022</year><pub-id pub-id-type="doi">10.1126/science.abf0529</pub-id><pub-id pub-id-type="pmid">35298263</pub-id><pub-id pub-id-type="pmcid">PMC9273333</pub-id></element-citation></ref><ref id="b13-ijmm-56-05-05613"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsvetkov</surname><given-names>P</given-names></name><name name-style="western"><surname>Detappe</surname><given-names>A</given-names></name><name name-style="western"><surname>Cai</surname><given-names>K</given-names></name><name name-style="western"><surname>Keys</surname><given-names>HR</given-names></name><name name-style="western"><surname>Brune</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ying</surname><given-names>W</given-names></name><name name-style="western"><surname>Thiru</surname><given-names>P</given-names></name><name name-style="western"><surname>Reidy</surname><given-names>M</given-names></name><name name-style="western"><surname>Kugener</surname><given-names>G</given-names></name><name name-style="western"><surname>Rossen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mitochondrial metabolism promotes adaptation to proteotoxic stress</article-title><source>Nat Chem Biol</source><volume>15</volume><fpage>681</fpage><lpage>689</lpage><year>2019</year><pub-id pub-id-type="doi">10.1038/s41589-019-0291-9</pub-id><pub-id pub-id-type="pmid">31133756</pub-id><pub-id pub-id-type="pmcid">PMC8183600</pub-id></element-citation></ref><ref id="b14-ijmm-56-05-05613"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagheri</surname><given-names>S</given-names></name><name name-style="western"><surname>Squitti</surname><given-names>R</given-names></name><name name-style="western"><surname>Haertl&#233;</surname><given-names>T</given-names></name><name name-style="western"><surname>Siotto</surname><given-names>M</given-names></name><name name-style="western"><surname>Saboury</surname><given-names>AA</given-names></name></person-group><article-title>Role of copper in the onset of Alzheimer's disease compared to other metals</article-title><source>Front Aging Neurosci</source><volume>9</volume><fpage>446</fpage><year>2017</year><pub-id pub-id-type="doi">10.3389/fnagi.2017.00446</pub-id><pub-id pub-id-type="pmid">29472855</pub-id><pub-id pub-id-type="pmcid">PMC5810277</pub-id></element-citation></ref><ref id="b15-ijmm-56-05-05613"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bareggi</surname><given-names>SR</given-names></name><name name-style="western"><surname>Cornelli</surname><given-names>U</given-names></name></person-group><article-title>Clioquinol: Review of its mechanisms of action and clinical uses in neurodegenerative disorders</article-title><source>CNS Neurosci Ther</source><volume>18</volume><fpage>41</fpage><lpage>46</lpage><year>2012</year><pub-id pub-id-type="doi">10.1111/j.1755-5949.2010.00231.x</pub-id><pub-id pub-id-type="pmid">21199452</pub-id><pub-id pub-id-type="pmcid">PMC6493473</pub-id></element-citation></ref><ref id="b16-ijmm-56-05-05613"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinn</surname><given-names>JF</given-names></name><name name-style="western"><surname>Harris</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Cobb</surname><given-names>KE</given-names></name><name name-style="western"><surname>Domes</surname><given-names>C</given-names></name><name name-style="western"><surname>Ralle</surname><given-names>M</given-names></name><name name-style="western"><surname>Brewer</surname><given-names>G</given-names></name><name name-style="western"><surname>Wadsworth</surname><given-names>TL</given-names></name></person-group><article-title>A copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of Alzheimer's disease</article-title><source>J Alzheimers Dis</source><volume>21</volume><fpage>903</fpage><lpage>914</lpage><year>2010</year><pub-id pub-id-type="doi">10.3233/JAD-2010-100408</pub-id><pub-id pub-id-type="pmid">20693639</pub-id><pub-id pub-id-type="pmcid">PMC2940947</pub-id></element-citation></ref><ref id="b17-ijmm-56-05-05613"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Victor</surname><given-names>TW</given-names></name><name name-style="western"><surname>Ambi</surname><given-names>A</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>JK</given-names></name><name name-style="western"><surname>Hatfield</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>F</given-names></name><name name-style="western"><surname>Miller</surname><given-names>LM</given-names></name><name name-style="western"><surname>Van Nostrand</surname><given-names>WE</given-names></name></person-group><article-title>Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques</article-title><source>Metallomics</source><volume>12</volume><fpage>539</fpage><lpage>546</lpage><year>2020</year><pub-id pub-id-type="doi">10.1039/c9mt00306a</pub-id><pub-id pub-id-type="pmid">32104807</pub-id><pub-id pub-id-type="pmcid">PMC8826596</pub-id></element-citation></ref><ref id="b18-ijmm-56-05-05613"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Squitti</surname><given-names>R</given-names></name><name name-style="western"><surname>Salustri</surname><given-names>C</given-names></name><name name-style="western"><surname>Rongioletti</surname><given-names>M</given-names></name><name name-style="western"><surname>Siotto</surname><given-names>M</given-names></name></person-group><article-title>Commentary: The case for abandoning therapeutic chelation of copper ions in Alzheimer's disease</article-title><source>Front Neurol</source><volume>8</volume><fpage>503</fpage><year>2017</year><pub-id pub-id-type="doi">10.3389/fneur.2017.00503</pub-id><pub-id pub-id-type="pmid">28993754</pub-id><pub-id pub-id-type="pmcid">PMC5622302</pub-id></element-citation></ref><ref id="b19-ijmm-56-05-05613"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linder</surname><given-names>MC</given-names></name><name name-style="western"><surname>Hazegh-Azam</surname><given-names>M</given-names></name></person-group><article-title>Copper biochemistry and molecular biology</article-title><source>Am J Clin Nutr</source><volume>63</volume><fpage>797S</fpage><lpage>811S</lpage><year>1996</year><pub-id pub-id-type="doi">10.1093/ajcn/63.5.797</pub-id><pub-id pub-id-type="pmid">8615367</pub-id></element-citation></ref><ref id="b20-ijmm-56-05-05613"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lutsenko</surname><given-names>S</given-names></name></person-group><article-title>Human copper homeostasis: A network of interconnected pathways</article-title><source>Curr Opin Chem Biol</source><volume>14</volume><fpage>211</fpage><lpage>217</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.cbpa.2010.01.003</pub-id><pub-id pub-id-type="pmid">20117961</pub-id><pub-id pub-id-type="pmcid">PMC6365103</pub-id></element-citation></ref><ref id="b21-ijmm-56-05-05613"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>BN</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>SY</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Julien</surname><given-names>JP</given-names></name><name name-style="western"><surname>David</surname><given-names>S</given-names></name></person-group><article-title>Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury</article-title><source>J Neurosci</source><volume>22</volume><fpage>6578</fpage><lpage>6586</lpage><year>2002</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-15-06578.2002</pub-id><pub-id pub-id-type="pmid">12151537</pub-id><pub-id pub-id-type="pmcid">PMC6758125</pub-id></element-citation></ref><ref id="b22-ijmm-56-05-05613"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnham</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Bush</surname><given-names>AI</given-names></name></person-group><article-title>Metals in Alzheimer's and Parkinson's diseases</article-title><source>Curr Opin Chem Biol</source><volume>12</volume><fpage>222</fpage><lpage>228</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.cbpa.2008.02.019</pub-id><pub-id pub-id-type="pmid">18342639</pub-id></element-citation></ref><ref id="b23-ijmm-56-05-05613"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>ZL</given-names></name><name name-style="western"><surname>Durley</surname><given-names>AP</given-names></name><name name-style="western"><surname>Man</surname><given-names>TK</given-names></name><name name-style="western"><surname>Gitlin</surname><given-names>JD</given-names></name></person-group><article-title>Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux</article-title><source>Proc Natl Acad Sci USA</source><volume>96</volume><fpage>10812</fpage><lpage>10817</lpage><year>1999</year><pub-id pub-id-type="doi">10.1073/pnas.96.19.10812</pub-id><pub-id pub-id-type="pmid">10485908</pub-id><pub-id pub-id-type="pmcid">PMC17965</pub-id></element-citation></ref><ref id="b24-ijmm-56-05-05613"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wapnir</surname><given-names>RA</given-names></name></person-group><article-title>Copper absorption and bioavailability</article-title><source>Am J Clin Nutr</source><volume>67</volume><issue>5 Suppl</issue><fpage>1054S</fpage><lpage>1060S</lpage><year>1998</year><pub-id pub-id-type="doi">10.1093/ajcn/67.5.1054S</pub-id><pub-id pub-id-type="pmid">9587151</pub-id></element-citation></ref><ref id="b25-ijmm-56-05-05613"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunt</surname><given-names>JR</given-names></name><name name-style="western"><surname>Vanderpool</surname><given-names>RA</given-names></name></person-group><article-title>Apparent copper absorption from a vegetarian diet</article-title><source>Am J Clin Nutr</source><volume>74</volume><fpage>803</fpage><lpage>807</lpage><year>2001</year><pub-id pub-id-type="doi">10.1093/ajcn/74.6.803</pub-id><pub-id pub-id-type="pmid">11722963</pub-id></element-citation></ref><ref id="b26-ijmm-56-05-05613"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>B</given-names></name><name name-style="western"><surname>Gitschier</surname><given-names>J</given-names></name></person-group><article-title>hCTR1: A human gene for copper uptake identified by complementation in yeast</article-title><source>Proc Natl Acad Sci USA</source><volume>94</volume><fpage>7481</fpage><lpage>7486</lpage><year>1997</year><pub-id pub-id-type="doi">10.1073/pnas.94.14.7481</pub-id><pub-id pub-id-type="pmid">9207117</pub-id><pub-id pub-id-type="pmcid">PMC23847</pub-id></element-citation></ref><ref id="b27-ijmm-56-05-05613"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Georgatsou</surname><given-names>E</given-names></name><name name-style="western"><surname>Mavrogiannis</surname><given-names>LA</given-names></name><name name-style="western"><surname>Fragiadakis</surname><given-names>GS</given-names></name><name name-style="western"><surname>Alexandraki</surname><given-names>D</given-names></name></person-group><article-title>The Yeast Fre1p/Fre2p cupric reductases facilitate copper uptake and are regulated by the copper-modulated Mac1p activator</article-title><source>J Biol Chem</source><volume>272</volume><fpage>13786</fpage><lpage>13792</lpage><year>1997</year><pub-id pub-id-type="doi">10.1074/jbc.272.21.13786</pub-id><pub-id pub-id-type="pmid">9153234</pub-id></element-citation></ref><ref id="b28-ijmm-56-05-05613"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohgami</surname><given-names>RS</given-names></name><name name-style="western"><surname>Campagna</surname><given-names>DR</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>A</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>MD</given-names></name></person-group><article-title>The Steap proteins are metalloreductases</article-title><source>Blood</source><volume>108</volume><fpage>1388</fpage><lpage>1394</lpage><year>2006</year><pub-id pub-id-type="doi">10.1182/blood-2006-02-003681</pub-id><pub-id pub-id-type="pmid">16609065</pub-id><pub-id pub-id-type="pmcid">PMC1785011</pub-id></element-citation></ref><ref id="b29-ijmm-56-05-05613"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prohaska</surname><given-names>JR</given-names></name></person-group><article-title>Role of copper transporters in copper homeostasis</article-title><source>Am J Clin Nutr</source><volume>88</volume><fpage>826S</fpage><lpage>829S</lpage><year>2008</year><pub-id pub-id-type="doi">10.1093/ajcn/88.3.826S</pub-id><pub-id pub-id-type="pmid">18779302</pub-id><pub-id pub-id-type="pmcid">PMC2799992</pub-id></element-citation></ref><ref id="b30-ijmm-56-05-05613"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriya</surname><given-names>M</given-names></name><name name-style="western"><surname>Ho</surname><given-names>YH</given-names></name><name name-style="western"><surname>Grana</surname><given-names>A</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>L</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>A</given-names></name><name name-style="western"><surname>Jamil</surname><given-names>R</given-names></name><name name-style="western"><surname>Ackland</surname><given-names>ML</given-names></name><name name-style="western"><surname>Michalczyk</surname><given-names>A</given-names></name><name name-style="western"><surname>Hamer</surname><given-names>P</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>D</given-names></name><etal/></person-group><article-title>Copper is taken up efficiently from albumin and alpha2-macroglobulin by cultured human cells by more than one mechanism</article-title><source>Am J Physiol Cell Physiol</source><volume>295</volume><fpage>C708</fpage><lpage>C721</lpage><year>2008</year><pub-id pub-id-type="doi">10.1152/ajpcell.00029.2008</pub-id><pub-id pub-id-type="pmid">18579803</pub-id><pub-id pub-id-type="pmcid">PMC2544443</pub-id></element-citation></ref><ref id="b31-ijmm-56-05-05613"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramos</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar</surname><given-names>D</given-names></name><name name-style="western"><surname>Ishida</surname><given-names>M</given-names></name><name name-style="western"><surname>Vargas</surname><given-names>R</given-names></name><name name-style="western"><surname>Gaite</surname><given-names>M</given-names></name><name name-style="western"><surname>Montgomery</surname><given-names>A</given-names></name><name name-style="western"><surname>Linder</surname><given-names>MC</given-names></name></person-group><article-title>Mechanism of copper uptake from blood plasma ceruloplasmin by mammalian cells</article-title><source>PLoS One</source><volume>11</volume><fpage>e0149516</fpage><year>2016</year><pub-id pub-id-type="doi">10.1371/journal.pone.0149516</pub-id><pub-id pub-id-type="pmid">26934375</pub-id><pub-id pub-id-type="pmcid">PMC4774968</pub-id></element-citation></ref><ref id="b32-ijmm-56-05-05613"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lutsenko</surname><given-names>S</given-names></name></person-group><article-title>Dynamic and cell-specific transport networks for intracellular copper ions</article-title><source>J Cell Sci</source><volume>134</volume><fpage>jcs240523</fpage><year>2021</year><pub-id pub-id-type="doi">10.1242/jcs.240523</pub-id><pub-id pub-id-type="pmid">34734631</pub-id><pub-id pub-id-type="pmcid">PMC8627558</pub-id></element-citation></ref><ref id="b33-ijmm-56-05-05613"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Son</surname><given-names>HY</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>SM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name></person-group><article-title>Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><volume>296</volume><fpage>G356</fpage><lpage>G364</lpage><year>2009</year><pub-id pub-id-type="doi">10.1152/ajpgi.90632.2008</pub-id><pub-id pub-id-type="pmid">19095764</pub-id><pub-id pub-id-type="pmcid">PMC2643901</pub-id></element-citation></ref><ref id="b34-ijmm-56-05-05613"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morgan</surname><given-names>MT</given-names></name><name name-style="western"><surname>Bourassa</surname><given-names>D</given-names></name><name name-style="western"><surname>Harankhedkar</surname><given-names>S</given-names></name><name name-style="western"><surname>McCallum</surname><given-names>AM</given-names></name><name name-style="western"><surname>Zlatic</surname><given-names>SA</given-names></name><name name-style="western"><surname>Calvo</surname><given-names>JS</given-names></name><name name-style="western"><surname>Meloni</surname><given-names>G</given-names></name><name name-style="western"><surname>Faundez</surname><given-names>V</given-names></name><name name-style="western"><surname>Fahrni</surname><given-names>CJ</given-names></name></person-group><article-title>Ratiometric two-photon microscopy reveals attomolar copper buffering in normal and Menkes mutant cells</article-title><source>Proc Natl Acad Sci USA</source><volume>116</volume><fpage>12167</fpage><lpage>12172</lpage><year>2019</year><pub-id pub-id-type="doi">10.1073/pnas.1900172116</pub-id><pub-id pub-id-type="pmid">31160463</pub-id><pub-id pub-id-type="pmcid">PMC6589653</pub-id></element-citation></ref><ref id="b35-ijmm-56-05-05613"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garza</surname><given-names>NM</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>AT</given-names></name><name name-style="western"><surname>Zulkifli</surname><given-names>M</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>C</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>CD</given-names></name><name name-style="western"><surname>Gohil</surname><given-names>VM</given-names></name></person-group><article-title>A genome-wide copper-sensitized screen identifies novel regulators of mitochondrial cytochrome c oxidase activity</article-title><source>J Biol Chem</source><volume>296</volume><fpage>100485</fpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.jbc.2021.100485</pub-id><pub-id pub-id-type="pmid">33662401</pub-id><pub-id pub-id-type="pmcid">PMC8027276</pub-id></element-citation></ref><ref id="b36-ijmm-56-05-05613"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furukawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>O'Halloran</surname><given-names>TV</given-names></name></person-group><article-title>Posttranslational modifications in Cu, Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis</article-title><source>Antioxid Redox Signal</source><volume>8</volume><fpage>847</fpage><lpage>867</lpage><year>2006</year><pub-id pub-id-type="doi">10.1089/ars.2006.8.847</pub-id><pub-id pub-id-type="pmid">16771675</pub-id><pub-id pub-id-type="pmcid">PMC1633719</pub-id></element-citation></ref><ref id="b37-ijmm-56-05-05613"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cotruvo</surname><given-names>JA</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Aron</surname><given-names>AT</given-names></name><name name-style="western"><surname>Ramos-Torres</surname><given-names>KM</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CJ</given-names></name></person-group><article-title>Synthetic fluorescent probes for studying copper in biological systems</article-title><source>Chem Soc Rev</source><volume>44</volume><fpage>4400</fpage><lpage>4414</lpage><year>2015</year><pub-id pub-id-type="doi">10.1039/C4CS00346B</pub-id><pub-id pub-id-type="pmid">25692243</pub-id><pub-id pub-id-type="pmcid">PMC4478099</pub-id></element-citation></ref><ref id="b38-ijmm-56-05-05613"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vo</surname><given-names>TTT</given-names></name><name name-style="western"><surname>Peng</surname><given-names>TY</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>TH</given-names></name><name name-style="western"><surname>Bui</surname><given-names>TNH</given-names></name><name name-style="western"><surname>Wang</surname><given-names>CS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YL</given-names></name><name name-style="western"><surname>Wu</surname><given-names>YC</given-names></name><name name-style="western"><surname>Lee</surname><given-names>IT</given-names></name></person-group><article-title>The crosstalk between copper-induced oxidative stress and cuproptosis: A novel potential anticancer paradigm</article-title><source>Cell Commun Signal</source><volume>22</volume><fpage>353</fpage><year>2024</year><pub-id pub-id-type="doi">10.1186/s12964-024-01726-3</pub-id><pub-id pub-id-type="pmid">38970072</pub-id><pub-id pub-id-type="pmcid">PMC11225285</pub-id></element-citation></ref><ref id="b39-ijmm-56-05-05613"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hatori</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lutsenko</surname><given-names>S</given-names></name></person-group><article-title>The role of copper chaperone Atox1 in coupling redox homeostasis to intracellular copper distribution</article-title><source>Antioxidants (Basel)</source><volume>5</volume><fpage>25</fpage><year>2016</year><pub-id pub-id-type="doi">10.3390/antiox5030025</pub-id><pub-id pub-id-type="pmid">27472369</pub-id><pub-id pub-id-type="pmcid">PMC5039574</pub-id></element-citation></ref><ref id="b40-ijmm-56-05-05613"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Itoh</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HW</given-names></name><name name-style="western"><surname>Nakagawa</surname><given-names>O</given-names></name><name name-style="western"><surname>Ozumi</surname><given-names>K</given-names></name><name name-style="western"><surname>Lessner</surname><given-names>SM</given-names></name><name name-style="western"><surname>Aoki</surname><given-names>H</given-names></name><name name-style="western"><surname>Akram</surname><given-names>K</given-names></name><name name-style="western"><surname>McKinney</surname><given-names>RD</given-names></name><name name-style="western"><surname>Ushio-Fukai</surname><given-names>M</given-names></name><name name-style="western"><surname>Fukai</surname><given-names>T</given-names></name></person-group><article-title>Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation</article-title><source>J Biol Chem</source><volume>283</volume><fpage>9157</fpage><lpage>9167</lpage><year>2008</year><pub-id pub-id-type="doi">10.1074/jbc.M709463200</pub-id><pub-id pub-id-type="pmid">18245776</pub-id><pub-id pub-id-type="pmcid">PMC2431038</pub-id></element-citation></ref><ref id="b41-ijmm-56-05-05613"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lutsenko</surname><given-names>S</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><name name-style="western"><surname>Tsvetkov</surname><given-names>P</given-names></name></person-group><article-title>Mammalian copper homeostasis: Physiological roles and molecular mechanisms</article-title><source>Physiol Rev</source><volume>105</volume><fpage>441</fpage><lpage>491</lpage><year>2025</year><pub-id pub-id-type="doi">10.1152/physrev.00011.2024</pub-id><pub-id pub-id-type="pmid">39172219</pub-id><pub-id pub-id-type="pmcid">PMC11918410</pub-id></element-citation></ref><ref id="b42-ijmm-56-05-05613"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vani&#353;ov&#225;</surname><given-names>M</given-names></name><name name-style="western"><surname>Bursk&#225;</surname><given-names>D</given-names></name><name name-style="western"><surname>K&#345;&#237;&#382;ov&#225;</surname><given-names>J</given-names></name><name name-style="western"><surname>Da&#328;helovsk&#225;</surname><given-names>T</given-names></name><name name-style="western"><surname>Dosoudilov&#225;</surname><given-names>&#381;</given-names></name><name name-style="western"><surname>Zeman</surname><given-names>J</given-names></name><name name-style="western"><surname>Stib&#367;rek</surname><given-names>L</given-names></name><name name-style="western"><surname>Hans&#237;kov&#225;</surname><given-names>H</given-names></name></person-group><article-title>Stable COX17 downregulation leads to alterations in mitochondrial ultrastructure, decreased copper content and impaired cytochrome c oxidase biogenesis in HEK293 cells</article-title><source>Folia Biol (Praha)</source><volume>65</volume><fpage>181</fpage><lpage>187</lpage><year>2019</year><pub-id pub-id-type="doi">10.14712/fb2019065040181</pub-id><pub-id pub-id-type="pmid">31903891</pub-id></element-citation></ref><ref id="b43-ijmm-56-05-05613"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palumaa</surname><given-names>P</given-names></name><name name-style="western"><surname>Kangur</surname><given-names>L</given-names></name><name name-style="western"><surname>Voronova</surname><given-names>A</given-names></name><name name-style="western"><surname>Sillard</surname><given-names>R</given-names></name></person-group><article-title>Metal-binding mechanism of Cox17, a copper chaperone for cytochrome c oxidase</article-title><source>Biochem J</source><volume>382</volume><fpage>307</fpage><lpage>314</lpage><year>2004</year><pub-id pub-id-type="doi">10.1042/BJ20040360</pub-id><pub-id pub-id-type="pmid">15142040</pub-id><pub-id pub-id-type="pmcid">PMC1133943</pub-id></element-citation></ref><ref id="b44-ijmm-56-05-05613"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wijmenga</surname><given-names>C</given-names></name><name name-style="western"><surname>Klomp</surname><given-names>LW</given-names></name></person-group><article-title>Molecular regulation of copper excretion in the liver</article-title><source>Proc Nutr Soc</source><volume>63</volume><fpage>31</fpage><lpage>39</lpage><year>2004</year><pub-id pub-id-type="doi">10.1079/PNS2003316</pub-id><pub-id pub-id-type="pmid">15099406</pub-id></element-citation></ref><ref id="b45-ijmm-56-05-05613"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bj&#248;rklund</surname><given-names>G</given-names></name><name name-style="western"><surname>Zou</surname><given-names>L</given-names></name><name name-style="western"><surname>Peana</surname><given-names>M</given-names></name><name name-style="western"><surname>Chasapis</surname><given-names>CT</given-names></name><name name-style="western"><surname>Hangan</surname><given-names>T</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Maes</surname><given-names>M</given-names></name></person-group><article-title>The role of the thioredoxin system in brain diseases</article-title><source>Antioxidants (Basel)</source><volume>11</volume><fpage>2161</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/antiox11112161</pub-id><pub-id pub-id-type="pmid">36358532</pub-id><pub-id pub-id-type="pmcid">PMC9686621</pub-id></element-citation></ref><ref id="b46-ijmm-56-05-05613"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>KH</given-names></name><name name-style="western"><surname>Lozoya</surname><given-names>JC</given-names></name><name name-style="western"><surname>Tuma</surname><given-names>S</given-names></name><name name-style="western"><surname>Gotthardt</surname><given-names>D</given-names></name><name name-style="western"><surname>Reichert</surname><given-names>J</given-names></name><name name-style="western"><surname>Ehehalt</surname><given-names>R</given-names></name><name name-style="western"><surname>Stremmel</surname><given-names>W</given-names></name><name name-style="western"><surname>F&#252;llekrug</surname><given-names>J</given-names></name></person-group><article-title>Copper-induced translocation of the Wilson disease protein ATP7B independent of Murr1/COMMD1 and Rab7</article-title><source>Am J Pathol</source><volume>173</volume><fpage>1783</fpage><lpage>1794</lpage><year>2008</year><pub-id pub-id-type="doi">10.2353/ajpath.2008.071134</pub-id><pub-id pub-id-type="pmid">18974300</pub-id><pub-id pub-id-type="pmcid">PMC2626389</pub-id></element-citation></ref><ref id="b47-ijmm-56-05-05613"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lutsenko</surname><given-names>S</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>NL</given-names></name><name name-style="western"><surname>Bartee</surname><given-names>MY</given-names></name><name name-style="western"><surname>Dmitriev</surname><given-names>OY</given-names></name></person-group><article-title>Function and regulation of human copper-transporting ATPases</article-title><source>Physiol Rev</source><volume>87</volume><fpage>1011</fpage><lpage>1046</lpage><year>2007</year><pub-id pub-id-type="doi">10.1152/physrev.00004.2006</pub-id><pub-id pub-id-type="pmid">17615395</pub-id></element-citation></ref><ref id="b48-ijmm-56-05-05613"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bartee</surname><given-names>MY</given-names></name><name name-style="western"><surname>Lutsenko</surname><given-names>S</given-names></name></person-group><article-title>Hepatic copper-transporting ATPase ATP7B: Function and inactivation at the molecular and cellular level</article-title><source>Biometals</source><volume>20</volume><fpage>627</fpage><lpage>637</lpage><year>2007</year><pub-id pub-id-type="doi">10.1007/s10534-006-9074-3</pub-id><pub-id pub-id-type="pmid">17268820</pub-id></element-citation></ref><ref id="b49-ijmm-56-05-05613"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>EA</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>B</given-names></name></person-group><article-title>Liver as a key organ in the supply, storage, and excretion of copper</article-title><source>Am J Clin Nutr</source><volume>88</volume><fpage>851S</fpage><lpage>854S</lpage><year>2008</year><pub-id pub-id-type="doi">10.1093/ajcn/88.3.851S</pub-id><pub-id pub-id-type="pmid">18779307</pub-id></element-citation></ref><ref id="b50-ijmm-56-05-05613"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Ji</surname><given-names>G</given-names></name><name name-style="western"><surname>Dang</surname><given-names>Y</given-names></name></person-group><article-title>Copper homeostasis and cuproptosis in health and disease</article-title><source>MedComm (2020)</source><volume>5</volume><fpage>e724</fpage><year>2024</year><pub-id pub-id-type="doi">10.1002/mco2.724</pub-id><pub-id pub-id-type="pmid">39290254</pub-id><pub-id pub-id-type="pmcid">PMC11406047</pub-id></element-citation></ref><ref id="b51-ijmm-56-05-05613"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name></person-group><article-title>Copper homeostasis dysregulation promoting cell damage and the association with liver diseases</article-title><source>Chin Med J (Engl)</source><volume>136</volume><fpage>1653</fpage><lpage>1662</lpage><year>2023</year><pub-id pub-id-type="doi">10.1097/CM9.0000000000002697</pub-id><pub-id pub-id-type="pmid">37284739</pub-id><pub-id pub-id-type="pmcid">PMC10344562</pub-id></element-citation></ref><ref id="b52-ijmm-56-05-05613"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name><name name-style="western"><surname>Lutsenko</surname><given-names>S</given-names></name></person-group><article-title>Human copper transporters: Mechanism, role in human diseases and therapeutic potential</article-title><source>Future Med Chem</source><volume>1</volume><fpage>1125</fpage><lpage>1142</lpage><year>2009</year><pub-id pub-id-type="doi">10.4155/fmc.09.84</pub-id><pub-id pub-id-type="pmid">20454597</pub-id><pub-id pub-id-type="pmcid">PMC2863355</pub-id></element-citation></ref><ref id="b53-ijmm-56-05-05613"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>JF</given-names></name><name name-style="western"><surname>Prohaska</surname><given-names>JR</given-names></name><name name-style="western"><surname>Knutson</surname><given-names>MD</given-names></name></person-group><article-title>Metabolic crossroads of iron and copper</article-title><source>Nutr Rev</source><volume>68</volume><fpage>133</fpage><lpage>147</lpage><year>2010</year><pub-id pub-id-type="doi">10.1111/j.1753-4887.2010.00271.x</pub-id><pub-id pub-id-type="pmid">20384844</pub-id><pub-id pub-id-type="pmcid">PMC3690345</pub-id></element-citation></ref><ref id="b54-ijmm-56-05-05613"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pajarillo</surname><given-names>EAB</given-names></name><name name-style="western"><surname>Lee</surname><given-names>E</given-names></name><name name-style="western"><surname>Kang</surname><given-names>DK</given-names></name></person-group><article-title>Trace metals and animal health: Interplay of the gut microbiota with iron, manganese, zinc, and copper</article-title><source>Anim Nutr</source><volume>7</volume><fpage>750</fpage><lpage>761</lpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.aninu.2021.03.005</pub-id><pub-id pub-id-type="pmid">34466679</pub-id><pub-id pub-id-type="pmcid">PMC8379138</pub-id></element-citation></ref><ref id="b55-ijmm-56-05-05613"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holloway</surname><given-names>ZG</given-names></name><name name-style="western"><surname>Velayos-Baeza</surname><given-names>A</given-names></name><name name-style="western"><surname>Howell</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Levecque</surname><given-names>C</given-names></name><name name-style="western"><surname>Ponnambalam</surname><given-names>S</given-names></name><name name-style="western"><surname>Sztul</surname><given-names>E</given-names></name><name name-style="western"><surname>Monaco</surname><given-names>AP</given-names></name></person-group><article-title>Trafficking of the Menkes copper transporter ATP7A is regulated by clathrin-, AP-2-, AP-1-, and Rab22-dependent steps</article-title><source>Mol Biol Cell</source><volume>24</volume><fpage>1735</fpage><lpage>1748</lpage><fpage>S1</fpage><lpage>S8</lpage><year>2013</year><pub-id pub-id-type="doi">10.1091/mbc.e12-08-0625</pub-id><pub-id pub-id-type="pmid">23596324</pub-id><pub-id pub-id-type="pmcid">PMC3667726</pub-id></element-citation></ref><ref id="b56-ijmm-56-05-05613"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Telianidis</surname><given-names>J</given-names></name><name name-style="western"><surname>Hung</surname><given-names>YH</given-names></name><name name-style="western"><surname>Materia</surname><given-names>S</given-names></name><name name-style="western"><surname>Fontaine</surname><given-names>SL</given-names></name></person-group><article-title>Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis</article-title><source>Front Aging Neurosci</source><volume>5</volume><fpage>44</fpage><year>2013</year><pub-id pub-id-type="doi">10.3389/fnagi.2013.00044</pub-id><pub-id pub-id-type="pmid">23986700</pub-id><pub-id pub-id-type="pmcid">PMC3750203</pub-id></element-citation></ref><ref id="b57-ijmm-56-05-05613"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gudekar</surname><given-names>N</given-names></name><name name-style="western"><surname>Shanbhag</surname><given-names>V</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ralle</surname><given-names>M</given-names></name><name name-style="western"><surname>Weisman</surname><given-names>GA</given-names></name><name name-style="western"><surname>Petris</surname><given-names>MJ</given-names></name></person-group><article-title>Metallothioneins regulate ATP7A trafficking and control cell viability during copper deficiency and excess</article-title><source>Sci Rep</source><volume>10</volume><fpage>7856</fpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41598-020-64521-3</pub-id><pub-id pub-id-type="pmid">32398691</pub-id><pub-id pub-id-type="pmcid">PMC7217913</pub-id></element-citation></ref><ref id="b58-ijmm-56-05-05613"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kr&#281;&#380;el</surname><given-names>A</given-names></name><name name-style="western"><surname>Maret</surname><given-names>W</given-names></name></person-group><article-title>The functions of metamorphic metallothioneins in zinc and copper metabolism</article-title><source>Int J Mol Sci</source><volume>18</volume><fpage>1237</fpage><year>2017</year><pub-id pub-id-type="doi">10.3390/ijms18061237</pub-id><pub-id pub-id-type="pmid">28598392</pub-id><pub-id pub-id-type="pmcid">PMC5486060</pub-id></element-citation></ref><ref id="b59-ijmm-56-05-05613"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name><name name-style="western"><surname>Monnot</surname><given-names>AD</given-names></name></person-group><article-title>Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases</article-title><source>Pharmacol Ther</source><volume>133</volume><fpage>177</fpage><lpage>188</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.pharmthera.2011.10.006</pub-id><pub-id pub-id-type="pmid">22115751</pub-id><pub-id pub-id-type="pmcid">PMC3268876</pub-id></element-citation></ref><ref id="b60-ijmm-56-05-05613"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaier</surname><given-names>ED</given-names></name><name name-style="western"><surname>Eipper</surname><given-names>BA</given-names></name><name name-style="western"><surname>Mains</surname><given-names>RE</given-names></name></person-group><article-title>Copper signaling in the mammalian nervous system: Synaptic effects</article-title><source>J Neurosci Res</source><volume>91</volume><fpage>2</fpage><lpage>19</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/jnr.23143</pub-id><pub-id pub-id-type="pmid">23115049</pub-id><pub-id pub-id-type="pmcid">PMC3926505</pub-id></element-citation></ref><ref id="b61-ijmm-56-05-05613"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Xu</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name></person-group><article-title>Copper homeostasis and neurodegenerative diseases</article-title><source>Neural Regen Res</source><volume>20</volume><fpage>3124</fpage><lpage>3143</lpage><year>2025</year><pub-id pub-id-type="doi">10.4103/NRR.NRR-D-24-00642</pub-id><pub-id pub-id-type="pmid">39589160</pub-id><pub-id pub-id-type="pmcid">PMC11881714</pub-id></element-citation></ref><ref id="b62-ijmm-56-05-05613"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locatelli</surname><given-names>M</given-names></name><name name-style="western"><surname>Farina</surname><given-names>C</given-names></name></person-group><article-title>Role of copper in central nervous system physiology and pathology</article-title><source>Neural Regen Res</source><volume>20</volume><fpage>1058</fpage><lpage>1068</lpage><year>2025</year><pub-id pub-id-type="doi">10.4103/NRR.NRR-D-24-00110</pub-id><pub-id pub-id-type="pmid">38989937</pub-id><pub-id pub-id-type="pmcid">PMC11438321</pub-id></element-citation></ref><ref id="b63-ijmm-56-05-05613"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gale</surname><given-names>J</given-names></name><name name-style="western"><surname>Aizenman</surname><given-names>E</given-names></name></person-group><article-title>The physiological and pathophysiological roles of copper in the nervous system</article-title><source>Eur J Neurosci</source><volume>60</volume><fpage>3505</fpage><lpage>3543</lpage><year>2024</year><pub-id pub-id-type="doi">10.1111/ejn.16370</pub-id><pub-id pub-id-type="pmid">38747014</pub-id><pub-id pub-id-type="pmcid">PMC11491124</pub-id></element-citation></ref><ref id="b64-ijmm-56-05-05613"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Petris</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Thiele</surname><given-names>DJ</given-names></name></person-group><article-title>Characterization of mouse embryonic cells deficient in the Ctr1 high affinity copper transporter</article-title><source>J Biol Chem</source><volume>277</volume><fpage>40253</fpage><lpage>40259</lpage><year>2022</year><pub-id pub-id-type="doi">10.1074/jbc.M208002200</pub-id><pub-id pub-id-type="pmid">12177073</pub-id></element-citation></ref><ref id="b65-ijmm-56-05-05613"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rihel</surname><given-names>J</given-names></name></person-group><article-title>Copper on the brain</article-title><source>Nat Chem Biol</source><volume>14</volume><fpage>638</fpage><lpage>639</lpage><year>2018</year><pub-id pub-id-type="doi">10.1038/s41589-018-0089-1</pub-id><pub-id pub-id-type="pmid">29915234</pub-id></element-citation></ref><ref id="b66-ijmm-56-05-05613"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burkhead</surname><given-names>JL</given-names></name><name name-style="western"><surname>Gogolin Reynolds</surname><given-names>KA</given-names></name><name name-style="western"><surname>Abdel-Ghany</surname><given-names>SE</given-names></name><name name-style="western"><surname>Cohu</surname><given-names>CM</given-names></name><name name-style="western"><surname>Pilon</surname><given-names>M</given-names></name></person-group><article-title>Copper homeostasis</article-title><source>New Phytol</source><volume>182</volume><fpage>799</fpage><lpage>816</lpage><year>2009</year><pub-id pub-id-type="doi">10.1111/j.1469-8137.2009.02846.x</pub-id><pub-id pub-id-type="pmid">19402880</pub-id></element-citation></ref><ref id="b67-ijmm-56-05-05613"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaier</surname><given-names>ED</given-names></name><name name-style="western"><surname>Rodriguiz</surname><given-names>RM</given-names></name><name name-style="western"><surname>Ma</surname><given-names>XM</given-names></name><name name-style="western"><surname>Sivaramakrishnan</surname><given-names>S</given-names></name><name name-style="western"><surname>Bousquet-Moore</surname><given-names>D</given-names></name><name name-style="western"><surname>Wetsel</surname><given-names>WC</given-names></name><name name-style="western"><surname>Eipper</surname><given-names>BA</given-names></name><name name-style="western"><surname>Mains</surname><given-names>RE</given-names></name></person-group><article-title>Haploinsufficiency in peptidylglycine alpha-amidating monooxygenase leads to altered synaptic transmission in the amygdala and impaired emotional responses</article-title><source>J Neurosci</source><volume>30</volume><fpage>13656</fpage><lpage>13669</lpage><year>2010</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2200-10.2010</pub-id><pub-id pub-id-type="pmid">20943906</pub-id><pub-id pub-id-type="pmcid">PMC2975325</pub-id></element-citation></ref><ref id="b68-ijmm-56-05-05613"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prohaska</surname><given-names>JR</given-names></name><name name-style="western"><surname>Broderius</surname><given-names>M</given-names></name></person-group><article-title>Plasma peptidylglycine alpha-amidating monooxygenase (PAM) and ceruloplasmin are affected by age and copper status in rats and mice</article-title><source>Comp Biochem Physiol B Biochem Mol Biol</source><volume>143</volume><fpage>360</fpage><lpage>366</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.cbpb.2005.12.010</pub-id><pub-id pub-id-type="pmid">16448835</pub-id><pub-id pub-id-type="pmcid">PMC2716669</pub-id></element-citation></ref><ref id="b69-ijmm-56-05-05613"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horn</surname><given-names>D</given-names></name><name name-style="western"><surname>Barrientos</surname><given-names>A</given-names></name></person-group><article-title>Mitochondrial copper metabolism and delivery to cytochrome c oxidase</article-title><source>IUBMB Life</source><volume>60</volume><fpage>421</fpage><lpage>429</lpage><year>2008</year><pub-id pub-id-type="doi">10.1002/iub.50</pub-id><pub-id pub-id-type="pmid">18459161</pub-id><pub-id pub-id-type="pmcid">PMC2864105</pub-id></element-citation></ref><ref id="b70-ijmm-56-05-05613"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruiz</surname><given-names>LM</given-names></name><name name-style="western"><surname>Libedinsky</surname><given-names>A</given-names></name><name name-style="western"><surname>Elorza</surname><given-names>AA</given-names></name></person-group><article-title>Role of copper on mitochondrial function and metabolism</article-title><source>Front Mol Biosc</source><volume>8</volume><fpage>711227</fpage><year>2021</year><pub-id pub-id-type="doi">10.3389/fmolb.2021.711227</pub-id><pub-id pub-id-type="pmcid">PMC8421569</pub-id><pub-id pub-id-type="pmid">34504870</pub-id></element-citation></ref><ref id="b71-ijmm-56-05-05613"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattie</surname><given-names>MD</given-names></name><name name-style="western"><surname>Freedman</surname><given-names>JH</given-names></name></person-group><article-title>Copper-inducible transcription: Regulation by metal- and oxidative stress-responsive pathways</article-title><source>Am J Physiol Cell Physiol</source><volume>286</volume><fpage>C293</fpage><lpage>C301</lpage><year>2004</year><pub-id pub-id-type="doi">10.1152/ajpcell.00293.2003</pub-id><pub-id pub-id-type="pmid">14576086</pub-id></element-citation></ref><ref id="b72-ijmm-56-05-05613"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>BE</given-names></name><name name-style="western"><surname>Nevitt</surname><given-names>T</given-names></name><name name-style="western"><surname>Thiele</surname><given-names>DJ</given-names></name></person-group><article-title>Mechanisms for copper acquisition, distribution and regulation</article-title><source>Nat Chem Biol</source><volume>4</volume><fpage>176</fpage><lpage>185</lpage><year>2008</year><pub-id pub-id-type="doi">10.1038/nchembio.72</pub-id><pub-id pub-id-type="pmid">18277979</pub-id></element-citation></ref><ref id="b73-ijmm-56-05-05613"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bakavayev</surname><given-names>S</given-names></name><name name-style="western"><surname>Chetrit</surname><given-names>N</given-names></name><name name-style="western"><surname>Zvagelsky</surname><given-names>T</given-names></name><name name-style="western"><surname>Mansour</surname><given-names>R</given-names></name><name name-style="western"><surname>Vyazmensky</surname><given-names>M</given-names></name><name name-style="western"><surname>Barak</surname><given-names>Z</given-names></name><name name-style="western"><surname>Israelson</surname><given-names>A</given-names></name><name name-style="western"><surname>Engel</surname><given-names>S</given-names></name></person-group><article-title>Cu/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H2O2 via cysteine-dependent redox short-circuit</article-title><source>Sci Rep</source><volume>9</volume><fpage>10826</fpage><year>2019</year><pub-id pub-id-type="doi">10.1038/s41598-019-47326-x</pub-id><pub-id pub-id-type="pmid">31346243</pub-id><pub-id pub-id-type="pmcid">PMC6658568</pub-id></element-citation></ref><ref id="b74-ijmm-56-05-05613"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Attieh</surname><given-names>ZK</given-names></name><name name-style="western"><surname>Mukhopadhyay</surname><given-names>CK</given-names></name><name name-style="western"><surname>Seshadri</surname><given-names>V</given-names></name><name name-style="western"><surname>Tripoulas</surname><given-names>NA</given-names></name><name name-style="western"><surname>Fox</surname><given-names>PL</given-names></name></person-group><article-title>Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism</article-title><source>J Biol Chem</source><volume>274</volume><fpage>1116</fpage><lpage>1123</lpage><year>1999</year><pub-id pub-id-type="doi">10.1074/jbc.274.2.1116</pub-id><pub-id pub-id-type="pmid">9873059</pub-id></element-citation></ref><ref id="b75-ijmm-56-05-05613"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guan</surname><given-names>R</given-names></name><name name-style="western"><surname>Tan</surname><given-names>S</given-names></name><name name-style="western"><surname>Su</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>G</given-names></name></person-group><article-title>Copper supplementation alleviates hypoxia-induced ferroptosis and oxidative stress in neuronal cells</article-title><source>Int J Mol Med</source><volume>54</volume><fpage>117</fpage><year>2024</year><pub-id pub-id-type="doi">10.3892/ijmm.2024.5441</pub-id><pub-id pub-id-type="pmid">39422051</pub-id><pub-id pub-id-type="pmcid">PMC11518577</pub-id></element-citation></ref><ref id="b76-ijmm-56-05-05613"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skj&#248;rringe</surname><given-names>T</given-names></name><name name-style="western"><surname>M&#248;ller</surname><given-names>LB</given-names></name><name name-style="western"><surname>Moos</surname><given-names>T</given-names></name></person-group><article-title>Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders</article-title><source>Front Pharmacol</source><volume>3</volume><fpage>169</fpage><year>2021</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2012.00169</pub-id><pub-id pub-id-type="pmcid">PMC3456798</pub-id><pub-id pub-id-type="pmid">23055972</pub-id></element-citation></ref><ref id="b77-ijmm-56-05-05613"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Song</surname><given-names>N</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J</given-names></name></person-group><article-title>Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases</article-title><source>Signal Transduct Target Ther</source><volume>10</volume><fpage>31</fpage><year>2025</year><pub-id pub-id-type="doi">10.1038/s41392-024-02071-0</pub-id><pub-id pub-id-type="pmid">39894843</pub-id><pub-id pub-id-type="pmcid">PMC11788444</pub-id></element-citation></ref><ref id="b78-ijmm-56-05-05613"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colombo</surname><given-names>E</given-names></name><name name-style="western"><surname>Triolo</surname><given-names>D</given-names></name><name name-style="western"><surname>Bassani</surname><given-names>C</given-names></name><name name-style="western"><surname>Bedogni</surname><given-names>F</given-names></name><name name-style="western"><surname>Di Dario</surname><given-names>M</given-names></name><name name-style="western"><surname>Dina</surname><given-names>G</given-names></name><name name-style="western"><surname>Fredrickx</surname><given-names>E</given-names></name><name name-style="western"><surname>Fermo</surname><given-names>I</given-names></name><name name-style="western"><surname>Martinelli</surname><given-names>V</given-names></name><name name-style="western"><surname>Newcombe</surname><given-names>J</given-names></name><etal/></person-group><article-title>Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes</article-title><source>Proc Natl Acad Sci USA</source><volume>118</volume><fpage>e2025804118</fpage><year>2021</year><pub-id pub-id-type="doi">10.1073/pnas.2025804118</pub-id><pub-id pub-id-type="pmid">34183414</pub-id><pub-id pub-id-type="pmcid">PMC8271600</pub-id></element-citation></ref><ref id="b79-ijmm-56-05-05613"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hilton</surname><given-names>JBW</given-names></name><name name-style="western"><surname>Kysenius</surname><given-names>K</given-names></name><name name-style="western"><surname>Liddell</surname><given-names>JR</given-names></name><name name-style="western"><surname>Mercer</surname><given-names>SW</given-names></name><name name-style="western"><surname>Hare</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Buncic</surname><given-names>G</given-names></name><name name-style="western"><surname>Paul</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Murray</surname><given-names>SS</given-names></name><name name-style="western"><surname>Kilpatrick</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice</article-title><source>Metallomics</source><volume>16</volume><fpage>mfad072</fpage><year>2024</year><pub-id pub-id-type="doi">10.1093/mtomcs/mfad072</pub-id><pub-id pub-id-type="pmid">38178638</pub-id><pub-id pub-id-type="pmcid">PMC10797489</pub-id></element-citation></ref><ref id="b80-ijmm-56-05-05613"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takikita</surname><given-names>S</given-names></name><name name-style="western"><surname>Takano</surname><given-names>T</given-names></name><name name-style="western"><surname>Narita</surname><given-names>T</given-names></name><name name-style="western"><surname>Maruo</surname><given-names>Y</given-names></name></person-group><article-title>Increased apoptosis and hypomyelination in cerebral white matter of macular mutant mouse brain</article-title><source>Mol Genet Metab Rep</source><volume>4</volume><fpage>25</fpage><lpage>29</lpage><year>2015</year><pub-id pub-id-type="pmid">26937406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymgmr.2015.05.005</pub-id><pub-id pub-id-type="pmcid">PMC4750634</pub-id></element-citation></ref><ref id="b81-ijmm-56-05-05613"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zlatic</surname><given-names>S</given-names></name><name name-style="western"><surname>Comstra</surname><given-names>HS</given-names></name><name name-style="western"><surname>Gokhale</surname><given-names>A</given-names></name><name name-style="western"><surname>Petris</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Faundez</surname><given-names>V</given-names></name></person-group><article-title>Molecular basis of neurodegeneration and neurodevelopmental defects in Menkes disease</article-title><source>Neurobiol Dis</source><volume>81</volume><fpage>154</fpage><lpage>161</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.nbd.2014.12.024</pub-id><pub-id pub-id-type="pmid">25583185</pub-id><pub-id pub-id-type="pmcid">PMC4499018</pub-id></element-citation></ref><ref id="b82-ijmm-56-05-05613"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hatori</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>K</given-names></name><name name-style="western"><surname>Furukawa</surname><given-names>E</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>NM</given-names></name><name name-style="western"><surname>Yang</surname><given-names>N</given-names></name><name name-style="western"><surname>Liu</surname><given-names>CN</given-names></name><name name-style="western"><surname>Sockanathan</surname><given-names>S</given-names></name><name name-style="western"><surname>Lutsenko</surname><given-names>S</given-names></name></person-group><article-title>Neuronal differentiation is associated with a redox-regulated increase of copper flow to the secretory pathway</article-title><source>Nat Commun</source><volume>7</volume><fpage>10640</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/ncomms10640</pub-id><pub-id pub-id-type="pmid">26879543</pub-id><pub-id pub-id-type="pmcid">PMC4757759</pub-id></element-citation></ref><ref id="b83-ijmm-56-05-05613"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>WT</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>AC</given-names></name><name name-style="western"><surname>Lozano</surname><given-names>AA</given-names></name></person-group><article-title>Maternal copper deficiency impairs the developmental expression of protein kinase C &#945;, &#946; and &#947; isoforms in neonatal rat brain</article-title><source>Nutr Neurosci</source><volume>3</volume><fpage>113</fpage><lpage>122</lpage><year>2000</year><pub-id pub-id-type="doi">10.1080/1028415X.2000.11747307</pub-id><pub-id pub-id-type="pmid">27416368</pub-id></element-citation></ref><ref id="b84-ijmm-56-05-05613"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xhabija</surname><given-names>B</given-names></name><name name-style="western"><surname>Kidder</surname><given-names>BL</given-names></name></person-group><article-title>KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer</article-title><source>Semin Cancer Biol</source><volume>57</volume><fpage>79</fpage><lpage>85</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.semcancer.2018.11.001</pub-id><pub-id pub-id-type="pmid">30448242</pub-id><pub-id pub-id-type="pmcid">PMC6522339</pub-id></element-citation></ref><ref id="b85-ijmm-56-05-05613"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>G</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cao</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><etal/></person-group><article-title>Insights into the role of copper in neurodegenerative diseases and the therapeutic potential of natural compounds</article-title><source>Curr Neuropharmacol</source><volume>22</volume><fpage>1650</fpage><lpage>1671</lpage><year>2024</year><pub-id pub-id-type="doi">10.2174/1570159X22666231103085859</pub-id><pub-id pub-id-type="pmid">38037913</pub-id><pub-id pub-id-type="pmcid">PMC11284712</pub-id></element-citation></ref><ref id="b86-ijmm-56-05-05613"><label>86</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ramani</surname><given-names>PK</given-names></name><name name-style="western"><surname>Parayil Sankaran</surname><given-names>B</given-names></name></person-group><article-title>Menkes Disease</article-title><source>StatPearls</source><publisher-name>StatPearls Publishing LLC</publisher-name><publisher-loc>Treasure Island, FL</publisher-loc><year>2025</year><pub-id pub-id-type="pmid">32809752</pub-id></element-citation></ref><ref id="b87-ijmm-56-05-05613"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pilozzi</surname><given-names>A</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Carreras</surname><given-names>I</given-names></name><name name-style="western"><surname>Cormier</surname><given-names>K</given-names></name><name name-style="western"><surname>Hartley</surname><given-names>D</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>J</given-names></name><name name-style="western"><surname>Dedeoglu</surname><given-names>A</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name></person-group><article-title>A preliminary study of Cu exposure effects upon Alzheimer's amyloid pathology</article-title><source>Biomolecules</source><volume>10</volume><fpage>408</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/biom10030408</pub-id><pub-id pub-id-type="pmid">32155778</pub-id><pub-id pub-id-type="pmcid">PMC7175127</pub-id></element-citation></ref><ref id="b88-ijmm-56-05-05613"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitazawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>D</given-names></name><name name-style="western"><surname>Laferla</surname><given-names>FM</given-names></name></person-group><article-title>Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD</article-title><source>J Neurochem</source><volume>108</volume><fpage>1550</fpage><lpage>1560</lpage><year>2009</year><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.05901.x</pub-id><pub-id pub-id-type="pmid">19183260</pub-id><pub-id pub-id-type="pmcid">PMC4096128</pub-id></element-citation></ref><ref id="b89-ijmm-56-05-05613"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crouch</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Hung</surname><given-names>LW</given-names></name><name name-style="western"><surname>Adlard</surname><given-names>PA</given-names></name><name name-style="western"><surname>Cortes</surname><given-names>M</given-names></name><name name-style="western"><surname>Lal</surname><given-names>V</given-names></name><name name-style="western"><surname>Filiz</surname><given-names>G</given-names></name><name name-style="western"><surname>Perez</surname><given-names>KA</given-names></name><name name-style="western"><surname>Nurjono</surname><given-names>M</given-names></name><name name-style="western"><surname>Caragounis</surname><given-names>A</given-names></name><name name-style="western"><surname>Du</surname><given-names>T</given-names></name><etal/></person-group><article-title>Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation</article-title><source>Proc Natl Acad Sci USA</source><volume>106</volume><fpage>381</fpage><lpage>386</lpage><year>2009</year><pub-id pub-id-type="doi">10.1073/pnas.0809057106</pub-id><pub-id pub-id-type="pmid">19122148</pub-id><pub-id pub-id-type="pmcid">PMC2626711</pub-id></element-citation></ref><ref id="b90-ijmm-56-05-05613"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tsim</surname><given-names>KWK</given-names></name><name name-style="western"><surname>Wang</surname><given-names>WX</given-names></name></person-group><article-title>Disruption of copper redox balance and dysfunction under in vivo and in vitro Alzheimer's disease models</article-title><source>Environ Health (Wash)</source><volume>3</volume><fpage>238</fpage><lpage>249</lpage><year>2024</year><pub-id pub-id-type="doi">10.1021/envhealth.4c00175</pub-id><pub-id pub-id-type="pmid">40144323</pub-id><pub-id pub-id-type="pmcid">PMC11934196</pub-id></element-citation></ref><ref id="b91-ijmm-56-05-05613"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hua</surname><given-names>H</given-names></name><name name-style="western"><surname>M&#252;nter</surname><given-names>L</given-names></name><name name-style="western"><surname>Harmeier</surname><given-names>A</given-names></name><name name-style="western"><surname>Georgiev</surname><given-names>O</given-names></name><name name-style="western"><surname>Multhaup</surname><given-names>G</given-names></name><name name-style="western"><surname>Schaffner</surname><given-names>W</given-names></name></person-group><article-title>Toxicity of Alzheimer's disease-associated A&#946; peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability</article-title><source>Biol Chem</source><volume>392</volume><fpage>919</fpage><lpage>926</lpage><year>2011</year><pub-id pub-id-type="doi">10.1515/BC.2011.084</pub-id><pub-id pub-id-type="pmid">21801085</pub-id></element-citation></ref><ref id="b92-ijmm-56-05-05613"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Chang</surname><given-names>RC</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis</article-title><source>J Alzheimers Dis</source><volume>44</volume><fpage>455</fpage><lpage>469</lpage><year>2015</year><pub-id pub-id-type="doi">10.3233/JAD-141776</pub-id><pub-id pub-id-type="pmid">25352456</pub-id></element-citation></ref><ref id="b93-ijmm-56-05-05613"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sparks</surname><given-names>DL</given-names></name><name name-style="western"><surname>Schreurs</surname><given-names>BG</given-names></name></person-group><article-title>Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease</article-title><source>Proc Natl Acad Sci USA</source><volume>100</volume><fpage>11065</fpage><lpage>11069</lpage><year>2003</year><pub-id pub-id-type="doi">10.1073/pnas.1832769100</pub-id><pub-id pub-id-type="pmid">12920183</pub-id><pub-id pub-id-type="pmcid">PMC196927</pub-id></element-citation></ref><ref id="b94-ijmm-56-05-05613"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sparks</surname><given-names>DL</given-names></name><name name-style="western"><surname>Friedland</surname><given-names>R</given-names></name><name name-style="western"><surname>Petanceska</surname><given-names>S</given-names></name><name name-style="western"><surname>Schreurs</surname><given-names>BG</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name><name name-style="western"><surname>Perry</surname><given-names>G</given-names></name><name name-style="western"><surname>Smith</surname><given-names>MA</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Derosa</surname><given-names>S</given-names></name><name name-style="western"><surname>Ziolkowski</surname><given-names>C</given-names></name><name name-style="western"><surname>Stankovic</surname><given-names>G</given-names></name></person-group><article-title>Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology</article-title><source>J Nutr Health Aging</source><volume>10</volume><fpage>247</fpage><lpage>254</lpage><year>2006</year><pub-id pub-id-type="pmid">16886094</pub-id><pub-id pub-id-type="pmcid">PMC3899576</pub-id></element-citation></ref><ref id="b95-ijmm-56-05-05613"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prohaska</surname><given-names>JR</given-names></name><name name-style="western"><surname>Brokate</surname><given-names>B</given-names></name></person-group><article-title>Copper deficiency alters rat dopamine beta-monooxygenase mRNA and activity</article-title><source>J Nutr</source><volume>129</volume><fpage>2147</fpage><lpage>2153</lpage><year>1999</year><pub-id pub-id-type="doi">10.1093/jn/129.12.2147</pub-id><pub-id pub-id-type="pmid">10573542</pub-id></element-citation></ref><ref id="b96-ijmm-56-05-05613"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name><name name-style="western"><surname>Saari</surname><given-names>JT</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>WT</given-names></name></person-group><article-title>Copper deficiency decreases complex IV but not complex I, II, III, or V in the mitochondrial respiratory chain in rat heart</article-title><source>J Nutr</source><volume>137</volume><fpage>14</fpage><lpage>18</lpage><year>2007</year><pub-id pub-id-type="doi">10.1093/jn/137.1.14</pub-id><pub-id pub-id-type="pmid">17182794</pub-id></element-citation></ref><ref id="b97-ijmm-56-05-05613"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plantone</surname><given-names>D</given-names></name><name name-style="western"><surname>Primiano</surname><given-names>G</given-names></name><name name-style="western"><surname>Renna</surname><given-names>R</given-names></name><name name-style="western"><surname>Restuccia</surname><given-names>D</given-names></name><name name-style="western"><surname>Iorio</surname><given-names>R</given-names></name><name name-style="western"><surname>Patanella</surname><given-names>KA</given-names></name><name name-style="western"><surname>Ferilli</surname><given-names>MN</given-names></name><name name-style="western"><surname>Servidei</surname><given-names>S</given-names></name></person-group><article-title>Copper deficiency myelopathy: A report of two cases</article-title><source>J Spinal Cord Med</source><volume>38</volume><fpage>559</fpage><lpage>562</lpage><year>2015</year><pub-id pub-id-type="doi">10.1179/2045772314Y.0000000268</pub-id><pub-id pub-id-type="pmid">25343982</pub-id><pub-id pub-id-type="pmcid">PMC4612215</pub-id></element-citation></ref><ref id="b98-ijmm-56-05-05613"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>N</given-names></name><name name-style="western"><surname>Gross</surname><given-names>JB</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Ahlskog</surname><given-names>JE</given-names></name></person-group><article-title>Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration</article-title><source>Neurology</source><volume>63</volume><fpage>33</fpage><lpage>39</lpage><year>2004</year><pub-id pub-id-type="doi">10.1212/01.WNL.0000132644.52613.FA</pub-id><pub-id pub-id-type="pmid">15249607</pub-id></element-citation></ref><ref id="b99-ijmm-56-05-05613"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaiser</surname><given-names>SR</given-names></name><name name-style="western"><surname>Winston</surname><given-names>GP</given-names></name></person-group><article-title>Copper deficiency myelopathy</article-title><source>J Neurol</source><volume>257</volume><fpage>869</fpage><lpage>881</lpage><year>2010</year><pub-id pub-id-type="doi">10.1007/s00415-010-5511-x</pub-id><pub-id pub-id-type="pmid">20232210</pub-id><pub-id pub-id-type="pmcid">PMC3691478</pub-id></element-citation></ref><ref id="b100-ijmm-56-05-05613"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naismith</surname><given-names>RT</given-names></name><name name-style="western"><surname>Shepherd</surname><given-names>JB</given-names></name><name name-style="western"><surname>Weihl</surname><given-names>CC</given-names></name><name name-style="western"><surname>Tutlam</surname><given-names>NT</given-names></name><name name-style="western"><surname>Cross</surname><given-names>AH</given-names></name></person-group><article-title>Acute and bilateral blindness due to optic neuropathy associated with copper deficiency</article-title><source>Arch Neurol</source><volume>66</volume><fpage>1025</fpage><lpage>1027</lpage><year>2009</year><pub-id pub-id-type="doi">10.1001/archneurol.2009.70</pub-id><pub-id pub-id-type="pmid">19667226</pub-id><pub-id pub-id-type="pmcid">PMC2893403</pub-id></element-citation></ref><ref id="b101-ijmm-56-05-05613"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lombardo</surname><given-names>MF</given-names></name><name name-style="western"><surname>Ciriolo</surname><given-names>MR</given-names></name><name name-style="western"><surname>Rotilio</surname><given-names>G</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>L</given-names></name></person-group><article-title>Prolonged copper depletion induces expression of antioxidants and triggers apoptosis in SH-SY5Y neuroblastoma cells</article-title><source>Cell Mol Life Sci</source><volume>60</volume><fpage>1733</fpage><lpage>1743</lpage><year>2003</year><pub-id pub-id-type="doi">10.1007/s00018-003-3153-1</pub-id><pub-id pub-id-type="pmid">14513838</pub-id><pub-id pub-id-type="pmcid">PMC11138813</pub-id></element-citation></ref><ref id="b102-ijmm-56-05-05613"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lane</surname><given-names>AR</given-names></name><name name-style="western"><surname>Scher</surname><given-names>NE</given-names></name><name name-style="western"><surname>Bhattacharjee</surname><given-names>S</given-names></name><name name-style="western"><surname>Zlatic</surname><given-names>SA</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>AM</given-names></name><name name-style="western"><surname>Gokhale</surname><given-names>A</given-names></name><name name-style="western"><surname>Singleton</surname><given-names>KS</given-names></name><name name-style="western"><surname>Duong</surname><given-names>DM</given-names></name><name name-style="western"><surname>McKenna</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>WL</given-names></name><etal/></person-group><article-title>Adaptive protein synthesis in genetic models of copper deficiency and childhood neurodegeneration</article-title><source>Mol Biol Cell</source><volume>36</volume><fpage>ar33</fpage><year>2025</year><pub-id pub-id-type="pmid">39878654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1091/mbc.E24-11-0512</pub-id><pub-id pub-id-type="pmcid">PMC11974963</pub-id></element-citation></ref><ref id="b103-ijmm-56-05-05613"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lutsenko</surname><given-names>S</given-names></name><name name-style="western"><surname>Washington-Hughes</surname><given-names>C</given-names></name><name name-style="western"><surname>Ralle</surname><given-names>M</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>K</given-names></name></person-group><article-title>Copper and the brain noradrenergic system</article-title><source>J Biol Inorg Chem</source><volume>24</volume><fpage>1179</fpage><lpage>1188</lpage><year>2019</year><pub-id pub-id-type="doi">10.1007/s00775-019-01737-3</pub-id><pub-id pub-id-type="pmid">31691104</pub-id><pub-id pub-id-type="pmcid">PMC6941745</pub-id></element-citation></ref><ref id="b104-ijmm-56-05-05613"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robertson</surname><given-names>D</given-names></name><name name-style="western"><surname>Haile</surname><given-names>V</given-names></name><name name-style="western"><surname>Perry</surname><given-names>SE</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>RM</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>JA</given-names><suffix>III</suffix></name><name name-style="western"><surname>Biaggioni</surname><given-names>I</given-names></name></person-group><article-title>Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation</article-title><source>Hypertension</source><volume>18</volume><fpage>1</fpage><lpage>8</lpage><year>1991</year><pub-id pub-id-type="doi">10.1161/01.HYP.18.1.1</pub-id><pub-id pub-id-type="pmid">1677640</pub-id></element-citation></ref><ref id="b105-ijmm-56-05-05613"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bortolato</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Shih</surname><given-names>JC</given-names></name></person-group><article-title>Monoamine oxidase inactivation: From pathophysiology to therapeutics</article-title><source>Adv Drug Deliv Rev</source><volume>60</volume><fpage>1527</fpage><lpage>1533</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.addr.2008.06.002</pub-id><pub-id pub-id-type="pmid">18652859</pub-id><pub-id pub-id-type="pmcid">PMC2630537</pub-id></element-citation></ref><ref id="b106-ijmm-56-05-05613"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Mao</surname><given-names>F</given-names></name><name name-style="western"><surname>Bao</surname><given-names>K</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Rational design of novel selective dual-target inhibitors of acetylcholinesterase and monoamine oxidase B as potential anti-Alzheimer's disease agents</article-title><source>ACS Chem Neurosci</source><volume>10</volume><fpage>482</fpage><lpage>496</lpage><year>2019</year><pub-id pub-id-type="doi">10.1021/acschemneuro.8b00357</pub-id><pub-id pub-id-type="pmid">30110536</pub-id></element-citation></ref><ref id="b107-ijmm-56-05-05613"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaler</surname><given-names>SG</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>CS</given-names></name></person-group><article-title>Catecholamine metabolites affected by the copper-dependent enzyme dopamine-beta-hydroxylase provide sensitive biomarkers for early diagnosis of menkes disease and viral-mediated ATP7A gene therapy</article-title><source>Adv Pharmacol</source><volume>68</volume><fpage>223</fpage><lpage>233</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/B978-0-12-411512-5.00011-7</pub-id><pub-id pub-id-type="pmid">24054147</pub-id><pub-id pub-id-type="pmcid">PMC6421562</pub-id></element-citation></ref><ref id="b108-ijmm-56-05-05613"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>MK</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>F</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>T</given-names></name><name name-style="western"><surname>Kato</surname><given-names>T</given-names></name></person-group><article-title>Dopamine-&#946;-Hydroxylase (DBH), Its cofactors and other biochemical parameters in the serum of neurological patients in Bangladesh</article-title><source>Int J Biomed Sci</source><volume>5</volume><fpage>395</fpage><lpage>401</lpage><year>2009</year><pub-id pub-id-type="doi">10.59566/IJBS.2009.5395</pub-id><pub-id pub-id-type="pmid">23675164</pub-id><pub-id pub-id-type="pmcid">PMC3614808</pub-id></element-citation></ref><ref id="b109-ijmm-56-05-05613"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>T</given-names></name><name name-style="western"><surname>Ackerman</surname><given-names>CM</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>EC</given-names></name><name name-style="western"><surname>Jia</surname><given-names>S</given-names></name><name name-style="western"><surname>Hoagland</surname><given-names>A</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J</given-names></name><name name-style="western"><surname>Thai</surname><given-names>B</given-names></name><name name-style="western"><surname>Liu</surname><given-names>CS</given-names></name><name name-style="western"><surname>Isacoff</surname><given-names>EY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CJ</given-names></name></person-group><article-title>Copper regulates rest-activity cycles through the locus coeruleus-norepinephrine system</article-title><source>Nat Chem Biol</source><volume>14</volume><fpage>655</fpage><lpage>663</lpage><year>2018</year><pub-id pub-id-type="doi">10.1038/s41589-018-0062-z</pub-id><pub-id pub-id-type="pmid">29867144</pub-id><pub-id pub-id-type="pmcid">PMC6008210</pub-id></element-citation></ref><ref id="b110-ijmm-56-05-05613"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bisaglia</surname><given-names>M</given-names></name><name name-style="western"><surname>Bubacco</surname><given-names>L</given-names></name></person-group><article-title>Copper Ions and Parkinson's disease: Why is homeostasis so relevant?</article-title><source>Biomolecules</source><volume>10</volume><fpage>195</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/biom10020195</pub-id><pub-id pub-id-type="pmid">32013126</pub-id><pub-id pub-id-type="pmcid">PMC7072482</pub-id></element-citation></ref><ref id="b111-ijmm-56-05-05613"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>JL</given-names></name><name name-style="western"><surname>Fan</surname><given-names>YG</given-names></name><name name-style="western"><surname>Yang</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name></person-group><article-title>Iron and Alzheimer's disease: From pathogenesis to therapeutic implications</article-title><source>Front Neurosci</source><volume>12</volume><fpage>632</fpage><year>2018</year><pub-id pub-id-type="doi">10.3389/fnins.2018.00632</pub-id><pub-id pub-id-type="pmid">30250423</pub-id><pub-id pub-id-type="pmcid">PMC6139360</pub-id></element-citation></ref><ref id="b112-ijmm-56-05-05613"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mondola</surname><given-names>P</given-names></name><name name-style="western"><surname>Damiano</surname><given-names>S</given-names></name><name name-style="western"><surname>Sasso</surname><given-names>A</given-names></name><name name-style="western"><surname>Santillo</surname><given-names>M</given-names></name></person-group><article-title>The Cu, Zn Superoxide Dismutase: Not only a dismutase enzyme</article-title><source>Front Physiol</source><volume>7</volume><fpage>594</fpage><year>2016</year><pub-id pub-id-type="doi">10.3389/fphys.2016.00594</pub-id><pub-id pub-id-type="pmid">27965593</pub-id><pub-id pub-id-type="pmcid">PMC5126113</pub-id></element-citation></ref><ref id="b113-ijmm-56-05-05613"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>S</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Luo</surname><given-names>SZ</given-names></name></person-group><article-title>A liquid-to-solid phase transition of Cu/Zn superoxide dismutase 1 initiated by oxidation and disease mutation</article-title><source>J Biol Chem</source><volume>299</volume><fpage>102857</fpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.jbc.2022.102857</pub-id><pub-id pub-id-type="pmid">36592929</pub-id><pub-id pub-id-type="pmcid">PMC9898760</pub-id></element-citation></ref><ref id="b114-ijmm-56-05-05613"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trist</surname><given-names>BG</given-names></name><name name-style="western"><surname>Hilton</surname><given-names>JB</given-names></name><name name-style="western"><surname>Hare</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Crouch</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Double</surname><given-names>KL</given-names></name></person-group><article-title>Superoxide dismutase 1 in health and disease: How a frontline antioxidant becomes neurotoxic</article-title><source>Angew Chem Int Ed Engl</source><volume>60</volume><fpage>9215</fpage><lpage>9246</lpage><year>2021</year><pub-id pub-id-type="doi">10.1002/anie.202000451</pub-id><pub-id pub-id-type="pmid">32144830</pub-id><pub-id pub-id-type="pmcid">PMC8247289</pub-id></element-citation></ref><ref id="b115-ijmm-56-05-05613"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furukawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Torres</surname><given-names>AS</given-names></name><name name-style="western"><surname>O'Halloran</surname><given-names>TV</given-names></name></person-group><article-title>Oxygen-induced maturation of SOD1: A key role for disulfide formation by the copper chaperone CCS</article-title><source>EMBO J</source><volume>23</volume><fpage>2872</fpage><lpage>2881</lpage><year>2004</year><pub-id pub-id-type="doi">10.1038/sj.emboj.7600276</pub-id><pub-id pub-id-type="pmid">15215895</pub-id><pub-id pub-id-type="pmcid">PMC1150991</pub-id></element-citation></ref><ref id="b116-ijmm-56-05-05613"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prohaska</surname><given-names>JR</given-names></name><name name-style="western"><surname>Brokate</surname><given-names>B</given-names></name></person-group><article-title>Lower copper, zinc-superoxide dismutase protein but not mRNA in organs of copper-deficient rats</article-title><source>Arch Biochem Biophys</source><volume>393</volume><fpage>170</fpage><lpage>176</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/abbi.2001.2470</pub-id><pub-id pub-id-type="pmid">11516174</pub-id></element-citation></ref><ref id="b117-ijmm-56-05-05613"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murakami</surname><given-names>K</given-names></name><name name-style="western"><surname>Murata</surname><given-names>N</given-names></name><name name-style="western"><surname>Noda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tahara</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaneko</surname><given-names>T</given-names></name><name name-style="western"><surname>Kinoshita</surname><given-names>N</given-names></name><name name-style="western"><surname>Hatsuta</surname><given-names>H</given-names></name><name name-style="western"><surname>Murayama</surname><given-names>S</given-names></name><name name-style="western"><surname>Barnham</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Irie</surname><given-names>K</given-names></name><etal/></person-group><article-title>SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid &#946; protein oligomerization and memory loss in mouse model of Alzheimer disease</article-title><source>J Biol Chem</source><volume>286</volume><fpage>44557</fpage><lpage>44568</lpage><year>2011</year><pub-id pub-id-type="doi">10.1074/jbc.M111.279208</pub-id><pub-id pub-id-type="pmid">22072713</pub-id><pub-id pub-id-type="pmcid">PMC3247976</pub-id></element-citation></ref><ref id="b118-ijmm-56-05-05613"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>PC</given-names></name><name name-style="western"><surname>Waggoner</surname><given-names>D</given-names></name><name name-style="western"><surname>Subramaniam</surname><given-names>JR</given-names></name><name name-style="western"><surname>Tessarollo</surname><given-names>L</given-names></name><name name-style="western"><surname>Bartnikas</surname><given-names>TB</given-names></name><name name-style="western"><surname>Culotta</surname><given-names>VC</given-names></name><name name-style="western"><surname>Price</surname><given-names>DL</given-names></name><name name-style="western"><surname>Rothstein</surname><given-names>J</given-names></name><name name-style="western"><surname>Gitlin</surname><given-names>JD</given-names></name></person-group><article-title>Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase</article-title><source>Proc Natl Acad Sci USA</source><volume>97</volume><fpage>2886</fpage><lpage>2891</lpage><year>2000</year><pub-id pub-id-type="doi">10.1073/pnas.040461197</pub-id><pub-id pub-id-type="pmid">10694572</pub-id><pub-id pub-id-type="pmcid">PMC16025</pub-id></element-citation></ref><ref id="b119-ijmm-56-05-05613"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>LR</given-names></name><name name-style="western"><surname>Glass</surname><given-names>JD</given-names></name></person-group><article-title>Oxidative stress induced by loss of Cu,Zn-superoxide dismutase (SOD1) or superoxide-generating herbicides causes axonal degeneration in mouse DRG cultures</article-title><source>Acta Neuropathol</source><volume>119</volume><fpage>249</fpage><lpage>259</lpage><year>2010</year><pub-id pub-id-type="doi">10.1007/s00401-009-0631-z</pub-id><pub-id pub-id-type="pmid">20039174</pub-id><pub-id pub-id-type="pmcid">PMC4334446</pub-id></element-citation></ref><ref id="b120-ijmm-56-05-05613"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dusek</surname><given-names>P</given-names></name><name name-style="western"><surname>Litwin</surname><given-names>T</given-names></name><name name-style="western"><surname>Cz&#322;onkowska</surname><given-names>A</given-names></name></person-group><article-title>Neurologic impairment in Wilson disease</article-title><source>Ann Transl Med</source><volume>7</volume><issue>Suppl 2</issue><fpage>S64</fpage><year>2019</year><pub-id pub-id-type="doi">10.21037/atm.2019.02.43</pub-id><pub-id pub-id-type="pmid">31179301</pub-id><pub-id pub-id-type="pmcid">PMC6531649</pub-id></element-citation></ref><ref id="b121-ijmm-56-05-05613"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>SS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Ni</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Wu</surname><given-names>ZY</given-names></name></person-group><article-title>The discrepancy between the absence of copper deposition and the presence of neuronal damage in the brain of Atp7b(-/-) mice</article-title><source>Metallomics</source><volume>7</volume><fpage>283</fpage><lpage>288</lpage><year>2015</year><pub-id pub-id-type="doi">10.1039/C4MT00242C</pub-id><pub-id pub-id-type="pmid">25594375</pub-id></element-citation></ref><ref id="b122-ijmm-56-05-05613"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Song</surname><given-names>B</given-names></name><name name-style="western"><surname>Yao</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Gao</surname><given-names>G</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name></person-group><article-title>Emerging insights into cuproptosis and copper metabolism: Implications for age-related diseases and potential therapeutic strategies</article-title><source>Front Aging Neurosci</source><volume>16</volume><fpage>1335122</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fnagi.2024.1335122</pub-id><pub-id pub-id-type="pmid">38715962</pub-id><pub-id pub-id-type="pmcid">PMC11074471</pub-id></element-citation></ref><ref id="b123-ijmm-56-05-05613"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>A</given-names></name></person-group><article-title>Copper-instigated modulatory cell mortality mechanisms and progress in oncological treatment investigations</article-title><source>Front Immunol</source><volume>14</volume><fpage>1236063</fpage><year>2023</year><pub-id pub-id-type="doi">10.3389/fimmu.2023.1236063</pub-id><pub-id pub-id-type="pmid">37600774</pub-id><pub-id pub-id-type="pmcid">PMC10433393</pub-id></element-citation></ref><ref id="b124-ijmm-56-05-05613"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shields</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Traa</surname><given-names>A</given-names></name><name name-style="western"><surname>Van Raamsdonk</surname><given-names>JM</given-names></name></person-group><article-title>Beneficial and detrimental effects of reactive oxygen species on lifespan: A comprehensive review of comparative and experimental studies</article-title><source>Front Cell Dev Biol</source><volume>9</volume><fpage>628157</fpage><year>2021</year><pub-id pub-id-type="doi">10.3389/fcell.2021.628157</pub-id><pub-id pub-id-type="pmid">33644065</pub-id><pub-id pub-id-type="pmcid">PMC7905231</pub-id></element-citation></ref><ref id="b125-ijmm-56-05-05613"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Juan</surname><given-names>CA</given-names></name><name name-style="western"><surname>P&#233;rez de la Lastra</surname><given-names>JM</given-names></name><name name-style="western"><surname>Plou</surname><given-names>FJ</given-names></name><name name-style="western"><surname>P&#233;rez-Lebe&#241;a</surname><given-names>E</given-names></name></person-group><article-title>The chemistry of reactive oxygen species (ROS) revisited: Outlining their role in biological macromolecules (DNA, Lipids and Proteins) and induced pathologies</article-title><source>Int J Mol Sci</source><volume>22</volume><fpage>4642</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/ijms22094642</pub-id><pub-id pub-id-type="pmid">33924958</pub-id><pub-id pub-id-type="pmcid">PMC8125527</pub-id></element-citation></ref><ref id="b126-ijmm-56-05-05613"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Gan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cai</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Fu</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>N</given-names></name></person-group><article-title>Role of copper homeostasis and cuproptosis in heart failure pathogenesis: Implications for therapeutic strategies</article-title><source>Front Pharmacol</source><volume>15</volume><fpage>1527901</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fphar.2024.1527901</pub-id><pub-id pub-id-type="pmid">39850564</pub-id><pub-id pub-id-type="pmcid">PMC11754225</pub-id></element-citation></ref><ref id="b127-ijmm-56-05-05613"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guan</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Han</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name></person-group><article-title>Copper metabolism in osteoarthritis and its relation to oxidative stress and ferroptosis in chondrocytes</article-title><source>Front Mol Biosci</source><volume>11</volume><fpage>1472492</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fmolb.2024.1472492</pub-id><pub-id pub-id-type="pmid">39329090</pub-id><pub-id pub-id-type="pmcid">PMC11425083</pub-id></element-citation></ref><ref id="b128-ijmm-56-05-05613"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>W</given-names></name><name name-style="western"><surname>Su</surname><given-names>S</given-names></name><name name-style="western"><surname>Song</surname><given-names>C</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Jia</surname><given-names>R</given-names></name><name name-style="western"><surname>Xu</surname><given-names>P</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name></person-group><article-title>Effects of copper exposure on oxidative stress, apoptosis, endoplasmic reticulum stress, autophagy and immune response in different tissues of Chinese mitten crab (Eriocheir sinensis)</article-title><source>Antioxidants (Basel)</source><volume>11</volume><fpage>2029</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/antiox11102029</pub-id><pub-id pub-id-type="pmid">36290752</pub-id><pub-id pub-id-type="pmcid">PMC9598082</pub-id></element-citation></ref><ref id="b129-ijmm-56-05-05613"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name></person-group><article-title>Imbalanced GSH/ROS and sequential cell death</article-title><source>J Biochem Mol Toxicol</source><volume>36</volume><fpage>e22942</fpage><year>2022</year><pub-id pub-id-type="doi">10.1002/jbt.22942</pub-id><pub-id pub-id-type="pmid">34725879</pub-id></element-citation></ref><ref id="b130-ijmm-56-05-05613"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medici</surname><given-names>V</given-names></name><name name-style="western"><surname>Sarode</surname><given-names>GV</given-names></name><name name-style="western"><surname>Napoli</surname><given-names>E</given-names></name><name name-style="western"><surname>Song</surname><given-names>GY</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>NM</given-names></name><name name-style="western"><surname>Guimar&#227;es</surname><given-names>AO</given-names></name><name name-style="western"><surname>Mordaunt</surname><given-names>CE</given-names></name><name name-style="western"><surname>Kieffer</surname><given-names>DA</given-names></name><name name-style="western"><surname>Mazi</surname><given-names>TA</given-names></name><name name-style="western"><surname>Czlonkowska</surname><given-names>A</given-names></name><etal/></person-group><article-title>mtDNA depletion-like syndrome in Wilson disease</article-title><source>Liver Int</source><volume>40</volume><fpage>2776</fpage><lpage>2787</lpage><year>2020</year><pub-id pub-id-type="doi">10.1111/liv.14646</pub-id><pub-id pub-id-type="pmid">32996699</pub-id><pub-id pub-id-type="pmcid">PMC8079140</pub-id></element-citation></ref><ref id="b131-ijmm-56-05-05613"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N</given-names></name><name name-style="western"><surname>Han</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name></person-group><article-title>DHPA Protects SH-SY5Y Cells from oxidative stress-induced apoptosis via mitochondria apoptosis and the Keap1/Nrf2/HO-1 signaling pathway</article-title><source>Antioxidants (Basel)</source><volume>11</volume><fpage>1794</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/antiox11091794</pub-id><pub-id pub-id-type="pmid">36139869</pub-id><pub-id pub-id-type="pmcid">PMC9495558</pub-id></element-citation></ref><ref id="b132-ijmm-56-05-05613"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Xia</surname><given-names>X</given-names></name><name name-style="western"><surname>He</surname><given-names>BL</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>TF</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name></person-group><article-title>Copper regulates the host innate immune response against bacterial infection via activation of ALPK1 kinase</article-title><source>Proc Natl Acad Sci USA</source><volume>121</volume><fpage>e2311630121</fpage><year>2024</year><pub-id pub-id-type="doi">10.1073/pnas.2311630121</pub-id><pub-id pub-id-type="pmid">38232278</pub-id><pub-id pub-id-type="pmcid">PMC10823219</pub-id></element-citation></ref><ref id="b133-ijmm-56-05-05613"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Shao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Xing</surname><given-names>M</given-names></name></person-group><article-title>Copper or/and arsenic induce oxidative stress-cascaded, nuclear factor kappa B-dependent inflammation and immune imbalance, trigging heat shock response in the kidney of chicken</article-title><source>Oncotarget</source><volume>8</volume><fpage>98103</fpage><lpage>98116</lpage><year>2017</year><pub-id pub-id-type="doi">10.18632/oncotarget.21463</pub-id><pub-id pub-id-type="pmid">29228677</pub-id><pub-id pub-id-type="pmcid">PMC5716717</pub-id></element-citation></ref><ref id="b134-ijmm-56-05-05613"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deigendesch</surname><given-names>N</given-names></name><name name-style="western"><surname>Zychlinsky</surname><given-names>A</given-names></name><name name-style="western"><surname>Meissner</surname><given-names>F</given-names></name></person-group><article-title>Copper regulates the canonical NLRP3 inflammasome</article-title><source>J Immunol</source><volume>200</volume><fpage>1607</fpage><lpage>1617</lpage><year>2018</year><pub-id pub-id-type="doi">10.4049/jimmunol.1700712</pub-id><pub-id pub-id-type="pmid">29358279</pub-id></element-citation></ref><ref id="b135-ijmm-56-05-05613"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Cao</surname><given-names>F</given-names></name><name name-style="western"><surname>Yin</surname><given-names>HL</given-names></name><name name-style="western"><surname>Huang</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Lin</surname><given-names>ZT</given-names></name><name name-style="western"><surname>Mao</surname><given-names>N</given-names></name><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name></person-group><article-title>Ferroptosis: Past, present and future</article-title><source>Cell Death Dis</source><volume>11</volume><fpage>88</fpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41419-020-2298-2</pub-id><pub-id pub-id-type="pmid">32015325</pub-id><pub-id pub-id-type="pmcid">PMC6997353</pub-id></element-citation></ref><ref id="b136-ijmm-56-05-05613"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>T</given-names></name><name name-style="western"><surname>Du</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name></person-group><article-title>GPX4-independent ferroptosis-a new strategy in disease's therapy</article-title><source>Cell Death Discov</source><volume>8</volume><fpage>434</fpage><year>2022</year><pub-id pub-id-type="doi">10.1038/s41420-022-01212-0</pub-id><pub-id pub-id-type="pmid">36309489</pub-id><pub-id pub-id-type="pmcid">PMC9617873</pub-id></element-citation></ref><ref id="b137-ijmm-56-05-05613"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yan</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Kang</surname><given-names>R</given-names></name><name name-style="western"><surname>Klionsky</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Tang</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Copper-dependent autophagic degradation of GPX4 drives ferroptosis</article-title><source>Autophagy</source><volume>19</volume><fpage>1982</fpage><lpage>1996</lpage><year>2023</year><pub-id pub-id-type="doi">10.1080/15548627.2023.2165323</pub-id><pub-id pub-id-type="pmid">36622894</pub-id><pub-id pub-id-type="pmcid">PMC10283421</pub-id></element-citation></ref><ref id="b138-ijmm-56-05-05613"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jomova</surname><given-names>K</given-names></name><name name-style="western"><surname>Raptova</surname><given-names>R</given-names></name><name name-style="western"><surname>Alomar</surname><given-names>SY</given-names></name><name name-style="western"><surname>Alwasel</surname><given-names>SH</given-names></name><name name-style="western"><surname>Nepovimova</surname><given-names>E</given-names></name><name name-style="western"><surname>Kuca</surname><given-names>K</given-names></name><name name-style="western"><surname>Valko</surname><given-names>M</given-names></name></person-group><article-title>Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging</article-title><source>Arch Toxicol</source><volume>97</volume><fpage>2499</fpage><lpage>2574</lpage><year>2023</year><pub-id pub-id-type="doi">10.1007/s00204-023-03562-9</pub-id><pub-id pub-id-type="pmid">37597078</pub-id><pub-id pub-id-type="pmcid">PMC10475008</pub-id></element-citation></ref><ref id="b139-ijmm-56-05-05613"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Formigari</surname><given-names>A</given-names></name><name name-style="western"><surname>Gregianin</surname><given-names>E</given-names></name><name name-style="western"><surname>Irato</surname><given-names>P</given-names></name></person-group><article-title>The effect of zinc and the role of p53 in copper-induced cellular stress responses</article-title><source>J Appl Toxicol</source><volume>33</volume><fpage>527</fpage><lpage>536</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/jat.2854</pub-id><pub-id pub-id-type="pmid">23401182</pub-id></element-citation></ref><ref id="b140-ijmm-56-05-05613"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aschner</surname><given-names>M</given-names></name><name name-style="western"><surname>Skalny</surname><given-names>AV</given-names></name><name name-style="western"><surname>Lu</surname><given-names>R</given-names></name><name name-style="western"><surname>Martins</surname><given-names>AC</given-names></name><name name-style="western"><surname>Tizabi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nekhoroshev</surname><given-names>SV</given-names></name><name name-style="western"><surname>Santamaria</surname><given-names>A</given-names></name><name name-style="western"><surname>Sinitskiy</surname><given-names>AI</given-names></name><name name-style="western"><surname>Tinkov</surname><given-names>AA</given-names></name></person-group><article-title>Mitochondrial pathways of copper neurotoxicity: Focus on mitochondrial dynamics and mitophagy</article-title><source>Front Mol Neurosci</source><volume>17</volume><fpage>1504802</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fnmol.2024.1504802</pub-id><pub-id pub-id-type="pmid">39703721</pub-id><pub-id pub-id-type="pmcid">PMC11655512</pub-id></element-citation></ref><ref id="b141-ijmm-56-05-05613"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tassone</surname><given-names>G</given-names></name><name name-style="western"><surname>Kola</surname><given-names>A</given-names></name><name name-style="western"><surname>Valensin</surname><given-names>D</given-names></name><name name-style="western"><surname>Pozzi</surname><given-names>C</given-names></name></person-group><article-title>dynamic interplay between copper toxicity and mitochondrial dysfunction in Alzheimer's disease</article-title><source>Life (Basel)</source><volume>11</volume><fpage>386</fpage><year>2021</year><pub-id pub-id-type="pmid">33923275</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/life11050386</pub-id><pub-id pub-id-type="pmcid">PMC8146034</pub-id></element-citation></ref><ref id="b142-ijmm-56-05-05613"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Cuproptosis: A copper-triggered modality of mitochondrial cell death</article-title><source>Cell Res</source><volume>32</volume><fpage>417</fpage><lpage>418</lpage><year>2022</year><pub-id pub-id-type="doi">10.1038/s41422-022-00653-7</pub-id><pub-id pub-id-type="pmid">35354936</pub-id><pub-id pub-id-type="pmcid">PMC9061796</pub-id></element-citation></ref><ref id="b143-ijmm-56-05-05613"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhen</surname><given-names>L</given-names></name><name name-style="western"><surname>Meng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Jia</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease</article-title><source>Biomed Pharmacother</source><volume>163</volume><fpage>114830</fpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.biopha.2023.114830</pub-id><pub-id pub-id-type="pmid">37150036</pub-id></element-citation></ref><ref id="b144-ijmm-56-05-05613"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>C</given-names></name><name name-style="western"><surname>Ling</surname><given-names>H</given-names></name><name name-style="western"><surname>Hao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name></person-group><article-title>Cuproptosis: p53-regulated metabolic cell death?</article-title><source>Cell Death Differ</source><volume>30</volume><fpage>876</fpage><lpage>884</lpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41418-023-01125-0</pub-id><pub-id pub-id-type="pmid">36755067</pub-id><pub-id pub-id-type="pmcid">PMC10070433</pub-id></element-citation></ref><ref id="b145-ijmm-56-05-05613"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brand</surname><given-names>MD</given-names></name><name name-style="western"><surname>Orr</surname><given-names>AL</given-names></name><name name-style="western"><surname>Perevoshchikova</surname><given-names>IV</given-names></name><name name-style="western"><surname>Quinlan</surname><given-names>CL</given-names></name></person-group><article-title>The role of mitochondrial function and cellular bioenergetics in ageing and disease</article-title><source>Br J Dermatol</source><volume>169</volume><issue>Suppl 2</issue><fpage>S1</fpage><lpage>S8</lpage><year>2013</year><pub-id pub-id-type="doi">10.1111/bjd.12208</pub-id><pub-id pub-id-type="pmcid">PMC4321783</pub-id><pub-id pub-id-type="pmid">23786614</pub-id></element-citation></ref><ref id="b146-ijmm-56-05-05613"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zulkifli</surname><given-names>M</given-names></name><name name-style="western"><surname>Spelbring</surname><given-names>AN</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Soma</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Le</surname><given-names>T</given-names></name><name name-style="western"><surname>Shanbhag</surname><given-names>V</given-names></name><name name-style="western"><surname>Petris</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>TY</given-names></name><etal/></person-group><article-title>FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery</article-title><source>Proc Natl Acad Sci USA</source><volume>120</volume><fpage>e2216722120</fpage><year>2023</year><pub-id pub-id-type="doi">10.1073/pnas.2216722120</pub-id><pub-id pub-id-type="pmid">36848556</pub-id><pub-id pub-id-type="pmcid">PMC10013847</pub-id></element-citation></ref><ref id="b147-ijmm-56-05-05613"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kar</surname><given-names>S</given-names></name><name name-style="western"><surname>Sen</surname><given-names>S</given-names></name><name name-style="western"><surname>Maji</surname><given-names>S</given-names></name><name name-style="western"><surname>Saraf</surname><given-names>D</given-names></name><name name-style="western"><surname>Ruturaj</surname></name><name name-style="western"><surname>Paul</surname><given-names>R</given-names></name><name name-style="western"><surname>Dutt</surname><given-names>S</given-names></name><name name-style="western"><surname>Mondal</surname><given-names>B</given-names></name><name name-style="western"><surname>Rodriguez-Boulan</surname><given-names>E</given-names></name><name name-style="western"><surname>Schreiner</surname><given-names>R</given-names></name><etal/></person-group><article-title>Copper(II) import and reduction are dependent on His-Met clusters in the extracellular amino terminus of human copper transporter-1</article-title><source>J Biol Chem</source><volume>298</volume><fpage>101631</fpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.jbc.2022.101631</pub-id><pub-id pub-id-type="pmid">35090891</pub-id><pub-id pub-id-type="pmcid">PMC8867124</pub-id></element-citation></ref><ref id="b148-ijmm-56-05-05613"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>An</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Shan</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name></person-group><article-title>The role of copper homeostasis in brain disease</article-title><source>Int J Mol Sci</source><volume>23</volume><fpage>13850</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/ijms232213850</pub-id><pub-id pub-id-type="pmid">36430330</pub-id><pub-id pub-id-type="pmcid">PMC9698384</pub-id></element-citation></ref><ref id="b149-ijmm-56-05-05613"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leary</surname><given-names>SC</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>BA</given-names></name><name name-style="western"><surname>Pellecchia</surname><given-names>G</given-names></name><name name-style="western"><surname>Guercin</surname><given-names>GH</given-names></name><name name-style="western"><surname>Mattman</surname><given-names>A</given-names></name><name name-style="western"><surname>Jaksch</surname><given-names>M</given-names></name><name name-style="western"><surname>Shoubridge</surname><given-names>EA</given-names></name></person-group><article-title>Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase</article-title><source>Hum Mol Genet</source><volume>13</volume><fpage>1839</fpage><lpage>1848</lpage><year>2004</year><pub-id pub-id-type="doi">10.1093/hmg/ddh197</pub-id><pub-id pub-id-type="pmid">15229189</pub-id></element-citation></ref><ref id="b150-ijmm-56-05-05613"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boulet</surname><given-names>A</given-names></name><name name-style="western"><surname>Vest</surname><given-names>KE</given-names></name><name name-style="western"><surname>Maynard</surname><given-names>MK</given-names></name><name name-style="western"><surname>Gammon</surname><given-names>MG</given-names></name><name name-style="western"><surname>Russell</surname><given-names>AC</given-names></name><name name-style="western"><surname>Mathews</surname><given-names>AT</given-names></name><name name-style="western"><surname>Cole</surname><given-names>SE</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>CB</given-names></name><name name-style="western"><surname>Kwong</surname><given-names>JQ</given-names></name><etal/></person-group><article-title>The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis</article-title><source>J Biol Chem</source><volume>293</volume><fpage>1887</fpage><lpage>1896</lpage><year>2018</year><pub-id pub-id-type="doi">10.1074/jbc.RA117.000265</pub-id><pub-id pub-id-type="pmid">29237729</pub-id><pub-id pub-id-type="pmcid">PMC5808751</pub-id></element-citation></ref><ref id="b151-ijmm-56-05-05613"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Winge</surname><given-names>DR</given-names></name></person-group><article-title>Copper metallochaperones</article-title><source>Annu Rev Biochem</source><volume>79</volume><fpage>537</fpage><lpage>562</lpage><year>2010</year><pub-id pub-id-type="doi">10.1146/annurev-biochem-030409-143539</pub-id><pub-id pub-id-type="pmid">20205585</pub-id><pub-id pub-id-type="pmcid">PMC3986808</pub-id></element-citation></ref><ref id="b152-ijmm-56-05-05613"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dela Cruz</surname><given-names>R</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>MY</given-names></name><name name-style="western"><surname>Winge</surname><given-names>DR</given-names></name></person-group><article-title>Cox1 mutation abrogates need for Cox23 in cytochrome c oxidase biogenesis</article-title><source>Microb Cell</source><volume>3</volume><fpage>275</fpage><lpage>284</lpage><year>2016</year><pub-id pub-id-type="doi">10.15698/mic2016.07.511</pub-id><pub-id pub-id-type="pmid">28357365</pub-id><pub-id pub-id-type="pmcid">PMC5354592</pub-id></element-citation></ref><ref id="b153-ijmm-56-05-05613"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garza</surname><given-names>NM</given-names></name><name name-style="western"><surname>Swaminathan</surname><given-names>AB</given-names></name><name name-style="western"><surname>Maremanda</surname><given-names>KP</given-names></name><name name-style="western"><surname>Zulkifli</surname><given-names>M</given-names></name><name name-style="western"><surname>Gohil</surname><given-names>VM</given-names></name></person-group><article-title>Mitochondrial copper in human genetic disorders</article-title><source>Trends Endocrinol Metab</source><volume>34</volume><fpage>21</fpage><lpage>33</lpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.tem.2022.11.001</pub-id><pub-id pub-id-type="pmid">36435678</pub-id><pub-id pub-id-type="pmcid">PMC9780195</pub-id></element-citation></ref><ref id="b154-ijmm-56-05-05613"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawamata</surname><given-names>H</given-names></name><name name-style="western"><surname>Manfredi</surname><given-names>G</given-names></name></person-group><article-title>Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space</article-title><source>Antioxid Redox Signal</source><volume>13</volume><fpage>1375</fpage><lpage>1384</lpage><year>2010</year><pub-id pub-id-type="doi">10.1089/ars.2010.3212</pub-id><pub-id pub-id-type="pmid">20367259</pub-id><pub-id pub-id-type="pmcid">PMC2962758</pub-id></element-citation></ref><ref id="b155-ijmm-56-05-05613"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyd</surname><given-names>SD</given-names></name><name name-style="western"><surname>Calvo</surname><given-names>JS</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Ullrich</surname><given-names>MS</given-names></name><name name-style="western"><surname>Skopp</surname><given-names>A</given-names></name><name name-style="western"><surname>Meloni</surname><given-names>G</given-names></name><name name-style="western"><surname>Winkler</surname><given-names>DD</given-names></name></person-group><article-title>The yeast copper chaperone for copper-zinc superoxide dismutase (CCS1) is a multifunctional chaperone promoting all levels of SOD1 maturation</article-title><source>J Biol Chem</source><volume>294</volume><fpage>1956</fpage><lpage>1966</lpage><year>2019</year><pub-id pub-id-type="doi">10.1074/jbc.RA118.005283</pub-id><pub-id pub-id-type="pmid">30530491</pub-id><pub-id pub-id-type="pmcid">PMC6369272</pub-id></element-citation></ref><ref id="b156-ijmm-56-05-05613"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>M</given-names></name><name name-style="western"><surname>Riemer</surname><given-names>J</given-names></name></person-group><article-title>Human copper chaperone for superoxide dismutase 1 mediates its own oxidation-dependent import into mitochondria</article-title><source>Nat Commun</source><volume>4</volume><fpage>2430</fpage><year>2013</year><pub-id pub-id-type="doi">10.1038/ncomms3430</pub-id><pub-id pub-id-type="pmid">24026195</pub-id></element-citation></ref><ref id="b157-ijmm-56-05-05613"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name></person-group><article-title>Cuproptosis: Molecular mechanisms, cancer prognosis, and therapeutic applications</article-title><source>J Transl Med</source><volume>23</volume><fpage>104</fpage><year>2025</year><pub-id pub-id-type="doi">10.1186/s12967-025-06121-1</pub-id><pub-id pub-id-type="pmid">39844182</pub-id><pub-id pub-id-type="pmcid">PMC11752808</pub-id></element-citation></ref><ref id="b158-ijmm-56-05-05613"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dreishpoon</surname><given-names>MB</given-names></name><name name-style="western"><surname>Bick</surname><given-names>NR</given-names></name><name name-style="western"><surname>Petrova</surname><given-names>B</given-names></name><name name-style="western"><surname>Warui</surname><given-names>DM</given-names></name><name name-style="western"><surname>Cameron</surname><given-names>A</given-names></name><name name-style="western"><surname>Booker</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kanarek</surname><given-names>N</given-names></name><name name-style="western"><surname>Golub</surname><given-names>TR</given-names></name><name name-style="western"><surname>Tsvetkov</surname><given-names>P</given-names></name></person-group><article-title>FDX1 regulates cellular protein lipoylation through direct binding to LIAS</article-title><source>J Biol Chem</source><volume>299</volume><fpage>105046</fpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.jbc.2023.105046</pub-id><pub-id pub-id-type="pmid">37453661</pub-id><pub-id pub-id-type="pmcid">PMC10462841</pub-id></element-citation></ref><ref id="b159-ijmm-56-05-05613"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rowland</surname><given-names>EA</given-names></name><name name-style="western"><surname>Snowden</surname><given-names>CK</given-names></name><name name-style="western"><surname>Cristea</surname><given-names>IM</given-names></name></person-group><article-title>Protein lipoylation: An evolutionarily conserved metabolic regulator of health and disease</article-title><source>Curr Opin Chem Biol</source><volume>42</volume><fpage>76</fpage><lpage>85</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.cbpa.2017.11.003</pub-id><pub-id pub-id-type="pmid">29169048</pub-id><pub-id pub-id-type="pmcid">PMC5965299</pub-id></element-citation></ref><ref id="b160-ijmm-56-05-05613"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Springer</surname><given-names>C</given-names></name><name name-style="western"><surname>Humayun</surname><given-names>D</given-names></name><name name-style="western"><surname>Skouta</surname><given-names>R</given-names></name></person-group><article-title>Cuproptosis: Unraveling the mechanisms of copper-induced cell death and its implication in cancer therapy</article-title><source>Cancers (Basel)</source><volume>16</volume><fpage>647</fpage><year>2024</year><pub-id pub-id-type="doi">10.3390/cancers16030647</pub-id><pub-id pub-id-type="pmid">38339398</pub-id><pub-id pub-id-type="pmcid">PMC10854864</pub-id></element-citation></ref><ref id="b161-ijmm-56-05-05613"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>B</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S</given-names></name></person-group><article-title>Mechanisms linking mitochondrial dysfunction and proteostasis failure</article-title><source>Trends Cell Biol</source><volume>30</volume><fpage>317</fpage><lpage>328</lpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.tcb.2020.01.008</pub-id><pub-id pub-id-type="pmid">32200806</pub-id><pub-id pub-id-type="pmcid">PMC7093050</pub-id></element-citation></ref><ref id="b162-ijmm-56-05-05613"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>V&#225;zquez</surname><given-names>G</given-names></name><name name-style="western"><surname>Caballero</surname><given-names>AB</given-names></name><name name-style="western"><surname>Kokinda</surname><given-names>J</given-names></name><name name-style="western"><surname>Hijano</surname><given-names>A</given-names></name><name name-style="western"><surname>Sabat&#233;</surname><given-names>R</given-names></name><name name-style="western"><surname>Gamez</surname><given-names>P</given-names></name></person-group><article-title>Copper, dityrosine cross-links and amyloid-&#946; aggregation</article-title><source>J Biol Inorg Chem</source><volume>24</volume><fpage>1217</fpage><lpage>1229</lpage><year>2019</year><pub-id pub-id-type="doi">10.1007/s00775-019-01734-6</pub-id><pub-id pub-id-type="pmid">31667594</pub-id></element-citation></ref><ref id="b163-ijmm-56-05-05613"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Ll</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>The diversified role of mitochondria in ferroptosis in cancer</article-title><source>Cell Death Dis</source><volume>14</volume><fpage>519</fpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41419-023-06045-y</pub-id><pub-id pub-id-type="pmid">37580393</pub-id><pub-id pub-id-type="pmcid">PMC10425449</pub-id></element-citation></ref><ref id="b164-ijmm-56-05-05613"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Chan</surname><given-names>KY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HS</given-names></name><name name-style="western"><surname>Lin</surname><given-names>KN</given-names></name><name name-style="western"><surname>Wang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Lau</surname><given-names>TS</given-names></name></person-group><article-title>Interplay of ferroptosis and cuproptosis in cancer: Dissecting metal-driven mechanisms for therapeutic potentials</article-title><source>Cancers (Basel)</source><volume>16</volume><fpage>512</fpage><year>2024</year><pub-id pub-id-type="doi">10.3390/cancers16030512</pub-id><pub-id pub-id-type="pmid">38339263</pub-id><pub-id pub-id-type="pmcid">PMC10854932</pub-id></element-citation></ref><ref id="b165-ijmm-56-05-05613"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saporito-Magri&#241;&#225;</surname><given-names>CM</given-names></name><name name-style="western"><surname>Musacco-Sebio</surname><given-names>RN</given-names></name><name name-style="western"><surname>Andrieux</surname><given-names>G</given-names></name><name name-style="western"><surname>Kook</surname><given-names>L</given-names></name><name name-style="western"><surname>Orrego</surname><given-names>MT</given-names></name><name name-style="western"><surname>Tuttolomondo</surname><given-names>MV</given-names></name><name name-style="western"><surname>Desimone</surname><given-names>MF</given-names></name><name name-style="western"><surname>Boerries</surname><given-names>M</given-names></name><name name-style="western"><surname>Borner</surname><given-names>C</given-names></name><name name-style="western"><surname>Repetto</surname><given-names>MG</given-names></name></person-group><article-title>Copper-induced cell death and the protective role of glutathione: The implication of impaired protein folding rather than oxidative stress</article-title><source>Metallomics</source><volume>10</volume><fpage>1743</fpage><lpage>1754</lpage><year>2018</year><pub-id pub-id-type="doi">10.1039/C8MT00182K</pub-id><pub-id pub-id-type="pmid">30311620</pub-id></element-citation></ref><ref id="b166-ijmm-56-05-05613"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ribas</surname><given-names>V</given-names></name><name name-style="western"><surname>Garc&#237;a-Ruiz</surname><given-names>C</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Checa</surname><given-names>JC</given-names></name></person-group><article-title>Glutathione and mitochondria</article-title><source>Front Pharmacol</source><volume>5</volume><fpage>151</fpage><year>2014</year><pub-id pub-id-type="doi">10.3389/fphar.2014.00151</pub-id><pub-id pub-id-type="pmid">25024695</pub-id><pub-id pub-id-type="pmcid">PMC4079069</pub-id></element-citation></ref><ref id="b167-ijmm-56-05-05613"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crouch</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Blake</surname><given-names>R</given-names></name><name name-style="western"><surname>Duce</surname><given-names>JA</given-names></name><name name-style="western"><surname>Ciccotosto</surname><given-names>GD</given-names></name><name name-style="western"><surname>Li</surname><given-names>QX</given-names></name><name name-style="western"><surname>Barnham</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Curtain</surname><given-names>CC</given-names></name><name name-style="western"><surname>Cherny</surname><given-names>RA</given-names></name><name name-style="western"><surname>Cappai</surname><given-names>R</given-names></name><name name-style="western"><surname>Dyrks</surname><given-names>T</given-names></name><etal/></person-group><article-title>Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42</article-title><source>J Neurosci</source><volume>25</volume><fpage>672</fpage><lpage>679</lpage><year>2005</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4276-04.2005</pub-id><pub-id pub-id-type="pmid">15659604</pub-id><pub-id pub-id-type="pmcid">PMC6725334</pub-id></element-citation></ref><ref id="b168-ijmm-56-05-05613"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okita</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rcom-H'cheo-Gauthier</surname><given-names>AN</given-names></name><name name-style="western"><surname>Goulding</surname><given-names>M</given-names></name><name name-style="western"><surname>Chung</surname><given-names>RS</given-names></name><name name-style="western"><surname>Faller</surname><given-names>P</given-names></name><name name-style="western"><surname>Pountney</surname><given-names>DL</given-names></name></person-group><article-title>Metallothionein, copper and alpha-synuclein in alpha-synucleinopathies</article-title><source>Front Neurosci</source><volume>11</volume><fpage>114</fpage><year>2017</year><pub-id pub-id-type="doi">10.3389/fnins.2017.00114</pub-id><pub-id pub-id-type="pmid">28420950</pub-id><pub-id pub-id-type="pmcid">PMC5380005</pub-id></element-citation></ref><ref id="b169-ijmm-56-05-05613"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Tan</surname><given-names>X</given-names></name></person-group><article-title>The efficacy and pharmacological mechanism of Zn7MT3 to protect against Alzheimer's disease</article-title><source>Sci Rep</source><volume>7</volume><fpage>13763</fpage><year>2017</year><pub-id pub-id-type="doi">10.1038/s41598-017-12800-x</pub-id><pub-id pub-id-type="pmid">29061973</pub-id><pub-id pub-id-type="pmcid">PMC5653791</pub-id></element-citation></ref><ref id="b170-ijmm-56-05-05613"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossi</surname><given-names>L</given-names></name><name name-style="western"><surname>Lippe</surname><given-names>G</given-names></name><name name-style="western"><surname>Marchese</surname><given-names>E</given-names></name><name name-style="western"><surname>De Martino</surname><given-names>A</given-names></name><name name-style="western"><surname>Mavelli</surname><given-names>I</given-names></name><name name-style="western"><surname>Rotilio</surname><given-names>G</given-names></name><name name-style="western"><surname>Ciriolo</surname><given-names>MR</given-names></name></person-group><article-title>Decrease of cytochrome c oxidase protein in heart mitochondria of copper-deficient rats</article-title><source>Biometals</source><volume>11</volume><fpage>207</fpage><lpage>212</lpage><year>1998</year><pub-id pub-id-type="doi">10.1023/A:1009274131473</pub-id><pub-id pub-id-type="pmid">9850563</pub-id></element-citation></ref><ref id="b171-ijmm-56-05-05613"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Exley</surname><given-names>C</given-names></name><name name-style="western"><surname>House</surname><given-names>E</given-names></name><name name-style="western"><surname>Polwart</surname><given-names>A</given-names></name><name name-style="western"><surname>Esiri</surname><given-names>MM</given-names></name></person-group><article-title>Brain burdens of aluminum, iron, and copper and their relationships with amyloid-&#946; pathology in 60 human brains</article-title><source>J Alzheimers Dis</source><volume>31</volume><fpage>725</fpage><lpage>730</lpage><year>2012</year><pub-id pub-id-type="doi">10.3233/JAD-2012-120766</pub-id><pub-id pub-id-type="pmid">22699848</pub-id></element-citation></ref><ref id="b172-ijmm-56-05-05613"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keskitalo</surname><given-names>S</given-names></name><name name-style="western"><surname>Farkas</surname><given-names>M</given-names></name><name name-style="western"><surname>Hanenberg</surname><given-names>M</given-names></name><name name-style="western"><surname>Szodorai</surname><given-names>A</given-names></name><name name-style="western"><surname>Kulic</surname><given-names>L</given-names></name><name name-style="western"><surname>Semmler</surname><given-names>A</given-names></name><name name-style="western"><surname>Weller</surname><given-names>M</given-names></name><name name-style="western"><surname>Nitsch</surname><given-names>RM</given-names></name><name name-style="western"><surname>Linnebank</surname><given-names>M</given-names></name></person-group><article-title>Reciprocal modulation of A&#946;42 aggregation by copper and homocysteine</article-title><source>Front Aging Neurosci</source><volume>6</volume><fpage>237</fpage><year>2014</year><pub-id pub-id-type="doi">10.3389/fnagi.2014.00237</pub-id><pub-id pub-id-type="pmid">25249976</pub-id><pub-id pub-id-type="pmcid">PMC4157544</pub-id></element-citation></ref><ref id="b173-ijmm-56-05-05613"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirss</surname><given-names>S</given-names></name><name name-style="western"><surname>Reinapu</surname><given-names>A</given-names></name><name name-style="western"><surname>Kabin</surname><given-names>E</given-names></name><name name-style="western"><surname>Smirnova</surname><given-names>J</given-names></name><name name-style="western"><surname>T&#245;ugu</surname><given-names>V</given-names></name><name name-style="western"><surname>Palumaa</surname><given-names>P</given-names></name></person-group><article-title>&#945;-Lipoic acid: A potential regulator of copper metabolism in Alzheimer's disease</article-title><source>Front Mol Biosci</source><volume>11</volume><fpage>1451536</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fmolb.2024.1451536</pub-id><pub-id pub-id-type="pmid">39290994</pub-id><pub-id pub-id-type="pmcid">PMC11405343</pub-id></element-citation></ref><ref id="b174-ijmm-56-05-05613"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kepp</surname><given-names>KP</given-names></name></person-group><article-title>Bioinorganic chemistry of Alzheimer's disease</article-title><source>Chem Rev</source><volume>112</volume><fpage>5193</fpage><lpage>5239</lpage><year>2012</year><pub-id pub-id-type="doi">10.1021/cr300009x</pub-id><pub-id pub-id-type="pmid">22793492</pub-id></element-citation></ref><ref id="b175-ijmm-56-05-05613"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Tan</surname><given-names>SS</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>G</given-names></name></person-group><article-title>The role of intracellular and extracellular copper compartmentalization in Alzheimer's disease pathology and its implications for diagnosis and therapy</article-title><source>Front Neurosci</source><volume>19</volume><fpage>1553064</fpage><year>2025</year><pub-id pub-id-type="doi">10.3389/fnins.2025.1553064</pub-id><pub-id pub-id-type="pmid">40143849</pub-id><pub-id pub-id-type="pmcid">PMC11936913</pub-id></element-citation></ref><ref id="b176-ijmm-56-05-05613"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brewer</surname><given-names>GJ</given-names></name></person-group><article-title>Alzheimer's disease causation by copper toxicity and treatment with zinc</article-title><source>Front Aging Neurosci</source><volume>6</volume><fpage>92</fpage><year>2014</year><pub-id pub-id-type="doi">10.3389/fnagi.2014.00092</pub-id><pub-id pub-id-type="pmid">24860501</pub-id><pub-id pub-id-type="pmcid">PMC4030141</pub-id></element-citation></ref><ref id="b177-ijmm-56-05-05613"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ventriglia</surname><given-names>M</given-names></name><name name-style="western"><surname>Bucossi</surname><given-names>S</given-names></name><name name-style="western"><surname>Panetta</surname><given-names>V</given-names></name><name name-style="western"><surname>Squitti</surname><given-names>R</given-names></name></person-group><article-title>Copper in Alzheimer's disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studies</article-title><source>J Alzheimers Dis</source><volume>30</volume><fpage>981</fpage><lpage>984</lpage><year>2012</year><pub-id pub-id-type="doi">10.3233/JAD-2012-120244</pub-id><pub-id pub-id-type="pmid">22475798</pub-id></element-citation></ref><ref id="b178-ijmm-56-05-05613"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Squitti</surname><given-names>R</given-names></name><name name-style="western"><surname>Pasqualetti</surname><given-names>P</given-names></name><name name-style="western"><surname>Dal Forno</surname><given-names>G</given-names></name><name name-style="western"><surname>Moffa</surname><given-names>F</given-names></name><name name-style="western"><surname>Cassetta</surname><given-names>E</given-names></name><name name-style="western"><surname>Lupoi</surname><given-names>D</given-names></name><name name-style="western"><surname>Vernieri</surname><given-names>F</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>L</given-names></name><name name-style="western"><surname>Baldassini</surname><given-names>M</given-names></name><name name-style="western"><surname>Rossini</surname><given-names>PM</given-names></name></person-group><article-title>Excess of serum copper not related to ceruloplasmin in Alzheimer disease</article-title><source>Neurology</source><volume>64</volume><fpage>1040</fpage><lpage>1046</lpage><year>2005</year><pub-id pub-id-type="doi">10.1212/01.WNL.0000154531.79362.23</pub-id><pub-id pub-id-type="pmid">15781823</pub-id></element-citation></ref><ref id="b179-ijmm-56-05-05613"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>CP</given-names></name></person-group><article-title>Copper overload promotes &#946;-amyloid induced NLRP3/Caspase-1/GSDMD-mediated pyroptosis in Alzheimer's disease</article-title><source>J Integr Neurosci</source><volume>23</volume><fpage>194</fpage><year>2024</year><pub-id pub-id-type="doi">10.31083/j.jin2310194</pub-id><pub-id pub-id-type="pmid">39473154</pub-id></element-citation></ref><ref id="b180-ijmm-56-05-05613"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selkoe</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>J</given-names></name></person-group><article-title>The amyloid hypothesis of Alzheimer's disease at 25 years</article-title><source>EMBO Mol Med</source><volume>8</volume><fpage>595</fpage><lpage>608</lpage><year>2016</year><pub-id pub-id-type="doi">10.15252/emmm.201606210</pub-id><pub-id pub-id-type="pmid">27025652</pub-id><pub-id pub-id-type="pmcid">PMC4888851</pub-id></element-citation></ref><ref id="b181-ijmm-56-05-05613"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santoro</surname><given-names>A</given-names></name><name name-style="western"><surname>Grimaldi</surname><given-names>M</given-names></name><name name-style="western"><surname>Buonocore</surname><given-names>M</given-names></name><name name-style="western"><surname>Stillitano</surname><given-names>I</given-names></name><name name-style="western"><surname>D'Ursi</surname><given-names>AM</given-names></name></person-group><article-title>Exploring the early stages of the amyloid A&#946;(1-42) peptide aggregation process: An NMR study</article-title><source>Pharmaceuticals (Basel)</source><volume>14</volume><fpage>732</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/ph14080732</pub-id><pub-id pub-id-type="pmid">34451828</pub-id><pub-id pub-id-type="pmcid">PMC8400958</pub-id></element-citation></ref><ref id="b182-ijmm-56-05-05613"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sgourakis</surname><given-names>NG</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name><name name-style="western"><surname>McCallum</surname><given-names>SA</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>AE</given-names></name></person-group><article-title>The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: A combined MD/NMR study</article-title><source>J Mol Biol</source><volume>368</volume><fpage>1448</fpage><lpage>1457</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.jmb.2007.02.093</pub-id><pub-id pub-id-type="pmid">17397862</pub-id><pub-id pub-id-type="pmcid">PMC1978067</pub-id></element-citation></ref><ref id="b183-ijmm-56-05-05613"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hampel</surname><given-names>H</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>J</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Perry</surname><given-names>G</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><name name-style="western"><surname>Villemagne</surname><given-names>VL</given-names></name><name name-style="western"><surname>Aisen</surname><given-names>P</given-names></name><name name-style="western"><surname>Vendruscolo</surname><given-names>M</given-names></name><name name-style="western"><surname>Iwatsubo</surname><given-names>T</given-names></name><etal/></person-group><article-title>The amyloid-&#946; pathway in Alzheimer's disease</article-title><source>Mol Psychiatry</source><volume>26</volume><fpage>5481</fpage><lpage>5503</lpage><year>2021</year><pub-id pub-id-type="doi">10.1038/s41380-021-01249-0</pub-id><pub-id pub-id-type="pmid">34456336</pub-id><pub-id pub-id-type="pmcid">PMC8758495</pub-id></element-citation></ref><ref id="b184-ijmm-56-05-05613"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shea</surname><given-names>D</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>CC</given-names></name><name name-style="western"><surname>Bi</surname><given-names>TM</given-names></name><name name-style="western"><surname>Paranjapye</surname><given-names>N</given-names></name><name name-style="western"><surname>Childers</surname><given-names>MC</given-names></name><name name-style="western"><surname>Cochran</surname><given-names>J</given-names></name><name name-style="western"><surname>Tomberlin</surname><given-names>CP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Paris</surname><given-names>D</given-names></name><name name-style="western"><surname>Zonderman</surname><given-names>J</given-names></name><etal/></person-group><article-title>&#945;-Sheet secondary structure in amyloid &#946;-peptide drives aggregation and toxicity in Alzheimer's disease</article-title><source>Proc Natl Acad Sci USA</source><volume>116</volume><fpage>8895</fpage><lpage>8900</lpage><year>2019</year><pub-id pub-id-type="doi">10.1073/pnas.1820585116</pub-id><pub-id pub-id-type="pmid">31004062</pub-id><pub-id pub-id-type="pmcid">PMC6500163</pub-id></element-citation></ref><ref id="b185-ijmm-56-05-05613"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abelein</surname><given-names>A</given-names></name><name name-style="western"><surname>Ciofi-Baffoni</surname><given-names>S</given-names></name><name name-style="western"><surname>M&#246;rman</surname><given-names>C</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><name name-style="western"><surname>Giachetti</surname><given-names>A</given-names></name><name name-style="western"><surname>Piccioli</surname><given-names>M</given-names></name><name name-style="western"><surname>Biverst&#229;l</surname><given-names>H</given-names></name></person-group><article-title>Molecular structure of Cu(II)-Bound Amyloid-&#946; monomer implicated in inhibition of peptide self-assembly in Alzheimer's disease</article-title><source>JACS Au</source><volume>2</volume><fpage>2571</fpage><lpage>2584</lpage><year>2022</year><pub-id pub-id-type="doi">10.1021/jacsau.2c00438</pub-id><pub-id pub-id-type="pmid">36465548</pub-id><pub-id pub-id-type="pmcid">PMC9709942</pub-id></element-citation></ref><ref id="b186-ijmm-56-05-05613"><label>186</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brewer</surname><given-names>GJ</given-names></name></person-group><article-title>Divalent copper as a major triggering agent in Alzheimer's disease</article-title><source>J Alzheimers Dis</source><volume>46</volume><fpage>593</fpage><lpage>604</lpage><year>2015</year><pub-id pub-id-type="doi">10.3233/JAD-143123</pub-id><pub-id pub-id-type="pmid">25854930</pub-id></element-citation></ref><ref id="b187-ijmm-56-05-05613"><label>187</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>DD</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>P</given-names></name></person-group><article-title>Serum copper, zinc, and iron levels in patients with Alzheimer's disease: A meta-analysis of case-control studies</article-title><source>Front Aging Neurosci</source><volume>9</volume><fpage>300</fpage><year>2017</year><pub-id pub-id-type="doi">10.3389/fnagi.2017.00300</pub-id><pub-id pub-id-type="pmid">28966592</pub-id><pub-id pub-id-type="pmcid">PMC5605551</pub-id></element-citation></ref><ref id="b188-ijmm-56-05-05613"><label>188</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faller</surname><given-names>P</given-names></name><name name-style="western"><surname>Hureau</surname><given-names>C</given-names></name></person-group><article-title>Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide</article-title><source>Dalton Trans</source><volume>7</volume><fpage>1080</fpage><lpage>1094</lpage><year>2009</year><pub-id pub-id-type="doi">10.1039/B813398K</pub-id><pub-id pub-id-type="pmid">19322475</pub-id></element-citation></ref><ref id="b189-ijmm-56-05-05613"><label>189</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Posadas</surname><given-names>Y</given-names></name><name name-style="western"><surname>S&#225;nchez-L&#243;pez</surname><given-names>C</given-names></name><name name-style="western"><surname>Quintanar</surname><given-names>L</given-names></name></person-group><article-title>Copper binding and protein aggregation: A journey from the brain to the human lens</article-title><source>RSC Chem Biol</source><volume>4</volume><fpage>974</fpage><lpage>985</lpage><year>2023</year><pub-id pub-id-type="doi">10.1039/D3CB00145H</pub-id><pub-id pub-id-type="pmid">38033729</pub-id><pub-id pub-id-type="pmcid">PMC10685798</pub-id></element-citation></ref><ref id="b190-ijmm-56-05-05613"><label>190</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sasanian</surname><given-names>N</given-names></name><name name-style="western"><surname>Bernson</surname><given-names>D</given-names></name><name name-style="western"><surname>Horvath</surname><given-names>I</given-names></name><name name-style="western"><surname>Wittung-Stafshede</surname><given-names>P</given-names></name><name name-style="western"><surname>Esbj&#246;rner</surname><given-names>EK</given-names></name></person-group><article-title>Redox-dependent copper ion modulation of amyloid-&#946; (1-42) aggregation in vitro</article-title><source>Biomolecules</source><volume>10</volume><fpage>924</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/biom10060924</pub-id><pub-id pub-id-type="pmid">32570820</pub-id><pub-id pub-id-type="pmcid">PMC7355640</pub-id></element-citation></ref><ref id="b191-ijmm-56-05-05613"><label>191</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Grant</surname><given-names>GPG</given-names></name><name name-style="western"><surname>Dudzik</surname><given-names>CG</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Patel</surname><given-names>S</given-names></name><name name-style="western"><surname>Hao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Millhauser</surname><given-names>GL</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>F</given-names></name></person-group><article-title>The elevated copper binding strength of amyloid-&#946; aggregates allows the sequestration of copper from albumin: A pathway to accumulation of copper in senile plaques</article-title><source>Biochemistry</source><volume>52</volume><fpage>547</fpage><lpage>556</lpage><year>2013</year><pub-id pub-id-type="doi">10.1021/bi301053h</pub-id><pub-id pub-id-type="pmid">23237523</pub-id><pub-id pub-id-type="pmcid">PMC3552001</pub-id></element-citation></ref><ref id="b192-ijmm-56-05-05613"><label>192</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Q</given-names></name><name name-style="western"><surname>Luo</surname><given-names>K</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pang</surname><given-names>D</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>G</given-names></name></person-group><article-title>Copper (II) promotes the formation of soluble neurotoxic PrP oligomers in acidic environment</article-title><source>J Cell Biochem</source><volume>111</volume><fpage>627</fpage><lpage>633</lpage><year>2010</year><pub-id pub-id-type="doi">10.1002/jcb.22743</pub-id><pub-id pub-id-type="pmid">20564047</pub-id></element-citation></ref><ref id="b193-ijmm-56-05-05613"><label>193</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garc&#237;a</surname><given-names>S</given-names></name><name name-style="western"><surname>Cusc&#243;</surname><given-names>C</given-names></name><name name-style="western"><surname>Brissos</surname><given-names>RF</given-names></name><name name-style="western"><surname>Torrents</surname><given-names>E</given-names></name><name name-style="western"><surname>Caubet</surname><given-names>A</given-names></name><name name-style="western"><surname>Gamez</surname><given-names>P</given-names></name></person-group><article-title>Dual role of Cu<sup>2+</sup> ions on the aggregation and degradation of soluble A&#946; oligomers and protofibrils investigated by fluorescence spectroscopy and AFM</article-title><source>J Inorg Biochem</source><volume>116</volume><fpage>26</fpage><lpage>36</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2012.07.007</pub-id><pub-id pub-id-type="pmid">23010326</pub-id></element-citation></ref><ref id="b194-ijmm-56-05-05613"><label>194</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>W</given-names></name><name name-style="western"><surname>Hu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>B</given-names></name><name name-style="western"><surname>Tian</surname><given-names>M</given-names></name><name name-style="western"><surname>Qin</surname><given-names>H</given-names></name></person-group><article-title>Effects of amyloid &#946; (A&#946;)42 and Gasdermin D on the progression of Alzheimer's disease in vitro and in vivo through the regulation of astrocyte pyroptosis</article-title><source>Aging (Albany NY)</source><volume>15</volume><fpage>12209</fpage><lpage>12224</lpage><year>2023</year><pub-id pub-id-type="doi">10.18632/aging.205174</pub-id><pub-id pub-id-type="pmid">37921870</pub-id><pub-id pub-id-type="pmcid">PMC10683627</pub-id></element-citation></ref><ref id="b195-ijmm-56-05-05613"><label>195</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>I</given-names></name><name name-style="western"><surname>Sagare</surname><given-names>AP</given-names></name><name name-style="western"><surname>Coma</surname><given-names>M</given-names></name><name name-style="western"><surname>Perlmutter</surname><given-names>D</given-names></name><name name-style="western"><surname>Gelein</surname><given-names>R</given-names></name><name name-style="western"><surname>Bell</surname><given-names>RD</given-names></name><name name-style="western"><surname>Deane</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>E</given-names></name><name name-style="western"><surname>Parisi</surname><given-names>M</given-names></name><name name-style="western"><surname>Ciszewski</surname><given-names>J</given-names></name><etal/></person-group><article-title>Low levels of copper disrupt brain amyloid-&#946; homeostasis by altering its production and clearance</article-title><source>Proc Natl Acad Sci USA</source><volume>110</volume><fpage>14771</fpage><lpage>14776</lpage><year>2013</year><pub-id pub-id-type="doi">10.1073/pnas.1302212110</pub-id><pub-id pub-id-type="pmid">23959870</pub-id><pub-id pub-id-type="pmcid">PMC3767519</pub-id></element-citation></ref><ref id="b196-ijmm-56-05-05613"><label>196</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hane</surname><given-names>F</given-names></name><name name-style="western"><surname>Tran</surname><given-names>G</given-names></name><name name-style="western"><surname>Attwood</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Leonenko</surname><given-names>Z</given-names></name></person-group><article-title>Cu(2+) affects amyloid-beta (1-42) aggregation by increasing peptide-peptide binding forces</article-title><source>PLoS One</source><volume>8</volume><fpage>e59005</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0059005</pub-id><pub-id pub-id-type="pmid">23536847</pub-id><pub-id pub-id-type="pmcid">PMC3594192</pub-id></element-citation></ref><ref id="b197-ijmm-56-05-05613"><label>197</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maghsoodi</surname><given-names>F</given-names></name><name name-style="western"><surname>Martin</surname><given-names>TD</given-names></name><name name-style="western"><surname>Chi</surname><given-names>EY</given-names></name></person-group><article-title>Partial destabilization of amyloid-&#946; protofibril by methionine photo-oxidation: A molecular dynamic simulation study</article-title><source>ACS Omega</source><volume>8</volume><fpage>10148</fpage><lpage>10159</lpage><year>2023</year><pub-id pub-id-type="doi">10.1021/acsomega.2c07468</pub-id><pub-id pub-id-type="pmid">36969430</pub-id><pub-id pub-id-type="pmcid">PMC10035002</pub-id></element-citation></ref><ref id="b198-ijmm-56-05-05613"><label>198</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pahrudin Arrozi</surname><given-names>A</given-names></name><name name-style="western"><surname>Shukri</surname><given-names>SNS</given-names></name><name name-style="western"><surname>Wan Ngah</surname><given-names>WZ</given-names></name><name name-style="western"><surname>Mohd Yusof</surname><given-names>YA</given-names></name><name name-style="western"><surname>Ahmad Damanhuri</surname><given-names>MH</given-names></name><name name-style="western"><surname>Makpol</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of the expression of amyloid precursor protein and the ratio of secreted amyloid beta 42 to amyloid beta 40 in SH-SY5Y cells stably transfected with wild-type, single-mutant and double-mutant forms of the APP gene for the study of Alzheimer's disease pathology</article-title><source>Appl Biochem Biotechnol</source><volume>183</volume><fpage>853</fpage><lpage>866</lpage><year>2017</year><pub-id pub-id-type="doi">10.1007/s12010-017-2468-6</pub-id><pub-id pub-id-type="pmid">28417423</pub-id></element-citation></ref><ref id="b199-ijmm-56-05-05613"><label>199</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zubcic</surname><given-names>K</given-names></name><name name-style="western"><surname>Hof</surname><given-names>PR</given-names></name><name name-style="western"><surname>Simic</surname><given-names>G</given-names></name><name name-style="western"><surname>Jazvinscak Jembrek</surname><given-names>M</given-names></name></person-group><article-title>The role of copper in Tau-related pathology in Alzheimer's disease</article-title><source>Front Mol Neurosci</source><volume>13</volume><fpage>572308</fpage><year>2020</year><pub-id pub-id-type="doi">10.3389/fnmol.2020.572308</pub-id><pub-id pub-id-type="pmid">33071757</pub-id><pub-id pub-id-type="pmcid">PMC7533614</pub-id></element-citation></ref><ref id="b200-ijmm-56-05-05613"><label>200</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larry Sparks</surname><given-names>D</given-names></name></person-group><article-title>Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid beta in rabbit brain</article-title><source>J Mol Neurosci</source><volume>24</volume><fpage>97</fpage><lpage>104</lpage><year>2004</year><pub-id pub-id-type="doi">10.1385/JMN:24:1:097</pub-id><pub-id pub-id-type="pmid">15314257</pub-id></element-citation></ref><ref id="b201-ijmm-56-05-05613"><label>201</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iqbal</surname><given-names>K</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Gong</surname><given-names>CX</given-names></name></person-group><article-title>Tau and neurodegenerative disease: The story so far</article-title><source>Nat Rev Neurol</source><volume>12</volume><fpage>15</fpage><lpage>27</lpage><year>2016</year><pub-id pub-id-type="doi">10.1038/nrneurol.2015.225</pub-id><pub-id pub-id-type="pmid">26635213</pub-id></element-citation></ref><ref id="b202-ijmm-56-05-05613"><label>202</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alonso</surname><given-names>AD</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>LS</given-names></name><name name-style="western"><surname>Corbo</surname><given-names>C</given-names></name><name name-style="western"><surname>Morozova</surname><given-names>V</given-names></name><name name-style="western"><surname>ElIdrissi</surname><given-names>A</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>G</given-names></name><name name-style="western"><surname>Kleiman</surname><given-names>FE</given-names></name></person-group><article-title>Hyperphosphorylation of Tau associates with changes in its function beyond microtubule stability</article-title><source>Front Cell Neurosci</source><volume>12</volume><fpage>338</fpage><year>2018</year><pub-id pub-id-type="doi">10.3389/fncel.2018.00338</pub-id><pub-id pub-id-type="pmid">30356756</pub-id><pub-id pub-id-type="pmcid">PMC6189415</pub-id></element-citation></ref><ref id="b203-ijmm-56-05-05613"><label>203</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medeiros</surname><given-names>R</given-names></name><name name-style="western"><surname>Baglietto-Vargas</surname><given-names>D</given-names></name><name name-style="western"><surname>LaFerla</surname><given-names>FM</given-names></name></person-group><article-title>The role of tau in Alzheimer's disease and related disorders</article-title><source>CNS Neurosci Ther</source><volume>17</volume><fpage>514</fpage><lpage>524</lpage><year>2011</year><pub-id pub-id-type="doi">10.1111/j.1755-5949.2010.00177.x</pub-id><pub-id pub-id-type="pmid">20553310</pub-id><pub-id pub-id-type="pmcid">PMC4072215</pub-id></element-citation></ref><ref id="b204-ijmm-56-05-05613"><label>204</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zwang</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Sastre</surname><given-names>ED</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>N</given-names></name><name name-style="western"><surname>Ruiz-Uribe</surname><given-names>N</given-names></name><name name-style="western"><surname>Woost</surname><given-names>B</given-names></name><name name-style="western"><surname>Hoglund</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>J</given-names></name><name name-style="western"><surname>Nfor</surname><given-names>L</given-names></name><name name-style="western"><surname>Bu&#233;e</surname><given-names>L</given-names></name><etal/></person-group><article-title>Neurofibrillary tangle-bearing neurons have reduced risk of cell death in mice with Alzheimer's pathology</article-title><source>Cell Rep</source><volume>43</volume><fpage>114574</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.celrep.2024.114574</pub-id><pub-id pub-id-type="pmid">39096489</pub-id><pub-id pub-id-type="pmcid">PMC11441076</pub-id></element-citation></ref><ref id="b205-ijmm-56-05-05613"><label>205</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>LX</given-names></name><name name-style="western"><surname>Du</surname><given-names>JT</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Wu</surname><given-names>WH</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>YF</given-names></name><name name-style="western"><surname>Kanazawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Ishizuka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nemoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakanishi</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>YM</given-names></name></person-group><article-title>Copper (II) modulates in vitro aggregation of a tau peptide</article-title><source>Peptides</source><volume>28</volume><fpage>2229</fpage><lpage>2234</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.peptides.2007.08.022</pub-id><pub-id pub-id-type="pmid">17919778</pub-id></element-citation></ref><ref id="b206-ijmm-56-05-05613"><label>206</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>N</given-names></name><name name-style="western"><surname>Yin</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D</given-names></name><name name-style="western"><surname>Cao</surname><given-names>M</given-names></name><name name-style="western"><surname>Gong</surname><given-names>CX</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>K</given-names></name><name name-style="western"><surname>Ding</surname><given-names>F</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name></person-group><article-title>Truncation and activation of GSK-3&#946; by calpain I: A molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease</article-title><source>Sci Rep</source><volume>5</volume><fpage>8187</fpage><year>2015</year><pub-id pub-id-type="doi">10.1038/srep08187</pub-id><pub-id pub-id-type="pmid">25641096</pub-id><pub-id pub-id-type="pmcid">PMC4313118</pub-id></element-citation></ref><ref id="b207-ijmm-56-05-05613"><label>207</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crnich</surname><given-names>E</given-names></name><name name-style="western"><surname>Lullo</surname><given-names>R</given-names></name><name name-style="western"><surname>Tabaka</surname><given-names>A</given-names></name><name name-style="western"><surname>Havens</surname><given-names>MA</given-names></name><name name-style="western"><surname>Kissel</surname><given-names>DS</given-names></name></person-group><article-title>Interactions of copper and copper chelate compounds with the amyloid beta peptide: An investigation into electrochemistry, reactive oxygen species and peptide aggregation</article-title><source>J Inorg Biochem</source><volume>222</volume><fpage>111493</fpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2021.111493</pub-id><pub-id pub-id-type="pmid">34116425</pub-id></element-citation></ref><ref id="b208-ijmm-56-05-05613"><label>208</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bush</surname><given-names>AI</given-names></name><name name-style="western"><surname>Tanzi</surname><given-names>RE</given-names></name></person-group><article-title>Therapeutics for Alzheimer's disease based on the metal hypothesis</article-title><source>Neurotherapeutics</source><volume>5</volume><fpage>421</fpage><lpage>432</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.nurt.2008.05.001</pub-id><pub-id pub-id-type="pmid">18625454</pub-id><pub-id pub-id-type="pmcid">PMC2518205</pub-id></element-citation></ref><ref id="b209-ijmm-56-05-05613"><label>209</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>M</given-names></name><name name-style="western"><surname>Shepardson</surname><given-names>N</given-names></name><name name-style="western"><surname>Yang</surname><given-names>T</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>D</given-names></name><name name-style="western"><surname>Selkoe</surname><given-names>DJ</given-names></name></person-group><article-title>Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration</article-title><source>Proc Natl Acad Sci USA</source><volume>108</volume><fpage>5819</fpage><lpage>5824</lpage><year>2011</year><pub-id pub-id-type="doi">10.1073/pnas.1017033108</pub-id><pub-id pub-id-type="pmid">21421841</pub-id><pub-id pub-id-type="pmcid">PMC3078381</pub-id></element-citation></ref><ref id="b210-ijmm-56-05-05613"><label>210</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name></person-group><article-title>A concise review on oxidative stress-mediated ferroptosis and cuproptosis in Alzheimer's disease</article-title><source>Cells</source><volume>12</volume><fpage>1369</fpage><year>2023</year><pub-id pub-id-type="doi">10.3390/cells12101369</pub-id><pub-id pub-id-type="pmid">37408203</pub-id><pub-id pub-id-type="pmcid">PMC10216514</pub-id></element-citation></ref><ref id="b211-ijmm-56-05-05613"><label>211</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xing</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Pan</surname><given-names>P</given-names></name><name name-style="western"><surname>Yang</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Cuproptosis in stroke: Focusing on pathogenesis and treatment</article-title><source>Front Mol Neurosci</source><volume>17</volume><fpage>1349123</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fnmol.2024.1349123</pub-id><pub-id pub-id-type="pmid">38605864</pub-id><pub-id pub-id-type="pmcid">PMC11007218</pub-id></element-citation></ref><ref id="b212-ijmm-56-05-05613"><label>212</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>R</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wu</surname><given-names>G</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dong</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name></person-group><article-title>Construction and validation of a bioinformatics-based screen for cuproptosis-related genes and risk model for Alzheimer's disease</article-title><source>Mol Med Rep</source><volume>30</volume><fpage>194</fpage><year>2024</year><pub-id pub-id-type="doi">10.3892/mmr.2024.13318</pub-id><pub-id pub-id-type="pmid">39219261</pub-id></element-citation></ref><ref id="b213-ijmm-56-05-05613"><label>213</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Xi</surname><given-names>E</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Q</given-names></name></person-group><article-title>The study on cuproptosis in Alzheimer's disease based on the cuproptosis key gene FDX1</article-title><source>Front Aging Neurosci</source><volume>16</volume><fpage>1480332</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fnagi.2024.1480332</pub-id><pub-id pub-id-type="pmid">39759399</pub-id><pub-id pub-id-type="pmcid">PMC11696982</pub-id></element-citation></ref><ref id="b214-ijmm-56-05-05613"><label>214</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>F</given-names></name><name name-style="western"><surname>Han</surname><given-names>W</given-names></name><name name-style="western"><surname>Gao</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name></person-group><article-title>Novel cuproptosis metabolism-related molecular clusters and diagnostic signature for Alzheimer's disease</article-title><source>Front Mol Biosci</source><volume>11</volume><fpage>1478611</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fmolb.2024.1478611</pub-id><pub-id pub-id-type="pmid">39513039</pub-id><pub-id pub-id-type="pmcid">PMC11540791</pub-id></element-citation></ref><ref id="b215-ijmm-56-05-05613"><label>215</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>MM</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CY</given-names></name></person-group><article-title>Identification of cuproptosis-related genes in Alzheimer's disease based on bioinformatic analysis</article-title><source>Eur J Med Res</source><volume>29</volume><fpage>495</fpage><year>2024</year><pub-id pub-id-type="doi">10.1186/s40001-024-02093-y</pub-id><pub-id pub-id-type="pmid">39396083</pub-id><pub-id pub-id-type="pmcid">PMC11470641</pub-id></element-citation></ref><ref id="b216-ijmm-56-05-05613"><label>216</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Dai</surname><given-names>A</given-names></name><name name-style="western"><surname>Orteg</surname><given-names>RMM</given-names></name><name name-style="western"><surname>Ma</surname><given-names>M</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Polystyrene nanoplastics exposure induces cognitive impairment in mice via induction of oxidative stress and ERK/MAPK-mediated neuronal cuproptosis</article-title><source>Part Fibre Toxicol</source><volume>22</volume><fpage>13</fpage><year>2025</year><pub-id pub-id-type="doi">10.1186/s12989-025-00633-w</pub-id><pub-id pub-id-type="pmid">40394693</pub-id><pub-id pub-id-type="pmcid">PMC12090536</pub-id></element-citation></ref><ref id="b217-ijmm-56-05-05613"><label>217</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gromadzka</surname><given-names>G</given-names></name><name name-style="western"><surname>Tarnacka</surname><given-names>B</given-names></name><name name-style="western"><surname>Flaga</surname><given-names>A</given-names></name><name name-style="western"><surname>Adamczyk</surname><given-names>A</given-names></name></person-group><article-title>Copper dyshomeostasis in neurodegenerative diseases-therapeutic implications</article-title><source>Int J Mol Sci</source><volume>21</volume><fpage>9259</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/ijms21239259</pub-id><pub-id pub-id-type="pmid">33291628</pub-id><pub-id pub-id-type="pmcid">PMC7730516</pub-id></element-citation></ref><ref id="b218-ijmm-56-05-05613"><label>218</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colledge</surname><given-names>M</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>EM</given-names></name><name name-style="western"><surname>Crozier</surname><given-names>RA</given-names></name><name name-style="western"><surname>Soderling</surname><given-names>JA</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Langeberg</surname><given-names>LK</given-names></name><name name-style="western"><surname>Lu</surname><given-names>H</given-names></name><name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name><name name-style="western"><surname>Scott</surname><given-names>JD</given-names></name></person-group><article-title>Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression</article-title><source>Neuron</source><volume>40</volume><fpage>595</fpage><lpage>607</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0896-6273(03)00687-1</pub-id><pub-id pub-id-type="pmid">14642282</pub-id><pub-id pub-id-type="pmcid">PMC3963808</pub-id></element-citation></ref><ref id="b219-ijmm-56-05-05613"><label>219</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magr&#236;</surname><given-names>A</given-names></name><name name-style="western"><surname>Tomasello</surname><given-names>B</given-names></name><name name-style="western"><surname>Naletova</surname><given-names>I</given-names></name><name name-style="western"><surname>Tabb&#236;</surname><given-names>G</given-names></name><name name-style="western"><surname>Cairns</surname><given-names>WRL</given-names></name><name name-style="western"><surname>Greco</surname><given-names>V</given-names></name><name name-style="western"><surname>Sciuto</surname><given-names>S</given-names></name><name name-style="western"><surname>La Mendola</surname><given-names>D</given-names></name><name name-style="western"><surname>Rizzarelli</surname><given-names>E</given-names></name></person-group><article-title>New BDNF and NT-3 cyclic mimetics concur with copper to activate trophic signaling pathways as potential molecular entities to protect old brains from neurodegeneration</article-title><source>Biomolecules</source><volume>14</volume><fpage>1104</fpage><year>2024</year><pub-id pub-id-type="doi">10.3390/biom14091104</pub-id><pub-id pub-id-type="pmid">39334869</pub-id><pub-id pub-id-type="pmcid">PMC11430436</pub-id></element-citation></ref><ref id="b220-ijmm-56-05-05613"><label>220</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Min</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name></person-group><article-title>Copper homeostasis and cuproptosis in health and disease</article-title><source>Signal Transduct Target Ther</source><volume>7</volume><fpage>378</fpage><year>2022</year><pub-id pub-id-type="doi">10.1038/s41392-022-01229-y</pub-id><pub-id pub-id-type="pmid">36414625</pub-id><pub-id pub-id-type="pmcid">PMC9681860</pub-id></element-citation></ref><ref id="b221-ijmm-56-05-05613"><label>221</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Church</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Patassini</surname><given-names>S</given-names></name><name name-style="western"><surname>Begley</surname><given-names>P</given-names></name><name name-style="western"><surname>Waldvogel</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>MA</given-names></name><name name-style="western"><surname>Faull</surname><given-names>RLM</given-names></name><name name-style="western"><surname>Unwin</surname><given-names>RD</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>GJS</given-names></name></person-group><article-title>Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia</article-title><source>Metallomics</source><volume>9</volume><fpage>1106</fpage><lpage>1119</lpage><year>2017</year><pub-id pub-id-type="doi">10.1039/C7MT00074J</pub-id><pub-id pub-id-type="pmid">28654115</pub-id></element-citation></ref><ref id="b222-ijmm-56-05-05613"><label>222</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schrag</surname><given-names>M</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>C</given-names></name><name name-style="western"><surname>Oyoyo</surname><given-names>U</given-names></name><name name-style="western"><surname>Smith</surname><given-names>MA</given-names></name><name name-style="western"><surname>Kirsch</surname><given-names>WM</given-names></name></person-group><article-title>Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion</article-title><source>Prog Neurobiol</source><volume>94</volume><fpage>296</fpage><lpage>306</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.pneurobio.2011.05.001</pub-id><pub-id pub-id-type="pmid">21600264</pub-id><pub-id pub-id-type="pmcid">PMC3134620</pub-id></element-citation></ref><ref id="b223-ijmm-56-05-05613"><label>223</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cilliers</surname><given-names>K</given-names></name></person-group><article-title>Trace element alterations in Alzheimer's disease: A review</article-title><source>Clin Anat</source><volume>34</volume><fpage>766</fpage><lpage>773</lpage><year>2021</year><pub-id pub-id-type="doi">10.1002/ca.23727</pub-id><pub-id pub-id-type="pmid">33580904</pub-id></element-citation></ref><ref id="b224-ijmm-56-05-05613"><label>224</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deibel</surname><given-names>MA</given-names></name><name name-style="western"><surname>Ehmann</surname><given-names>WD</given-names></name><name name-style="western"><surname>Markesbery</surname><given-names>WR</given-names></name></person-group><article-title>Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: Possible relation to oxidative stress</article-title><source>J Neurol Sci</source><volume>143</volume><fpage>137</fpage><lpage>142</lpage><year>1996</year><pub-id pub-id-type="doi">10.1016/S0022-510X(96)00203-1</pub-id><pub-id pub-id-type="pmid">8981312</pub-id></element-citation></ref><ref id="b225-ijmm-56-05-05613"><label>225</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bucossi</surname><given-names>S</given-names></name><name name-style="western"><surname>Ventriglia</surname><given-names>M</given-names></name><name name-style="western"><surname>Panetta</surname><given-names>V</given-names></name><name name-style="western"><surname>Salustri</surname><given-names>C</given-names></name><name name-style="western"><surname>Pasqualetti</surname><given-names>P</given-names></name><name name-style="western"><surname>Mariani</surname><given-names>S</given-names></name><name name-style="western"><surname>Siotto</surname><given-names>M</given-names></name><name name-style="western"><surname>Rossini</surname><given-names>PM</given-names></name><name name-style="western"><surname>Squitti</surname><given-names>R</given-names></name></person-group><article-title>Copper in Alzheimer's disease: A meta-analysis of serum,plasma, and cerebrospinal fluid studies</article-title><source>J Alzheimers Dis</source><volume>24</volume><fpage>175</fpage><lpage>185</lpage><year>2011</year><pub-id pub-id-type="doi">10.3233/JAD-2010-101473</pub-id><pub-id pub-id-type="pmid">21187586</pub-id></element-citation></ref><ref id="b226-ijmm-56-05-05613"><label>226</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loef</surname><given-names>M</given-names></name><name name-style="western"><surname>Walach</surname><given-names>H</given-names></name></person-group><article-title>Copper and iron in Alzheimer's disease: A systematic review and its dietary implications</article-title><source>Br J Nutr</source><volume>107</volume><fpage>7</fpage><lpage>19</lpage><year>2012</year><pub-id pub-id-type="doi">10.1017/S000711451100376X</pub-id><pub-id pub-id-type="pmid">21767446</pub-id></element-citation></ref><ref id="b227-ijmm-56-05-05613"><label>227</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sensi</surname><given-names>SL</given-names></name><name name-style="western"><surname>Granzotto</surname><given-names>A</given-names></name><name name-style="western"><surname>Siotto</surname><given-names>M</given-names></name><name name-style="western"><surname>Squitti</surname><given-names>R</given-names></name></person-group><article-title>Copper and zinc dysregulation in Alzheimer's disease</article-title><source>Trends Pharmacol Sci</source><volume>39</volume><fpage>1049</fpage><lpage>1063</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.tips.2018.10.001</pub-id><pub-id pub-id-type="pmid">30352697</pub-id></element-citation></ref><ref id="b228-ijmm-56-05-05613"><label>228</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>R</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Ye</surname><given-names>XY</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xie</surname><given-names>T</given-names></name></person-group><article-title>Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease</article-title><source>Ageing Res Rev</source><volume>77</volume><fpage>101619</fpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.arr.2022.101619</pub-id><pub-id pub-id-type="pmid">35395415</pub-id></element-citation></ref><ref id="b229-ijmm-56-05-05613"><label>229</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Squitti</surname><given-names>R</given-names></name><name name-style="western"><surname>Ventriglia</surname><given-names>M</given-names></name><name name-style="western"><surname>Simonelli</surname><given-names>I</given-names></name><name name-style="western"><surname>Bonvicini</surname><given-names>C</given-names></name><name name-style="western"><surname>Costa</surname><given-names>A</given-names></name><name name-style="western"><surname>Perini</surname><given-names>G</given-names></name><name name-style="western"><surname>Binetti</surname><given-names>G</given-names></name><name name-style="western"><surname>Benussi</surname><given-names>L</given-names></name><name name-style="western"><surname>Ghidoni</surname><given-names>R</given-names></name><name name-style="western"><surname>Koch</surname><given-names>G</given-names></name><etal/></person-group><article-title>Copper imbalance in Alzheimer's disease: Meta-analysis of serum, plasma, and brain specimens, and replication study evaluating ATP7B gene variants</article-title><source>Biomolecules</source><volume>11</volume><fpage>960</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/biom11070960</pub-id><pub-id pub-id-type="pmid">34209820</pub-id><pub-id pub-id-type="pmcid">PMC8301962</pub-id></element-citation></ref><ref id="b230-ijmm-56-05-05613"><label>230</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Keen</surname><given-names>CL</given-names></name><name name-style="western"><surname>Lanoue</surname><given-names>L</given-names></name><name name-style="western"><surname>Rucker</surname><given-names>RB</given-names></name><name name-style="western"><surname>Uriu-Adams</surname><given-names>JY</given-names></name></person-group><article-title>Low nitric oxide: A key factor underlying copper-deficiency teratogenicity</article-title><source>Free Radic Biol Med</source><volume>43</volume><fpage>1639</fpage><lpage>1648</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.08.031</pub-id><pub-id pub-id-type="pmid">18037129</pub-id><pub-id pub-id-type="pmcid">PMC2289431</pub-id></element-citation></ref><ref id="b231-ijmm-56-05-05613"><label>231</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hureau</surname><given-names>C</given-names></name></person-group><article-title>Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-&#946; peptides involved in Alzheimer disease. Part 1: An overview</article-title><source>Coord Chem Rev</source><volume>256</volume><fpage>2164</fpage><lpage>2174</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.ccr.2012.03.037</pub-id></element-citation></ref><ref id="b232-ijmm-56-05-05613"><label>232</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szabo</surname><given-names>ST</given-names></name><name name-style="western"><surname>Harry</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Hayden</surname><given-names>KM</given-names></name><name name-style="western"><surname>Szabo</surname><given-names>DT</given-names></name><name name-style="western"><surname>Birnbaum</surname><given-names>L</given-names></name></person-group><article-title>Comparison of metal levels between postmortem brain and ventricular fluid in Alzheimer's disease and nondemented elderly controls</article-title><source>Toxicol Sci</source><volume>150</volume><fpage>292</fpage><lpage>300</lpage><year>2016</year><pub-id pub-id-type="doi">10.1093/toxsci/kfv325</pub-id><pub-id pub-id-type="pmid">26721301</pub-id><pub-id pub-id-type="pmcid">PMC4881830</pub-id></element-citation></ref><ref id="b233-ijmm-56-05-05613"><label>233</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Sterling</surname><given-names>K</given-names></name><name name-style="western"><surname>Song</surname><given-names>W</given-names></name></person-group><article-title>Amyloid &#946;-based therapy for Alzheimer's disease: Challenges, successes and future</article-title><source>Signal Transduct Target Ther</source><volume>8</volume><fpage>248</fpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41392-023-01484-7</pub-id><pub-id pub-id-type="pmid">37386015</pub-id><pub-id pub-id-type="pmcid">PMC10310781</pub-id></element-citation></ref><ref id="b234-ijmm-56-05-05613"><label>234</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>IS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HH</given-names></name><name name-style="western"><surname>Aiba</surname><given-names>I</given-names></name><name name-style="western"><surname>Hossain</surname><given-names>A</given-names></name><name name-style="western"><surname>Liang</surname><given-names>ZD</given-names></name><name name-style="western"><surname>Klomp</surname><given-names>LW</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>MT</given-names></name></person-group><article-title>Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells</article-title><source>Mol Pharmacol</source><volume>74</volume><fpage>705</fpage><lpage>713</lpage><year>2008</year><pub-id pub-id-type="doi">10.1124/mol.108.046771</pub-id><pub-id pub-id-type="pmid">18483225</pub-id><pub-id pub-id-type="pmcid">PMC2574735</pub-id></element-citation></ref><ref id="b235-ijmm-56-05-05613"><label>235</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bayer</surname><given-names>TA</given-names></name><name name-style="western"><surname>Sch&#228;fer</surname><given-names>S</given-names></name><name name-style="western"><surname>Simons</surname><given-names>A</given-names></name><name name-style="western"><surname>Kemmling</surname><given-names>A</given-names></name><name name-style="western"><surname>Kamer</surname><given-names>T</given-names></name><name name-style="western"><surname>Tepests</surname><given-names>R</given-names></name><name name-style="western"><surname>Eckert</surname><given-names>A</given-names></name><name name-style="western"><surname>Sch&#252;ssel</surname><given-names>K</given-names></name><name name-style="western"><surname>Eikenberg</surname><given-names>O</given-names></name><name name-style="western"><surname>Sturchler-Pierrat</surname><given-names>C</given-names></name><etal/></person-group><article-title>Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid A&#946; production in APP23 transgenic mice</article-title><source>Proc Natl Acad Sci USA</source><volume>100</volume><fpage>14187</fpage><lpage>14192</lpage><year>2003</year><pub-id pub-id-type="doi">10.1073/pnas.2332818100</pub-id><pub-id pub-id-type="pmid">14617773</pub-id><pub-id pub-id-type="pmcid">PMC283567</pub-id></element-citation></ref><ref id="b236-ijmm-56-05-05613"><label>236</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sch&#228;fer</surname><given-names>S</given-names></name><name name-style="western"><surname>Pajonk</surname><given-names>FG</given-names></name><name name-style="western"><surname>Multhaup</surname><given-names>G</given-names></name><name name-style="western"><surname>Bayer</surname><given-names>TA</given-names></name></person-group><article-title>Copper and clioquinol treatment in young APP transgenic and wild-type mice: Effects on life expectancy, body weight, and metal-ion levels</article-title><source>J Mol Med (Berl)</source><volume>85</volume><fpage>405</fpage><lpage>413</lpage><year>2007</year><pub-id pub-id-type="doi">10.1007/s00109-006-0140-7</pub-id><pub-id pub-id-type="pmid">17211610</pub-id></element-citation></ref><ref id="b237-ijmm-56-05-05613"><label>237</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acevedo</surname><given-names>KM</given-names></name><name name-style="western"><surname>Hung</surname><given-names>YH</given-names></name><name name-style="western"><surname>Dalziel</surname><given-names>AH</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q-X</given-names></name><name name-style="western"><surname>Laughton</surname><given-names>K</given-names></name><name name-style="western"><surname>Wikhe</surname><given-names>K</given-names></name><name name-style="western"><surname>Rembach</surname><given-names>A</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>B</given-names></name><name name-style="western"><surname>Masters</surname><given-names>CL</given-names></name><name name-style="western"><surname>Bush</surname><given-names>AI</given-names></name><name name-style="western"><surname>Camakaris</surname><given-names>J</given-names></name></person-group><article-title>Copper promotes the trafficking of the amyloid precursor protein</article-title><source>J Biol Chem</source><volume>286</volume><fpage>8252</fpage><lpage>8262</lpage><year>2011</year><pub-id pub-id-type="doi">10.1074/jbc.M110.128512</pub-id><pub-id pub-id-type="pmid">21177866</pub-id><pub-id pub-id-type="pmcid">PMC3048711</pub-id></element-citation></ref><ref id="b238-ijmm-56-05-05613"><label>238</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bao</surname><given-names>WD</given-names></name><name name-style="western"><surname>Pang</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>XT</given-names></name><name name-style="western"><surname>Hu</surname><given-names>F</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Xie</surname><given-names>D</given-names></name><name name-style="western"><surname>Hu</surname><given-names>YZ</given-names></name><etal/></person-group><article-title>Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease</article-title><source>Cell Death Differ</source><volume>28</volume><fpage>1548</fpage><lpage>1562</lpage><year>2021</year><pub-id pub-id-type="doi">10.1038/s41418-020-00685-9</pub-id><pub-id pub-id-type="pmid">33398092</pub-id><pub-id pub-id-type="pmcid">PMC8166828</pub-id></element-citation></ref><ref id="b239-ijmm-56-05-05613"><label>239</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soni</surname><given-names>P</given-names></name><name name-style="western"><surname>Ammal Kaidery</surname><given-names>N</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>SM</given-names></name><name name-style="western"><surname>Gazaryan</surname><given-names>I</given-names></name><name name-style="western"><surname>Nikulin</surname><given-names>SV</given-names></name><name name-style="western"><surname>Hushpulian</surname><given-names>DM</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>B</given-names></name></person-group><article-title>A critical appraisal of ferroptosis in Alzheimer's and Parkinson's disease: New insights into emerging mechanisms and therapeutic targets</article-title><source>Front Pharmacol</source><volume>15</volume><fpage>1390798</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fphar.2024.1390798</pub-id><pub-id pub-id-type="pmid">39040474</pub-id><pub-id pub-id-type="pmcid">PMC11260649</pub-id></element-citation></ref><ref id="b240-ijmm-56-05-05613"><label>240</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cherny</surname><given-names>RA</given-names></name><name name-style="western"><surname>Atwood</surname><given-names>CS</given-names></name><name name-style="western"><surname>Xilinas</surname><given-names>ME</given-names></name><name name-style="western"><surname>Gray</surname><given-names>DN</given-names></name><name name-style="western"><surname>Jones</surname><given-names>WD</given-names></name><name name-style="western"><surname>McLean</surname><given-names>CA</given-names></name><name name-style="western"><surname>Barnham</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Volitakis</surname><given-names>I</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>FW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice</article-title><source>Neuron</source><volume>30</volume><fpage>665</fpage><lpage>676</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0896-6273(01)00317-8</pub-id><pub-id pub-id-type="pmid">11430801</pub-id></element-citation></ref><ref id="b241-ijmm-56-05-05613"><label>241</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faux</surname><given-names>NG</given-names></name><name name-style="western"><surname>Ritchie</surname><given-names>CW</given-names></name><name name-style="western"><surname>Gunn</surname><given-names>A</given-names></name><name name-style="western"><surname>Rembach</surname><given-names>A</given-names></name><name name-style="western"><surname>Tsatsanis</surname><given-names>A</given-names></name><name name-style="western"><surname>Bedo</surname><given-names>J</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>J</given-names></name><name name-style="western"><surname>Lannfelt</surname><given-names>L</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name><etal/></person-group><article-title>PBT2 rapidly improves cognition in Alzheimer's disease: Additional phase II analyses</article-title><source>J Alzheimers Dis</source><volume>20</volume><fpage>509</fpage><lpage>516</lpage><year>2010</year><pub-id pub-id-type="doi">10.3233/JAD-2010-1390</pub-id><pub-id pub-id-type="pmid">20164561</pub-id></element-citation></ref><ref id="b242-ijmm-56-05-05613"><label>242</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lannfelt</surname><given-names>L</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Batsman</surname><given-names>S</given-names></name><name name-style="western"><surname>Ames</surname><given-names>D</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>J</given-names></name><name name-style="western"><surname>Masters</surname><given-names>CL</given-names></name><name name-style="western"><surname>Targum</surname><given-names>S</given-names></name><name name-style="western"><surname>Bush</surname><given-names>AI</given-names></name><name name-style="western"><surname>Murdoch</surname><given-names>R</given-names></name><etal/></person-group><article-title>Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: A phase IIa, double-blind, randomised, placebo-controlled trial</article-title><source>Lancet Neurol</source><volume>7</volume><fpage>779</fpage><lpage>786</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/S1474-4422(08)70167-4</pub-id><pub-id pub-id-type="pmid">18672400</pub-id></element-citation></ref><ref id="b243-ijmm-56-05-05613"><label>243</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Shan</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Teng</surname><given-names>WP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZY</given-names></name></person-group><article-title>Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in A&#946;PP/PS1 transgenic mouse brain</article-title><source>J Alzheimers Dis</source><volume>29</volume><fpage>549</fpage><lpage>559</lpage><year>2012</year><pub-id pub-id-type="doi">10.3233/JAD-2011-111874</pub-id><pub-id pub-id-type="pmid">22269164</pub-id></element-citation></ref><ref id="b244-ijmm-56-05-05613"><label>244</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matlack</surname><given-names>KE</given-names></name><name name-style="western"><surname>Tardiff</surname><given-names>DF</given-names></name><name name-style="western"><surname>Narayan</surname><given-names>P</given-names></name><name name-style="western"><surname>Hamamichi</surname><given-names>S</given-names></name><name name-style="western"><surname>Caldwell</surname><given-names>KA</given-names></name><name name-style="western"><surname>Caldwell</surname><given-names>GA</given-names></name><name name-style="western"><surname>Lindquist</surname><given-names>S</given-names></name></person-group><article-title>Clioquinol promotes the degradation of metal-dependent amyloid-&#946; (A&#946;) oligomers to restore endocytosis and ameliorate A&#946; toxicity</article-title><source>Proc Natl Acad Sci USA</source><volume>111</volume><fpage>4013</fpage><lpage>4018</lpage><year>2014</year><pub-id pub-id-type="doi">10.1073/pnas.1402228111</pub-id><pub-id pub-id-type="pmid">24591589</pub-id><pub-id pub-id-type="pmcid">PMC3964050</pub-id></element-citation></ref><ref id="b245-ijmm-56-05-05613"><label>245</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name></person-group><article-title>Copper and cuproptosis: New therapeutic approaches for Alzheimer's disease</article-title><source>Front Aging Neurosci</source><volume>15</volume><fpage>1300405</fpage><year>2023</year><pub-id pub-id-type="doi">10.3389/fnagi.2023.1300405</pub-id><pub-id pub-id-type="pmid">38178962</pub-id><pub-id pub-id-type="pmcid">PMC10766373</pub-id></element-citation></ref><ref id="b246-ijmm-56-05-05613"><label>246</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenberg</surname><given-names>BD</given-names></name><name name-style="western"><surname>Carrillo</surname><given-names>MC</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gold</surname><given-names>M</given-names></name><name name-style="western"><surname>Gallagher</surname><given-names>K</given-names></name><name name-style="western"><surname>Grundman</surname><given-names>M</given-names></name><name name-style="western"><surname>Berman</surname><given-names>RM</given-names></name><name name-style="western"><surname>Ashwood</surname><given-names>T</given-names></name><name name-style="western"><surname>Siemers</surname><given-names>ER</given-names></name></person-group><article-title>Improving Alzheimer's disease phase II clinical trials</article-title><source>Alzheimers Dement</source><volume>9</volume><fpage>39</fpage><lpage>49</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.jalz.2012.02.002</pub-id><pub-id pub-id-type="pmid">23164548</pub-id></element-citation></ref><ref id="b247-ijmm-56-05-05613"><label>247</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villemagne</surname><given-names>VL</given-names></name><name name-style="western"><surname>Rowe</surname><given-names>CC</given-names></name><name name-style="western"><surname>Barnham</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Cherny</surname><given-names>R</given-names></name><name name-style="western"><surname>Woodward</surname><given-names>M</given-names></name><name name-style="western"><surname>Bozinosvski</surname><given-names>S</given-names></name><name name-style="western"><surname>Salvado</surname><given-names>O</given-names></name><name name-style="western"><surname>Bourgeat</surname><given-names>P</given-names></name><name name-style="western"><surname>Perez</surname><given-names>K</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>C</given-names></name><etal/></person-group><article-title>A randomized, exploratory molecular imaging study targeting amyloid &#946; with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study</article-title><source>Alzheimers Dement (NY)</source><volume>3</volume><fpage>622</fpage><lpage>635</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.trci.2017.10.001</pub-id><pub-id pub-id-type="pmcid">PMC5702880</pub-id><pub-id pub-id-type="pmid">29201996</pub-id></element-citation></ref><ref id="b248-ijmm-56-05-05613"><label>248</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Squitti</surname><given-names>R</given-names></name><name name-style="western"><surname>Polimanti</surname><given-names>R</given-names></name></person-group><article-title>Copper phenotype in Alzheimer's disease: Dissecting the pathway</article-title><source>Am J Neurodegener Dis</source><volume>2</volume><fpage>46</fpage><lpage>56</lpage><year>2013</year><pub-id pub-id-type="pmid">23844331</pub-id><pub-id pub-id-type="pmcid">PMC3703119</pub-id></element-citation></ref><ref id="b249-ijmm-56-05-05613"><label>249</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drew</surname><given-names>SC</given-names></name></person-group><article-title>The case for abandoning therapeutic chelation of copper ions in Alzheimer's disease</article-title><source>Front Neurosci</source><volume>11</volume><fpage>317</fpage><year>2017</year><pub-id pub-id-type="doi">10.3389/fnins.2017.00317</pub-id><pub-id pub-id-type="pmid">28626387</pub-id><pub-id pub-id-type="pmcid">PMC5455140</pub-id></element-citation></ref><ref id="b250-ijmm-56-05-05613"><label>250</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>SK</given-names></name><name name-style="western"><surname>Balendra</surname><given-names>V</given-names></name><name name-style="western"><surname>Obaid</surname><given-names>AA</given-names></name><name name-style="western"><surname>Esposto</surname><given-names>J</given-names></name><name name-style="western"><surname>Tikhonova</surname><given-names>MA</given-names></name><name name-style="western"><surname>Gautam</surname><given-names>NK</given-names></name><name name-style="western"><surname>Poeggeler</surname><given-names>B</given-names></name></person-group><article-title>Copper-mediated &#946;-amyloid toxicity and its chelation therapy in Alzheimer's disease</article-title><source>Metallomics</source><volume>14</volume><fpage>mfac018</fpage><year>2022</year><pub-id pub-id-type="doi">10.1093/mtomcs/mfac018</pub-id><pub-id pub-id-type="pmid">35333348</pub-id></element-citation></ref><ref id="b251-ijmm-56-05-05613"><label>251</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name><name name-style="western"><surname>Xia</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yan</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Lei</surname><given-names>T</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>G</given-names></name><name name-style="western"><surname>Gao</surname><given-names>H</given-names></name></person-group><article-title>Pathological BBB crossing melanin-like nanoparticles as metal-ion chelators and neuroinflammation regulators against Alzheimer's disease</article-title><source>Research (Wash DC)</source><volume>6</volume><fpage>0180</fpage><year>2023</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.34133/research.0180</pub-id><pub-id pub-id-type="pmcid">PMC10289297</pub-id><pub-id pub-id-type="pmid">37363131</pub-id></element-citation></ref><ref id="b252-ijmm-56-05-05613"><label>252</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>H</given-names></name><name name-style="western"><surname>Han</surname><given-names>M</given-names></name><name name-style="western"><surname>Xue</surname><given-names>J</given-names></name><name name-style="western"><surname>Baek</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chang</surname><given-names>J</given-names></name><name name-style="western"><surname>Hu</surname><given-names>S</given-names></name><name name-style="western"><surname>Nam</surname><given-names>H</given-names></name><name name-style="western"><surname>Jo</surname><given-names>MJ</given-names></name><name name-style="western"><surname>El Fakhri</surname><given-names>G</given-names></name><name name-style="western"><surname>Hutchens</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Renal clearable nanochelators for iron overload therapy</article-title><source>Nat Commun</source><volume>10</volume><fpage>5134</fpage><year>2019</year><pub-id pub-id-type="doi">10.1038/s41467-019-13143-z</pub-id><pub-id pub-id-type="pmid">31723130</pub-id><pub-id pub-id-type="pmcid">PMC6853917</pub-id></element-citation></ref><ref id="b253-ijmm-56-05-05613"><label>253</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dodani</surname><given-names>SC</given-names></name><name name-style="western"><surname>Firl</surname><given-names>A</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J</given-names></name><name name-style="western"><surname>Nam</surname><given-names>CI</given-names></name><name name-style="western"><surname>Aron</surname><given-names>AT</given-names></name><name name-style="western"><surname>Onak</surname><given-names>CS</given-names></name><name name-style="western"><surname>Ramos-Torres</surname><given-names>KM</given-names></name><name name-style="western"><surname>Paek</surname><given-names>J</given-names></name><name name-style="western"><surname>Webster</surname><given-names>CM</given-names></name><name name-style="western"><surname>Feller</surname><given-names>MB</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CJ</given-names></name></person-group><article-title>Copper is an endogenous modulator of neural circuit spontaneous activity</article-title><source>Proc Natl Acad Sci USA</source><volume>111</volume><fpage>16280</fpage><lpage>16285</lpage><year>2014</year><pub-id pub-id-type="doi">10.1073/pnas.1409796111</pub-id><pub-id pub-id-type="pmid">25378701</pub-id><pub-id pub-id-type="pmcid">PMC4246333</pub-id></element-citation></ref><ref id="b254-ijmm-56-05-05613"><label>254</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schlief</surname><given-names>ML</given-names></name><name name-style="western"><surname>Craig</surname><given-names>AM</given-names></name><name name-style="western"><surname>Gitlin</surname><given-names>JD</given-names></name></person-group><article-title>NMDA receptor activation mediates copper homeostasis in hippocampal neurons</article-title><source>J Neurosci</source><volume>25</volume><fpage>239</fpage><lpage>246</lpage><year>2005</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3699-04.2005</pub-id><pub-id pub-id-type="pmid">15634787</pub-id><pub-id pub-id-type="pmcid">PMC6725203</pub-id></element-citation></ref><ref id="b255-ijmm-56-05-05613"><label>255</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>GK</given-names></name><name name-style="western"><surname>Miles</surname><given-names>LA</given-names></name><name name-style="western"><surname>Crespi</surname><given-names>GA</given-names></name><name name-style="western"><surname>Morton</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ng</surname><given-names>HL</given-names></name><name name-style="western"><surname>Barnham</surname><given-names>KJ</given-names></name><name name-style="western"><surname>McKinstry</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Cappai</surname><given-names>R</given-names></name><name name-style="western"><surname>Parker</surname><given-names>MW</given-names></name></person-group><article-title>Copper binding to the Alzheimer's disease amyloid precursor protein</article-title><source>Eur Biophys J</source><volume>37</volume><fpage>269</fpage><lpage>279</lpage><year>2008</year><pub-id pub-id-type="doi">10.1007/s00249-007-0234-3</pub-id><pub-id pub-id-type="pmid">18030462</pub-id><pub-id pub-id-type="pmcid">PMC2921068</pub-id></element-citation></ref><ref id="b256-ijmm-56-05-05613"><label>256</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milton</surname><given-names>B</given-names></name><name name-style="western"><surname>Farrell</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Birkett</surname><given-names>N</given-names></name><name name-style="western"><surname>Krewski</surname><given-names>D</given-names></name></person-group><article-title>Modeling U-Shaped exposure-response relationships for agents that demonstrate toxicity due to both excess and deficiency</article-title><source>Risk Anal</source><volume>37</volume><fpage>265</fpage><lpage>279</lpage><year>2017</year><pub-id pub-id-type="doi">10.1111/risa.12603</pub-id><pub-id pub-id-type="pmid">27043736</pub-id></element-citation></ref><ref id="b257-ijmm-56-05-05613"><label>257</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Song</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title>U-shaped nonlinear relationship between dietary copper intake and peripheral neuropathy</article-title><source>Sci Rep</source><volume>14</volume><fpage>25263</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41598-024-76159-6</pub-id><pub-id pub-id-type="pmid">39448725</pub-id><pub-id pub-id-type="pmcid">PMC11502861</pub-id></element-citation></ref><ref id="b258-ijmm-56-05-05613"><label>258</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chambers</surname><given-names>A</given-names></name><name name-style="western"><surname>Krewski</surname><given-names>D</given-names></name><name name-style="western"><surname>Birkett</surname><given-names>N</given-names></name><name name-style="western"><surname>Plunkett</surname><given-names>L</given-names></name><name name-style="western"><surname>Hertzberg</surname><given-names>R</given-names></name><name name-style="western"><surname>Danzeisen</surname><given-names>R</given-names></name><name name-style="western"><surname>Aggett</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Starr</surname><given-names>TB</given-names></name><name name-style="western"><surname>Baker</surname><given-names>S</given-names></name><name name-style="western"><surname>Dourson</surname><given-names>M</given-names></name><etal/></person-group><article-title>An exposure-response curve for copper excess and deficiency</article-title><source>J Toxicol Environ Health B Crit Rev</source><volume>13</volume><fpage>546</fpage><lpage>578</lpage><year>2010</year><pub-id pub-id-type="doi">10.1080/10937404.2010.538657</pub-id><pub-id pub-id-type="pmid">21170809</pub-id></element-citation></ref><ref id="b259-ijmm-56-05-05613"><label>259</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stern</surname><given-names>BR</given-names></name><name name-style="western"><surname>Solioz</surname><given-names>M</given-names></name><name name-style="western"><surname>Krewski</surname><given-names>D</given-names></name><name name-style="western"><surname>Aggett</surname><given-names>P</given-names></name><name name-style="western"><surname>Aw</surname><given-names>TC</given-names></name><name name-style="western"><surname>Baker</surname><given-names>S</given-names></name><name name-style="western"><surname>Crump</surname><given-names>K</given-names></name><name name-style="western"><surname>Dourson</surname><given-names>M</given-names></name><name name-style="western"><surname>Haber</surname><given-names>L</given-names></name><name name-style="western"><surname>Hertzberg</surname><given-names>R</given-names></name><etal/></person-group><article-title>Copper and human health: Biochemistry, genetics, and strategies for modeling dose-response relationships</article-title><source>J Toxicol Environ Health B Crit Rev</source><volume>10</volume><fpage>157</fpage><lpage>222</lpage><year>2007</year><pub-id pub-id-type="doi">10.1080/10937400600755911</pub-id><pub-id pub-id-type="pmid">17454552</pub-id></element-citation></ref><ref id="b260-ijmm-56-05-05613"><label>260</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name></person-group><article-title>Copper homeostasis and cuproptosis in atherosclerosis: Metabolism, mechanisms and potential therapeutic strategies</article-title><source>Cell Death Discov</source><volume>10</volume><fpage>25</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41420-023-01796-1</pub-id><pub-id pub-id-type="pmid">38218941</pub-id><pub-id pub-id-type="pmcid">PMC10787750</pub-id></element-citation></ref><ref id="b261-ijmm-56-05-05613"><label>261</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Opazo</surname><given-names>CM</given-names></name><name name-style="western"><surname>Greenough</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bush</surname><given-names>AI</given-names></name></person-group><article-title>Copper: From neurotransmission to neuroproteostasis</article-title><source>Front Aging Neurosci</source><volume>6</volume><fpage>143</fpage><year>2014</year><pub-id pub-id-type="doi">10.3389/fnagi.2014.00143</pub-id><pub-id pub-id-type="pmid">25071552</pub-id><pub-id pub-id-type="pmcid">PMC4080678</pub-id></element-citation></ref><ref id="b262-ijmm-56-05-05613"><label>262</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name><name name-style="western"><surname>Ding</surname><given-names>P</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name></person-group><article-title>FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production</article-title><source>Redox Biol</source><volume>75</volume><fpage>103302</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.redox.2024.103302</pub-id><pub-id pub-id-type="pmid">39128228</pub-id><pub-id pub-id-type="pmcid">PMC11366913</pub-id></element-citation></ref><ref id="b263-ijmm-56-05-05613"><label>263</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>F</given-names></name><name name-style="western"><surname>Fan</surname><given-names>X</given-names></name><name name-style="western"><surname>Jin</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name></person-group><article-title>Disulfiram downregulates ferredoxin 1 to maintain copper homeostasis and inhibit inflammation in cerebral ischemia/reperfusion injury</article-title><source>Sci Rep</source><volume>14</volume><fpage>15175</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41598-024-64981-x</pub-id><pub-id pub-id-type="pmid">38956251</pub-id><pub-id pub-id-type="pmcid">PMC11219760</pub-id></element-citation></ref><ref id="b264-ijmm-56-05-05613"><label>264</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nie</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>C</given-names></name></person-group><article-title>Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis</article-title><source>Blood Sci</source><volume>4</volume><fpage>152</fpage><lpage>154</lpage><year>2022</year><pub-id pub-id-type="doi">10.1097/BS9.0000000000000117</pub-id><pub-id pub-id-type="pmid">36518588</pub-id><pub-id pub-id-type="pmcid">PMC9742096</pub-id></element-citation></ref><ref id="b265-ijmm-56-05-05613"><label>265</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joshi</surname><given-names>PR</given-names></name><name name-style="western"><surname>Sadre</surname><given-names>S</given-names></name><name name-style="western"><surname>Guo</surname><given-names>XA</given-names></name><name name-style="western"><surname>McCoy</surname><given-names>JG</given-names></name><name name-style="western"><surname>Mootha</surname><given-names>VK</given-names></name></person-group><article-title>Lipoylation is dependent on the ferredoxin FDX1 and dispensable under hypoxia in human cells</article-title><source>J Biol Chem</source><volume>299</volume><fpage>105075</fpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.jbc.2023.105075</pub-id><pub-id pub-id-type="pmid">37481209</pub-id><pub-id pub-id-type="pmcid">PMC10470009</pub-id></element-citation></ref><ref id="b266-ijmm-56-05-05613"><label>266</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kabin</surname><given-names>E</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><name name-style="western"><surname>Smirnova</surname><given-names>J</given-names></name><name name-style="western"><surname>Smith</surname><given-names>JW</given-names></name><name name-style="western"><surname>Ralle</surname><given-names>M</given-names></name><name name-style="western"><surname>Summers</surname><given-names>K</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Dev</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>&#945;-lipoic acid ameliorates consequences of copper overload by up-regulating selenoproteins and decreasing redox misbalance</article-title><source>Proc Natl Acad Sci USA</source><volume>120</volume><fpage>e2305961120</fpage><year>2023</year><pub-id pub-id-type="doi">10.1073/pnas.2305961120</pub-id><pub-id pub-id-type="pmid">37751556</pub-id><pub-id pub-id-type="pmcid">PMC10556618</pub-id></element-citation></ref><ref id="b267-ijmm-56-05-05613"><label>267</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dieter</surname><given-names>F</given-names></name><name name-style="western"><surname>Esselun</surname><given-names>C</given-names></name><name name-style="western"><surname>Eckert</surname><given-names>GP</given-names></name></person-group><article-title>Redox active &#945;-Lipoic acid differentially improves mitochondrial dysfunction in a cellular model of Alzheimer and its control cells</article-title><source>Int J Mol Sci</source><volume>23</volume><fpage>9186</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/ijms23169186</pub-id><pub-id pub-id-type="pmid">36012451</pub-id><pub-id pub-id-type="pmcid">PMC9409376</pub-id></element-citation></ref><ref id="b268-ijmm-56-05-05613"><label>268</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lin</surname><given-names>C</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lin</surname><given-names>F</given-names></name></person-group><article-title>Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease</article-title><source>Front Aging Neurosci</source><volume>14</volume><fpage>932676</fpage><year>2022</year><pub-id pub-id-type="doi">10.3389/fnagi.2022.932676</pub-id><pub-id pub-id-type="pmid">35966780</pub-id><pub-id pub-id-type="pmcid">PMC9366224</pub-id></element-citation></ref><ref id="b269-ijmm-56-05-05613"><label>269</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qian</surname><given-names>S</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>W</given-names></name></person-group><article-title>Unravelling the complex interplay of cuproptosis, lncRNAs, and immune infiltration in Alzheimer's disease: A step towards novel therapeutic targets</article-title><source>Ann Hum Biol</source><volume>51</volume><fpage>2342531</fpage><year>2024</year><pub-id pub-id-type="doi">10.1080/03014460.2024.2342531</pub-id><pub-id pub-id-type="pmid">38771661</pub-id></element-citation></ref><ref id="b270-ijmm-56-05-05613"><label>270</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stremmel</surname><given-names>W</given-names></name></person-group><article-title>Bis-choline tetrathiomolybdate as old drug in a new design for Wilson's disease: Good for brain and liver?</article-title><source>Hepatology</source><volume>69</volume><fpage>901</fpage><lpage>903</lpage><year>2019</year><pub-id pub-id-type="doi">10.1002/hep.30130</pub-id><pub-id pub-id-type="pmid">30070374</pub-id><pub-id pub-id-type="pmcid">PMC6590651</pub-id></element-citation></ref><ref id="b271-ijmm-56-05-05613"><label>271</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>BS</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name></person-group><article-title>Copper transport to the brain by the blood-brain barrier and blood-CSF barrier</article-title><source>Brain Res</source><volume>1248</volume><fpage>14</fpage><lpage>21</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.brainres.2008.10.056</pub-id><pub-id pub-id-type="pmid">19014916</pub-id><pub-id pub-id-type="pmcid">PMC2677986</pub-id></element-citation></ref><ref id="b272-ijmm-56-05-05613"><label>272</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borchard</surname><given-names>S</given-names></name><name name-style="western"><surname>Raschke</surname><given-names>S</given-names></name><name name-style="western"><surname>Zak</surname><given-names>KM</given-names></name><name name-style="western"><surname>Eberhagen</surname><given-names>C</given-names></name><name name-style="western"><surname>Einer</surname><given-names>C</given-names></name><name name-style="western"><surname>Weber</surname><given-names>E</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>SM</given-names></name><name name-style="western"><surname>Michalke</surname><given-names>B</given-names></name><name name-style="western"><surname>Lichtmannegger</surname><given-names>J</given-names></name><name name-style="western"><surname>Wieser</surname><given-names>A</given-names></name><etal/></person-group><article-title>Bis-choline tetrathiomolybdate prevents copper-induced blood-brain barrier damage</article-title><source>Life Sci Alliance</source><volume>5</volume><fpage>e202101164</fpage><year>2021</year><pub-id pub-id-type="doi">10.26508/lsa.202101164</pub-id><pub-id pub-id-type="pmid">34857647</pub-id><pub-id pub-id-type="pmcid">PMC8675913</pub-id></element-citation></ref><ref id="b273-ijmm-56-05-05613"><label>273</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>H</given-names></name><name name-style="western"><surname>Du</surname><given-names>B</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name></person-group><article-title>Nanoscale drug formulations for the treatment of Alzheimer's disease progression</article-title><source>RSC Adv</source><volume>15</volume><fpage>4031</fpage><lpage>4078</lpage><year>2025</year><pub-id pub-id-type="doi">10.1039/D4RA08128E</pub-id><pub-id pub-id-type="pmid">39926227</pub-id><pub-id pub-id-type="pmcid">PMC11803502</pub-id></element-citation></ref><ref id="b274-ijmm-56-05-05613"><label>274</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Park</surname><given-names>JH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Nam</surname><given-names>JM</given-names></name></person-group><article-title>How do the size, charge and shape of nanoparticles affect amyloid &#946; aggregation on brain lipid bilayer?</article-title><source>Sci Rep</source><volume>6</volume><fpage>19548</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/srep19548</pub-id><pub-id pub-id-type="pmid">26782664</pub-id><pub-id pub-id-type="pmcid">PMC4726094</pub-id></element-citation></ref><ref id="b275-ijmm-56-05-05613"><label>275</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Robert</surname><given-names>A</given-names></name><name name-style="western"><surname>Meunier</surname><given-names>B</given-names></name></person-group><article-title>The specific copper(II) Chelator TDMQ20 is efficient for the treatment of Wilson's disease in mice</article-title><source>Pharmaceutics</source><volume>15</volume><fpage>2719</fpage><year>2023</year><pub-id pub-id-type="doi">10.3390/pharmaceutics15122719</pub-id><pub-id pub-id-type="pmid">38140060</pub-id><pub-id pub-id-type="pmcid">PMC10747306</pub-id></element-citation></ref><ref id="b276-ijmm-56-05-05613"><label>276</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>P</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J</given-names></name><name name-style="western"><surname>Qu</surname><given-names>X</given-names></name></person-group><article-title>Gold nanocage-based dual responsive 'caged metal chelator' release system: Noninvasive remote control with near infrared for potential treatment of Alzheimer's disease</article-title><source>Adv Funct Mater</source><volume>23</volume><fpage>5412</fpage><lpage>5419</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/adfm.201301015</pub-id></element-citation></ref><ref id="b277-ijmm-56-05-05613"><label>277</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andreozzi</surname><given-names>EM</given-names></name><name name-style="western"><surname>Torres</surname><given-names>JB</given-names></name><name name-style="western"><surname>Sunassee</surname><given-names>K</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>J</given-names></name><name name-style="western"><surname>Walker-Samuel</surname><given-names>S</given-names></name><name name-style="western"><surname>Szanda</surname><given-names>I</given-names></name><name name-style="western"><surname>Blower</surname><given-names>PJ</given-names></name></person-group><article-title>Studies of copper trafficking in a mouse model of Alzheimer's disease by positron emission tomography: comparison of 64Cu acetate and 64CuGTSM</article-title><source>Metallomics</source><volume>9</volume><fpage>1622</fpage><lpage>1633</lpage><year>2017</year><pub-id pub-id-type="doi">10.1039/C7MT00227K</pub-id><pub-id pub-id-type="pmid">29063080</pub-id><pub-id pub-id-type="pmcid">PMC6205627</pub-id></element-citation></ref><ref id="b278-ijmm-56-05-05613"><label>278</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hartard</surname><given-names>C</given-names></name><name name-style="western"><surname>Weisner</surname><given-names>B</given-names></name><name name-style="western"><surname>Dieu</surname><given-names>C</given-names></name><name name-style="western"><surname>Kunze</surname><given-names>K</given-names></name></person-group><article-title>Wilson's disease with cerebral manifestation: Monitoring therapy by CSF copper concentration</article-title><source>J Neurol</source><volume>241</volume><fpage>101</fpage><lpage>107</lpage><year>1993</year><pub-id pub-id-type="doi">10.1007/BF00869772</pub-id><pub-id pub-id-type="pmid">8138824</pub-id></element-citation></ref><ref id="b279-ijmm-56-05-05613"><label>279</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torres</surname><given-names>JB</given-names></name><name name-style="western"><surname>Andreozzi</surname><given-names>EM</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>JT</given-names></name><name name-style="western"><surname>Siddique</surname><given-names>M</given-names></name><name name-style="western"><surname>Szanda</surname><given-names>I</given-names></name><name name-style="western"><surname>Howlett</surname><given-names>DR</given-names></name><name name-style="western"><surname>Sunassee</surname><given-names>K</given-names></name><name name-style="western"><surname>Blower</surname><given-names>PJ</given-names></name></person-group><article-title>PET imaging of copper trafficking in a mouse model of Alzheimer disease</article-title><source>J Nucl Med</source><volume>57</volume><fpage>109</fpage><lpage>114</lpage><year>2016</year><pub-id pub-id-type="doi">10.2967/jnumed.115.162370</pub-id><pub-id pub-id-type="pmid">26449834</pub-id><pub-id pub-id-type="pmcid">PMC6207347</pub-id></element-citation></ref><ref id="b280-ijmm-56-05-05613"><label>280</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>F</given-names></name><name name-style="western"><surname>Xie</surname><given-names>F</given-names></name><name name-style="western"><surname>Muzik</surname><given-names>O</given-names></name></person-group><article-title>Alteration of copper fluxes in brain aging: A longitudinal study in rodent using (64)CuCl(2)-PET/CT</article-title><source>Aging Dis</source><volume>9</volume><fpage>109</fpage><lpage>118</lpage><year>2018</year><pub-id pub-id-type="doi">10.14336/AD.2017.1025</pub-id><pub-id pub-id-type="pmid">29392086</pub-id><pub-id pub-id-type="pmcid">PMC5772849</pub-id></element-citation></ref><ref id="b281-ijmm-56-05-05613"><label>281</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohr</surname><given-names>I</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>KH</given-names></name></person-group><article-title>Biochemical markers for the diagnosis and monitoring of Wilson disease</article-title><source>Clin Biochem Rev</source><volume>40</volume><fpage>59</fpage><lpage>77</lpage><year>2019</year><pub-id pub-id-type="doi">10.33176/AACB-18-00014</pub-id><pub-id pub-id-type="pmid">31205375</pub-id><pub-id pub-id-type="pmcid">PMC6544250</pub-id></element-citation></ref><ref id="b282-ijmm-56-05-05613"><label>282</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>White</surname><given-names>C</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>TS</given-names></name><name name-style="western"><surname>Bush</surname><given-names>AI</given-names></name><name name-style="western"><surname>Sun</surname><given-names>GY</given-names></name><name name-style="western"><surname>Weisman</surname><given-names>GA</given-names></name><name name-style="western"><surname>Petris</surname><given-names>MJ</given-names></name></person-group><article-title>Altered microglial copper homeostasis in a mouse model of Alzheimer's disease</article-title><source>J Neurochem</source><volume>114</volume><fpage>1630</fpage><lpage>1638</lpage><year>2010</year><pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06888.x</pub-id><pub-id pub-id-type="pmid">20626553</pub-id><pub-id pub-id-type="pmcid">PMC2945454</pub-id></element-citation></ref><ref id="b283-ijmm-56-05-05613"><label>283</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pyun</surname><given-names>J</given-names></name><name name-style="western"><surname>McInnes</surname><given-names>LE</given-names></name><name name-style="western"><surname>Donnelly</surname><given-names>PS</given-names></name><name name-style="western"><surname>Mawal</surname><given-names>C</given-names></name><name name-style="western"><surname>Bush</surname><given-names>AI</given-names></name><name name-style="western"><surname>Short</surname><given-names>JL</given-names></name><name name-style="western"><surname>Nicolazzo</surname><given-names>JA</given-names></name></person-group><article-title>Copper bis(thiosemicarbazone) complexes modulate P-glycoprotein expression and function in human brain microvascular endothelial cells</article-title><source>J Neurochem</source><volume>162</volume><fpage>226</fpage><lpage>244</lpage><year>2022</year><pub-id pub-id-type="doi">10.1111/jnc.15609</pub-id><pub-id pub-id-type="pmid">35304760</pub-id><pub-id pub-id-type="pmcid">PMC9540023</pub-id></element-citation></ref><ref id="b284-ijmm-56-05-05613"><label>284</label><element-citation publication-type="journal"><article-title>Erratum to: Flavonoids as an intervention for Alzheimer's disease: Progress and hurdles towards defining a mechanism of action</article-title><source>Brain Plast</source><volume>9</volume><fpage>97</fpage><year>2024</year><pub-id pub-id-type="doi">10.3233/BPL-239000</pub-id><pub-id pub-id-type="pmid">38993578</pub-id><pub-id pub-id-type="pmcid">PMC11234686</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="f1-ijmm-56-05-05613" orientation="portrait"><label>Figure 1</label><caption><p>Copper absorption and transport. Dietary copper is primarily absorbed in the duodenum and proximal small intestine via the CTR1 transporter, following reduction of Cu<sup>2+</sup> to Cu<sup>+</sup> by STEAP and DCYTB. Once absorbed, copper is either stored in intestinal cells by metallothioneins or transported to the liver via ATP7A. In the liver, copper is distributed and stored, with any excess excreted through bile. This process ensures systemic copper homeostasis and bioavailability. CP, ceruloplasmin; CTR1, copper transporter 1; DCYTB, duodenal cytochrome B; HIS, histidine; HSA, human serum albumin; MG, metal group; MT, metallothionein; STEAP, six-transmembrane epithelial antigen of the prostate.</p></caption><graphic position="float" orientation="portrait" xlink:href="ijmm-56-05-05613-g00.jpg"/></fig><fig position="float" id="f2-ijmm-56-05-05613" orientation="portrait"><label>Figure 2</label><caption><p>Mechanism of cuproptosis in neurons. Excessive copper [Cu<sup>2+</sup>] is transported into cells via elesclomol. The accumulation of Cu<sup>2+</sup> disrupts Fe-S cluster proteins and lipoic acid-dependent enzymes such as DLAT. Copper-induced stress depletes GSH, an antioxidant that protects cells from oxidative damage. Additionally, some extracellular Cu<sup>2+</sup> is reduced to Cu<sup>+</sup> by metalloreductases and transported into cells via CTR1. This Cu<sup>+</sup> in mitochondria can directly trigger cuproptosis. Cu<sup>+</sup>/Cu<sup>2+</sup>, reduced/oxidized copper ion; CTR1, copper transporter 1; DLAT, dihydrolipoamide S-acetyltransferase; FDX1, ferredoxin 1; Fe-S, iron-sulfur; GSH, glutathione; LA, lipoic acid; LIAS, lipoic acid synthase; MT, metallothionein.</p></caption><graphic position="float" orientation="portrait" xlink:href="ijmm-56-05-05613-g01.jpg"/></fig><fig position="float" id="f3-ijmm-56-05-05613" orientation="portrait"><label>Figure 3</label><caption><p>Copper dyshomeostasis and its dual impact on AD. Both copper excess and deficiency contribute to AD pathogenesis. Copper overload induces A&#946; aggregation, Tau phosphorylation, oxidative stress (via the Fenton reaction) and neuroinflammation with neuronal loss. Conversely, copper deficiency reduces antioxidant enzymes (such as SOD, CP and LOX) and Cox activity, leading to impaired mitochondrial function and elevated ROS levels. These disruptions in copper homeostasis accelerate neurodegeneration. A&#946;, amyloid-&#946;; AD, Alzheimer's disease; CP, ceruloplasmin; Cox, cyclooxygenase; CTR1, copper transporter 1; DLAT, dihydrolipoamide S-acetyltransferase; Fe-S, iron-sulfur; LOX, lysyl oxidase; ROS, reactive oxygen species; SOD, superoxide dismutase; STEAP, six-transmembrane epithelial antigen of the prostate.</p></caption><graphic position="float" orientation="portrait" xlink:href="ijmm-56-05-05613-g02.jpg"/></fig><table-wrap position="float" id="tI-ijmm-56-05-05613" orientation="portrait"><label>Table I</label><caption><p>Summary of the effects of copper on Alzheimer's disease.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="6" valign="top" align="left" rowspan="1">A, <italic toggle="yes">In vitro</italic>
<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Authors, year</th><th valign="top" align="center" rowspan="1" colspan="1">Experimental model</th><th valign="top" align="center" rowspan="1" colspan="1">Dose and route</th><th valign="top" align="center" rowspan="1" colspan="1">Duration</th><th valign="top" align="center" rowspan="1" colspan="1">Findings and pathological features</th><th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Pilozzi <italic toggle="yes">et al</italic>, 2020</td><td valign="top" align="left" rowspan="1" colspan="1">SH-SY5Y neuroblastoma cells</td><td valign="top" align="left" rowspan="1" colspan="1">CuCl<sub>2</sub> (0.01, 0.1 and 1 <italic toggle="yes">&#956;</italic>M) in culture medium</td><td valign="top" align="left" rowspan="1" colspan="1">48 h</td><td valign="top" align="left" rowspan="1" colspan="1">A&#946; oligomerization &#8593;; APP translation &#8593;; APP protein expression &#8593;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b87-ijmm-56-05-05613" ref-type="bibr">87</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kitazawa <italic toggle="yes">et al</italic>, 2009</td><td valign="top" align="left" rowspan="1" colspan="1">SH-SY5Y neuroblastoma cells</td><td valign="top" align="left" rowspan="1" colspan="1">Copper exposure (10 <italic toggle="yes">&#956;</italic>M to 1 mM in culture medium)</td><td valign="top" align="left" rowspan="1" colspan="1">24 h</td><td valign="top" align="left" rowspan="1" colspan="1">APP protein levels &#8593; (dose-dependent; &#8804;0.1 mM); APP protein levels &#8595; (at 1 mM; due to toxicity); no change in APP mRNA levels</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b88-ijmm-56-05-05613" ref-type="bibr">88</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Crouch <italic toggle="yes">et al</italic>, 2009</td><td valign="top" align="left" rowspan="1" colspan="1">SH-SY5Y neuroblastoma cells</td><td valign="top" align="left" rowspan="1" colspan="1">Cu<sup>2+</sup>(gtsm) and Cu<sup>2+</sup> (atsm) (25 <italic toggle="yes">&#956;</italic>M in culture medium)</td><td valign="top" align="left" rowspan="1" colspan="1">5 h</td><td valign="top" align="left" rowspan="1" colspan="1">GSK3&#946; inhibition &#8593;; Tau phosphorylation &#8595;; A&#946; oligomer levels &#8595;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b89-ijmm-56-05-05613" ref-type="bibr">89</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Xia <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">SH-SY5Y neuroblastoma cells</td><td valign="top" align="left" rowspan="1" colspan="1">A&#946;1-42 fibrils (1-5 <italic toggle="yes">&#956;</italic>M) in culture medium</td><td valign="top" align="left" rowspan="1" colspan="1">24 h</td><td valign="top" align="left" rowspan="1" colspan="1">Cu<sup>2+</sup> &#8595;; Cu<sup>+</sup> &#8593; (mitochondria and lysosomes); ROS &#8593;; mitochondrial damage &#8593;; GSH &#8595;; autophagy &#8593;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b90-ijmm-56-05-05613" ref-type="bibr">90</xref>)</td></tr><tr><td colspan="6" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="6" valign="top" align="left" rowspan="1">B, <italic toggle="yes">In vivo</italic></td></tr><tr><td colspan="6" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Authors, year</td><td valign="top" align="center" rowspan="1" colspan="1">Experimental model</td><td valign="top" align="center" rowspan="1" colspan="1">Dose and route</td><td valign="top" align="center" rowspan="1" colspan="1">Duration</td><td valign="top" align="center" rowspan="1" colspan="1">Findings and pathological features</td><td valign="top" align="center" rowspan="1" colspan="1">(Refs.)</td></tr><tr><td colspan="6" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hua <italic toggle="yes">et al</italic>, 2011</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Drosophila</italic> (fruit flies)</td><td valign="top" align="left" rowspan="1" colspan="1">Dietary copper supplementation (concentration not specified)</td><td valign="top" align="left" rowspan="1" colspan="1">Lifespan</td><td valign="top" align="left" rowspan="1" colspan="1">Copper exacerbates A&#946;42-induced eye damage; copper chelators or metallothioneins ameliorate neurodegeneration</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b91-ijmm-56-05-05613" ref-type="bibr">91</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pilozzi <italic toggle="yes">et al</italic>, 2020</td><td valign="top" align="left" rowspan="1" colspan="1">APP/PS1 transgenic mice</td><td valign="top" align="left" rowspan="1" colspan="1">Dietary copper supplementation (300 mg Cu/kg)</td><td valign="top" align="left" rowspan="1" colspan="1">24 days</td><td valign="top" align="left" rowspan="1" colspan="1">A&#946;1-40 and A&#946;1-42 levels &#8593;; A&#946; plaque area &#8593;; astrogliosis (GFAP) &#8593;; pro-inflammatory cytokines (MCP-5) &#8593;; spatial working memory and short-term memory &#8595;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b87-ijmm-56-05-05613" ref-type="bibr">87</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kitazawa <italic toggle="yes">et al</italic>, 2009</td><td valign="top" align="left" rowspan="1" colspan="1">3xTg-AD mice</td><td valign="top" align="left" rowspan="1" colspan="1">250 ppm CuSO<sub>4</sub> in drinking water (with 5% sucrose)</td><td valign="top" align="left" rowspan="1" colspan="1">3 months</td><td valign="top" align="left" rowspan="1" colspan="1">APP and C99 levels &#8593;; A&#946;40 levels &#8593;; BACE1 expression &#8593;; AT8-positive neurons in CA1 &#8593;; slight increase in tau phosphorylation</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b88-ijmm-56-05-05613" ref-type="bibr">88</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kitazawa <italic toggle="yes">et al</italic>, 2009</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">9 months</td><td valign="top" align="left" rowspan="1" colspan="1">APP, C99 and C83 levels &#8593;; A&#946;40 and A&#946;42 levels &#8593;; BACE1 and ADAM10 expression &#8593;; marked increase in tau phosphorylation (AT8, AT180 and PHF-1 &#8593;); cdk5/p25 activation &#8593;</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yu <italic toggle="yes">et al</italic>, 2015</td><td valign="top" align="left" rowspan="1" colspan="1">3xTg-AD mice</td><td valign="top" align="left" rowspan="1" colspan="1">250 ppm copper sulfate in drinking water</td><td valign="top" align="left" rowspan="1" colspan="1">6 months</td><td valign="top" align="left" rowspan="1" colspan="1">Memory impairment &#8593;; hippocampal protein expression altered (44 proteins differentially expressed); complexin-1 and complexin-2 &#8595; (key memory-associated proteins)</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b92-ijmm-56-05-05613" ref-type="bibr">92</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sparks and Schreurs, 2003</td><td valign="top" align="left" rowspan="1" colspan="1">Cholesterol-fed rabbits</td><td valign="top" align="left" rowspan="1" colspan="1">0.12 ppm copper sulfate in drinking water</td><td valign="top" align="left" rowspan="1" colspan="1">10 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">A&#946; accumulation &#8593;; senile plaque-like structures &#8593; (hippocampus and temporal lobe); learning deficits &#8593; (trace conditioning task); SOD activity &#8593;; GPX activity &#8595;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b93-ijmm-56-05-05613" ref-type="bibr">93</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sparks <italic toggle="yes">et al</italic>, 2006</td><td valign="top" align="left" rowspan="1" colspan="1">PS1/APP transgenic mice</td><td valign="top" align="left" rowspan="1" colspan="1">0.12 ppm copper sulfate in drinking water</td><td valign="top" align="left" rowspan="1" colspan="1">6 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">A&#946; deposition &#8593; (similar plaque number but larger plaque size in copper-treated mice); distilled water reduces plaque size</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b94-ijmm-56-05-05613" ref-type="bibr">94</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Crouch <italic toggle="yes">et al</italic>, 2009</td><td valign="top" align="left" rowspan="1" colspan="1">APP/PS1 transgenic mice</td><td valign="top" align="left" rowspan="1" colspan="1">Cu<sup>2+</sup>(gtsm) (10 mg/kg; daily gavage)</td><td valign="top" align="left" rowspan="1" colspan="1">6 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">Cognitive performance &#8593; (Y-maze test); A&#946; trimer levels &#8595;; Tau phosphorylation &#8595;; GSK3&#946; inhibition &#8593; (via Akt activation)</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b89-ijmm-56-05-05613" ref-type="bibr">89</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Xia <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">5xFAD transgenic mice</td><td valign="top" align="left" rowspan="1" colspan="1">Endogenous A&#946; accumulation (geneticmodel)</td><td valign="top" align="left" rowspan="1" colspan="1">12 months</td><td valign="top" align="left" rowspan="1" colspan="1">Cu<sup>2+</sup> &#8595;; Cu<sup>+</sup> &#8593; (brain tissue); A&#946; plaques &#8593;; mitochondrial dysfunction &#8593;; Cu transport genes (ATP7A/B) &#8593;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b90-ijmm-56-05-05613" ref-type="bibr">90</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prohaska and Brokate, 1999</td><td valign="top" align="left" rowspan="1" colspan="1">Sprague-Dawley and Holtzman rats</td><td valign="top" align="left" rowspan="1" colspan="1">Cu-deficient or Cu-adequate diet and water</td><td valign="top" align="left" rowspan="1" colspan="1">4 weeks (postweanling); perinatal exposure</td><td valign="top" align="left" rowspan="1" colspan="1">Cu deficiency: DBH activity and mRNA &#8593;; norepinephrine &#8595;; dopamine &#8593;; Cu repletion restored DBH mRNA levels</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b95-ijmm-56-05-05613" ref-type="bibr">95</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ijmm-56-05-05613"><p>3xTg-AD, triple transgenic Alzheimer's disease mouse model; 5xFAD, five familial Alzheimer's disease mutations mouse model; A&#946;, amyloid-&#946;; ADAM10, ADAM metallopeptidase domain 10; APP, amyloid precursor protein; BACE1, &#946;-site APP cleaving enzyme 1; Cu<sup>+</sup>, cuprous ion; Cu<sup>2+</sup>, cupric ion; Cu<sup>2+</sup>(gtsm), copper<sup>2+</sup>-glyoxalbis(N4-methylthiosemicarbazonato); Cu<sup>2+</sup>(atsm), copper<sup>2+</sup> diacetylbis(N4-methylthiosemicarbazone); DBH, dopamine &#946;-hydroxylase; GFAP, glial fibrillary acidic protein; GSH, glutathione; GPX, glutathione peroxidase; MCP-5, monocyte chemoattractant protein-5; PHF-1, paired helical filament-1; PS1, presenilin 1; ROS, reactive oxygen species; SOD, superoxide dismutase.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tII-ijmm-56-05-05613" orientation="portrait"><label>Table II</label><caption><p>Dysfunction of cuproenzymes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Authors, year</th><th valign="top" align="center" rowspan="1" colspan="1">Protein</th><th valign="top" align="center" rowspan="1" colspan="1">Role in AD</th><th valign="top" align="center" rowspan="1" colspan="1">Copper interaction and effects</th><th valign="top" align="center" rowspan="1" colspan="1">Pathological consequences</th><th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gu <italic toggle="yes">et al</italic>, 2023; Trist <italic toggle="yes">et al</italic>, 2021; Furukawa <italic toggle="yes">et al</italic>, 2004</td><td valign="top" align="left" rowspan="1" colspan="1">Cu/Zn-SOD1</td><td valign="top" align="left" rowspan="1" colspan="1">Antioxidant enzyme that detoxifies superoxide radicals</td><td valign="top" align="left" rowspan="1" colspan="1">Cu<sup>+</sup> is essential for Cu/Zn-SOD1 activity; copper deficiency reduces Cu/Zn-superoxide dismutase 1 activity; oxidative stress can cause misfolding and aggregation</td><td valign="top" align="left" rowspan="1" colspan="1">Oxidative stress &#8593;, neuronal damage &#8593; and aggregation-related toxicity &#8593;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b113-ijmm-56-05-05613" ref-type="bibr">113</xref>-<xref rid="b115-ijmm-56-05-05613" ref-type="bibr">115</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Saporito-Magri&#241;&#225; <italic toggle="yes">et al</italic>, 2018; Ribas <italic toggle="yes">et al</italic>, 2014</td><td valign="top" align="left" rowspan="1" colspan="1">GSH</td><td valign="top" align="left" rowspan="1" colspan="1">Major antioxidant that protects cells from oxidative stress</td><td valign="top" align="left" rowspan="1" colspan="1">Cu<sup>+</sup> binds to GSH, forming a Cu<sup>+</sup>-GSH complex, leading to GSH depletion and impaired redox homeostasis</td><td valign="top" align="left" rowspan="1" colspan="1">Antioxidant capacity &#8595;, oxidative stress &#8593; and cellular damage &#8593;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b165-ijmm-56-05-05613" ref-type="bibr">165</xref>,<xref rid="b166-ijmm-56-05-05613" ref-type="bibr">166</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zhu <italic toggle="yes">et al</italic>, 2024; Yang <italic toggle="yes">et al</italic>, 2024; Ruiz <italic toggle="yes">et al</italic>, 2021; Crouch <italic toggle="yes">et al</italic>, 2005</td><td valign="top" align="left" rowspan="1" colspan="1">CCO</td><td valign="top" align="left" rowspan="1" colspan="1">Mitochondrial enzyme crucial for electron transport and ATP production</td><td valign="top" align="left" rowspan="1" colspan="1">Cu<sup>+</sup> is directly utilized by COX, while Cu<sup>2+</sup> delivers copper; excessive Cu<sup>+</sup> disrupts mitochondrial function via oxidative stress</td><td valign="top" align="left" rowspan="1" colspan="1">Energy metabolism impaired and mitochondrial dysfunction &#8593;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b8-ijmm-56-05-05613" ref-type="bibr">8</xref>,<xref rid="b50-ijmm-56-05-05613" ref-type="bibr">50</xref>,<xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>,<xref rid="b167-ijmm-56-05-05613" ref-type="bibr">167</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Okita <italic toggle="yes">et al</italic>, 2017; Xu <italic toggle="yes">et al</italic>, 2017</td><td valign="top" align="left" rowspan="1" colspan="1">MTs</td><td valign="top" align="left" rowspan="1" colspan="1">Metal-binding proteins that detoxify excess metals and reduce oxidative stress</td><td valign="top" align="left" rowspan="1" colspan="1">Cu<sup>+</sup> binds to MTs with high affinity; however, excessive copper overwhelms MT capacity, impairing detoxification</td><td valign="top" align="left" rowspan="1" colspan="1">Oxidative stress &#8593;, metal toxicity &#8593; and metal homeostasis is dysregulated</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b168-ijmm-56-05-05613" ref-type="bibr">168</xref>,<xref rid="b169-ijmm-56-05-05613" ref-type="bibr">169</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ruiz <italic toggle="yes">et al</italic>, 2021; Garza <italic toggle="yes">et al</italic>, 2023; Rossi <italic toggle="yes">et al</italic>, 1998</td><td valign="top" align="left" rowspan="1" colspan="1">CCO</td><td valign="top" align="left" rowspan="1" colspan="1">Mitochondrial enzyme crucial for electron transport and ATP production</td><td valign="top" align="left" rowspan="1" colspan="1">Copper is a critical cofactor for CCO, and is required for its proper function in the electron transport chain</td><td valign="top" align="left" rowspan="1" colspan="1">Copper deficiency impairs CCO activity, leading to energy metabolism &#8595;, mitochondrial dysfunction &#8593; and neurological deficits</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b70-ijmm-56-05-05613" ref-type="bibr">70</xref>,<xref rid="b153-ijmm-56-05-05613" ref-type="bibr">153</xref>,<xref rid="b170-ijmm-56-05-05613" ref-type="bibr">170</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rahman <italic toggle="yes">et al</italic>, 2009; Xiao <italic toggle="yes">et al</italic>, 2018</td><td valign="top" align="left" rowspan="1" colspan="1">Neurotransmitter synthesis enzymes</td><td valign="top" align="left" rowspan="1" colspan="1">Enzymes (such as dopamine &#946;-hydroxylase) that synthesize neurotransmitters</td><td valign="top" align="left" rowspan="1" colspan="1">Copper is a cofactor for these enzymes, and its deficiency reduces their activity, impairing neurotransmitter synthesis</td><td valign="top" align="left" rowspan="1" colspan="1">Neurotransmitter (such as dopamine and norepinephrine) levels &#8595;, leading to synaptic dysfunction and cognitive deficits</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b108-ijmm-56-05-05613" ref-type="bibr">108</xref>,<xref rid="b109-ijmm-56-05-05613" ref-type="bibr">109</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-ijmm-56-05-05613"><p>AD, Alzheimer's disease; Cu/Zn-SOD1, copper/zinc superoxide dismutase 1; SOD1, superoxide dismutase 1; Cu<sup>+</sup>, cuprous ion (reduced copper ion); Cu<sup>2+</sup>, cupric ion (oxidized copper ion); GSH, glutathione; CCO, cytochrome c oxidase; COX, cyclooxygenase; MTs, metallothioneins.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>